ࡱ>  q` R<bjbjqPqPn::s&&&&&&&&&8&g ^ "0 0 0   \)0@BBBBBB$hfY& " f&&0 0 }Tx0x0x0t&0 &0 @x0@x0x0W&&V\0   ` #Y8fLTgZT%x pV\V\v&_Y7 x0CYYYff 0XYYYg&&+l\&&+&&&&&&&&& Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.q\qge兡N gPlQSShandong Xinhua Pharmaceutical Company Limiteda joint stock company established in the People s Republic of China with limited liability Stock Code: 0719 2012 INTERIM RESULTS ANNOUNCEMENTThe board of directors (the  Board ) and directors (Directors) of Shandong Xinhua Pharmaceutical Company Limited (the Company or Xinhua Pharm) hereby announce the unaudited consolidated results of the Company and its subsidiaries (the Group) for the half year ended 30 June 2012 (the Reporting Period). The following financial information has been prepared in accordance with Hong Kong Generally Accepted Accounting Principles (HKGAAP) and PRC accounting standards. This results announcement (the Announcement) is summarised from the Companys 2012 interim report (the Interim Report) and investors are advised to read the full text of the Interim Report for full information. The Announcement is published in Chinese and English. The Chinese version shall prevail if there are discrepancies between the Chinese version and the English version. I. COMPANY INFORMATIONChinese Name of the Company : q\qge兡N gPlQSEnglish Name of the Company: SHANDONG XINHUA PHARMACEUTICALCOMPANY LIMITEDLegal Representative: Mr. Zhang DaimingCompany Secretaries: Mr. Cao Changqiu, Ms. Guo LeiTelephone Number: 86-533-2196024Facsimile Number: 86-533-2287508E-mail Address of Company Secretaries: cqcao@xhzy.com, H HYPERLINK "mailto:guolei@xhzy.com" guolei@xhzy.comRegistered Address: Chemical Industry Area of Zibo Hi-tech Industry Development Zone, Zibo City, Shandong Province, the Peoples Republic of China (the PRC)Office Address: No. 1 Lutai Ave., Hi-tech Industry Development Zone, Zibo City, Shandong Province, the PRCPostal Code: 255086Website of the Company: H HYPERLINK "" E-mail Address of the Company: H HYPERLINK "mailto:xhzy@xhzy.com" Uxhzy@xhzy.comUPRC newspaper for information disclosure: Securities TimesWebsite designated by the China Securities Regulatory Commission (the CSRC): H HYPERLINK "http://www.cninfo.com.cn" http://www.cninfo.com.cnListing InformationH SharesStock Exchange: The Stock Exchange of Hong Kong Limited (the SEHK)Abbreviated Name: Shandong XinhuaStock Code: 0719A SharesStock Exchange: Shenzhen Stock ExchangeAbbreviated Name: Xinhua PharmStock Code: 000756a!. SUMMARY OF FINANCIAL RESULTS(i) In accordance with PRC accounting standards (RMB)ItemAs at 30 June 2012(Unaudited)As at 31 December 2011 (the  End of Last Year )(Audited)Change as compared to the End of Last Year (%)Total assets3,398,464,127.003,004,190,190.6813.12Total equity attributable to equity holders of Company1,740,887,172.031,709,932,330.071.81Capital457,312,830.00457,312,830.00-Net assets per share attributable to equity holders of Company3.813.741.87Asset-liability ratio (%)47.5541.76Increase 5.79 pointsSix months ended 30 June 2012(Unaudited)Six months ended 30 June 2011 (the Same Period Last Year)(Unaudited)Change as compared to the Same Period Last Year (%)Total operating income1,537,930,023.231,522,811,524.540.99Operating profit25,524,759.0479,496,686.58(67.89)Profit before taxation40,002,473.6577,517,940.76(48.40)Profit attributable to the equity holders of Company31,195,182.8260,702,135.83(48.61)Profit attributable to the equity holders of Company after extraordinary items (Note)18,012,640.7460,845,003.76(70.40)Basic earnings per share 0.070.13(46.50)Diluted earnings per share 0.070.13(46.15)Return on equity of weighted average (%)1.813.56Decrease 1.75 pointsReturn on equity of weighted average after extraordinary loss (%)1.043.56Decrease 2.52 pointsNet cash flow from operating activities(42,186,834.32)27,512,297.58(253.34)Net cash flow from operating activities per share (0.09)0.06(250.00)Note:Extraordinary items include:ItemAmount (RMB)Notes (if applicable)Profit or loss from disposal of non-current assets(6,299,924.27)Loss of disposal of fixed assetsGovernment subsidies recognised in current profit and loss, (excluding those closely related to the Companys normal operations and granted on an ongoing basis under the national policies according to certain fixed quota of amount or volume)22,103,692.89Received government subsidies reckoned into current termGains (losses) from fair value changes of trading financial assets and trading financial liabilities, and investment income from disposal of trading financial assets, trading financial liabilities and available-for-sale financial assets, except effective hedging activities related to the Companys normal operations2,571,920.00Dividends from available-for-sale financial assetsOther non-operating income or cost except the above items(1,326,054.01)-Non-controlling interests(1,363.19)-Income tax expense(3,865,729.34)-Total13,182,542.08-(ii) In accordance with HKGAAP (RMB000)Consolidated Income StatementItemSix months ended 30 June 2012Unaudited Six months ended 30 June 2011Unaudited Revenue1,525,0081,509,029Profit before tax39,08776,764Income tax expense(6,831)(15,305)Profit for the period32,25661,459Includes: Profit attributable to owners of the Company30,41660,061Non-controlling interests1,8401,398Consolidated Statement of Financial PositionItemAs at 30 June 2012Unaudited As at 31 December 2011Audited Total assets3,406,4283,017,412Total liabilities(1,616,786)(1,259,624)Non-controlling interests(41,486)(39,807)Equity attributable to owners of the Company1,748,1561,717,981(iii) Reconciliation of accounts prepared in accordance with PRC accounting standards and HKGAAP (RMB) (Unaudited)ItemProfit attributable to the equity holders of CompanyTotal equity attributable to equity holders of Companythe Reporting PeriodSame Period Last YearAs at 30 June 2012As at 1 January 2012Prepared under PRC accounting standards31,195,182.8260,702,135.831,740,887,172.031,709,932,330.07HKGAAP adjustments:Provision for education fund(916,000.00)(753,000.00)8,554,000.009,469,000.00Deferred taxation136,817.18111,864.17(1,285,172.03)(1,420,330.07)Total of the difference between the PRC accounting standards and HKGAAP(779,182.82)(641,135.83)7,268,827.978,048,669.93Prepared under HKGAAP30,416,000.0060,061,000.001,748,156,000.001,717,981,000.00Explanation of the difference between the PRC accounting standards and HKGAAP:1. Education fees are set out as per the actual circumstances, without the need of provision under HKGAAP. As at 30 June 2012 provision made for the balance of education fees under the PRC accounting standards was RMB8,554,000 with an amount in education fees of RMB916,000 for this period.2. Education fees also led to the difference in the Companys deferred income tax, with the difference in accumulated deferred income tax of RMB1,285,172.03 and that in deferred income tax of the current period of RMB136,817.18. III. CHANGES IN SHARE CAPITAL STRUCTURE AND INFORMATION ON SHAREHOLDERS1. Share Capital structure30 Jun 20121 Jan 2012Class of sharesNumber of shares (share)% of the total share capitalNumber of shares (share)% of the total share capital1. Total number of conditional tradable shares96105,3310Stated-owned shares0000Domestic legal person shares0000Conditional tradable senior management A shares96105,3310Others00002. Total number of unconditional tradable shares457,311,869100.00457,307,499100.00Renminbi ordinary shares (A shares)307,311,86967.20307,307,49967.20Overseas listed foreign shares (H shares)150,000,00032.80150,000,00032.803. Total number of shares457,312,830100.00457,312,830100.002. As at 30 June 2012, the Company had on record a total of 39,195 shareholders, including 55 holders of H Shares and 39,140 holders of A Shares.3. As at 30 June 2012, the ten largest shareholders of the Company were as follows: Unit: shareName of ShareholderTypes of shareholdersNumber of shares held% of the total share capitalNumber of conditional tradable shares heldNumber of shares being charged or frozenShandong Xinhua Pharmaceutical Group Company Limited (SXPGC)State-owned shareholder, A shares166,115,72036.3200HKSCC (Nominees) LimitedListed H shares147,963,99832.3600Qingdao Haowei Investment Development Company LimitedDomestic general legal person shares11,536,1432.5200Wang CuipingDomestic person751,4000.1600Zeng XiulingDomestic person650,8150.1400Zhang LinlinDomestic person639,0000.1400Liu ShidaDomestic person591,8000.1300Zheng HuidanDomestic person499,9900.1100China Construction Bank-Morgan Stanley Huaxin multiple factor selection strategy stock type investment securities fundFund0A shares471,7680.1000WANG ZHIHAIListed H shares456,0000.10004. As at 30 June 2012, the ten largest shareholders of the unconditional tradable shares of the Company were as follows:Name of ShareholderNumber of unconditional listed shares (share)Class of sharesSXPGC166,115,720A SharesHKSCC (Nominees) Limited147,963,998H SharesQingdao Haowei Investment Development Company Limited11,536,143A SharesWang Cuiping751,400A SharesZeng Xiuling650,815A SharesZhang Linlin639,000A SharesLiu Shida591,800A SharesZheng Huidan499,990A SharesChina Construction Bank-Morgan Stanley Huaxin multiple factor selection strategy stock type investment securities fund471,768A SharesWANG ZHIHAI456,000H SharesNote:1. The Directors are not aware as to whether there is any association amongst the ten largest shareholders of the Company, nor the persons acting in concert as defined in the Rules for the information Disclosure of Changes in the Shareholding of Listed Companies issued by the CSRC. In addition, the Directors do not know whether there is any association amongst the shareholders of H Shares of the Company or persons acting in concert as referred to above. The Directors do not know whether there is any association amongst the ten largest shareholders of unconditional tradable shares of the Company, any association between the ten largest shareholders of the Company or the persons acting in concert as defined in the Rules for the information Disclosure of Changes in the Shareholding of Listed Companies.2. The only domestic shareholder with more than 5% of the total issued shares of the Company is SXPGC.3. There was no change of controlling shareholder of the Company during the Reporting Period.4. Save as disclosed above and so far as the Directors are aware, as at 30 June 2012, no other person (other than the Directors, supervisors of the Company (the Supervisors), chief executives or members of senior management of the Company (the Senior Officers)) had an interest or short position in the Companys shares or underlying shares (as the case may be) which would fall to be disclosed to the Company and the SEHK under the provisions of Divisions 2 and 3 of Part XV of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong (SFO) and as recorded in the register required to be kept under section 336 of the SFO), or was otherwise a substantial shareholder (as defined in the Rules Governing the Listing of Securities on the SEHK (the Listing Rules)) of the Company.IV. DIRECTORS, SUPERVISORS AND SENIOR OFFICERSThe number of shares held by the Directors, Supervisors and Senior Officers of the Company were as follows:NamePositionNumber of Shares (share) as at 1 January 2012Change in number of SharesNumber of Shares (share) as at 30 June 2012Directors:Mr. Zhang DaimingChairmanNilNilNilMr. Ren FulongNon-executive DirectorNilNilNilMr. Du DepingExecutive Director, General ManagerNilNilNilMr. Zhao SongguoExecutive Director, Deputy generalmanager & Financial ControllerNilNilNilMr. Xu LieNon-executive Director NilNilNilMr. Zhao BinNon-executive Director NilNilNilMr. Zhu BaoquanIndependent non-executive DirectorNilNilNilMr. Bai HuiliangIndependent non-executive DirectorNilNilNilMr. Kwong Chi Kit, VictorIndependent non-executive DirectorNilNilNilSupervisors:Mr. Li TianzhongChairman of Supervisory CommitteeNilNilNilMr. Zhang YueshunIndependent SupervisorNilNilNilMr. Tao ZhichaoIndependent SupervisorNilNilNilMs. Hu YanhuaEmployee SupervisorNilNilNilSenior Officers:Mr. Dou XuejieDeputy General ManagerNilNilNilMr. Du DeqingDeputy General Manager NilNilNilMr. He TongqingDeputy General Manager NilNilNilMr. Cao ChangqiuCompany Secretary1,281Nil1,281Ms. Guo LeiCompany SecretaryNilNilNilTotal1,281Nil1,281All shares held by the Directors, Supervisors and Senior Officers are A shares. The number of shares held by the Directors, Supervisors and Senior Officers has no change during this Reporting period.So far as the Directors, Senior Officers and Supervisors are aware, save as disclosed above, as at 30 June 2012, no Director, Senior Officer or Supervisor had any interest or short position in the shares, underlying shares and / or debentures (as the case may be) of the Company or any of its associated corporations (as defined in Part XV of the SFO) which was required to be notified to the Company and the SEHK pursuant to Divisions 7 and 8 of Part XV of the SFO (including any interest or short position which any such Director, Senior Officer or Supervisor is taken or deemed to have under such provisions of the SFO) or which was required to be entered in the register required to be kept by the Company pursuant to Section 352 of the SFO or which was otherwise required to be notified to the Company and the SEHK pursuant to the Model Code for Securities Transactions by Directors of Listed Issuers as contained in Appendix 10 to the Listing Rules.CHANGES OF DIRECTORS, SUPERVISORS AND SENIOR OFFICERSDuring this Reporting Period, there were no changes of Directors, Supervisors and Senior Offices.V. CHAIRMANS STATEMENTDear shareholders,I am pleased to report the operating results of the Company for the six months ended 30 June 2012.For the six months ended 30 June 2012, pursuant to the PRC accounting standards, the operating income of the Group was RMB1,537,930,000 and net profit attributable to equity holders of the Company was RMB31,195,000, representing an increase of 0.99% and a decrease of 48.61% respectively, as compared to that of the Same Period Last Year.The Group had a turnover of RMB1,525,008,000 and the profit attributable to owners of the Company of RMB30,416,000 for the six months ended 30 June 2012 under HKGAAP, representing an increase of 1.06% and a decrease of 49.36% respectively, as compared with that of the Same Period Last Year.The Board did not recommend the payment of an interim dividend for the six months ended 30 June 2012.BUSINESS REVIEWIn the first half of 2012, the Group took proactive measures against a series of adverse factors such as weak demand in the pharmaceutical market, increased pressure on the tender system for essential drugs and on environmental protection and the implementation of the new version of GMP. By further carrying out the Year of Fundamental Management event, seizing market opportunities, focusing on technological innovation and placing emphasis on energy saving and consumption reduction as well as project construction, with details set out as follows:1. Seized opportunities and increased efforts to explore markets During the first half of 2012, by fully leveraging on its comprehensive competitive edges, the Company continued to consolidate its key markets and key customers, and increased its efforts in exploring international emerging markets and developing new domestic pharmaceuticals clients, the Company experienced encouraging growth in sales of strategic products. Upon passing the on-site audit of the Medicines and Healthcare Products Regulatory Agency (MHRA) of the United Kingdom in last year, the amount of preparation products exported to the European Union grew substantially.We insisted on increasing efforts in the building of the terminal marketing teams for hospitals and in market development, while aggressively developed markets for new products and strove to cultivate major products, leading to a significant rise of the sales of new key products such as rabeprazole, glimepiride and aspirin enteric-coated sustained release tablets. 2. Aggressively promoted innovation and accelerated R&DDuring the first half of the year, the Company continued to accelerate its strategic deployment of new products and construction of R&D platforms, turning 8 projects into full production and completing mid-scale trial production of 7 pharmaceuticals. Meanwhile, the Company concluded agreements of intent for cooperation with a number of domestic and foreign research institutions and universities. During the first half of the year, the Company was granted three invention patents and one new utility model patent.3. Focused on deployment and steadily advanced construction of parks and projectsDuring the first half of 2012, the phase-1 relocation project for the Hutian Park proceeded smoothly, the commissioning of the salicylic acid and aspirin projects achieved a success with stable technical parameters and remarkable increase in single-pass conversion rate. With the application of new process, new equipment and new materials in the construction of parks a foundation will be established for effective reduction of raw material consumption. The project for construction of the modern chemical pharmaceuticals industrialization center went smoothly; and other projects for product technological renovation proceeded in an orderly way. During the first half of 2012, Xinhua Pharmaceutical (Gaomi) Co., Ltd. (e6Rؚ[ gPlQS) completed the registration of changes, filling the gap of the Company in the area of powder injections.4. Strengthened quality control to boost corporate comprehensive competitivenessIn the first half of 2012, the Company successfully passed the audit on quality by 53 clients including GSK, Merck and Roche. It also successfully passed the on-site audit on caffeine food additives by the Shandong Bureau of Quality and Technical Supervision, the on-site audit on the production of amlodipine besylate by Shandong Bureau of Food and Drug Administration and the review of the HYPERLINK "http://www.lrqa.co.uk/standards-and-schemes/food/fssc22000.aspx"food safety system certification (FSSC) for the food supply chain of caffeine products by SGS of Switzerland.The Company has formulated the internal control inspection standards about hollow capsules according to the CP2010 version of Pharmaceutical Codex, and has maintained strict compliance of such standards. As such, pharmaceuticals produced by us are in line with the national quality standards. Our products succeeded in withstanding the test of the poison capsule incident and were widely praised by different sectors of the society. We strengthened the control of the production process, and the passing rate of market surveillance checks was 100%. 5. Upgraded technology to focus on energy saving and consumption reductionWe stuck to the one strategy for one product approach to make breakthroughs in product technology and saved raw materials of RMB5,430,000 in the first half of 2012.By actively promoting the application of new energy saving technologies such as MVR, the Company worked intently on energy conservation and consumption reduction, and recorded 4.26% drop in energy consumption per RMB10,000 production value during the first half of 2012, saving energy amounting to approximately RMB3,880,000. MAJOR WORKS FOR THE SECOND HALF OF THE YEAR 2012In the second half of 2012, the Group is still facing the adverse impact of many unfavourable factors, but the two interest cuts in June has eased some pressure on capital. The meticulously planned marketing campaign for the new products of preparations has laid a good foundation for its future sales. The construction of parks has enabled the application of new technologies and equipment to project construction as well as the overall improvement in economic indicators of product technologies and production capacity. The low market price of chemicals is helpful for the reduction in procurement cost. Considering these factors, the Group will focus on the following in the second half of 2012:1. Ramp up efforts for market expansion and product sales. The Company will take advantage of its comprehensive competitive edges in leading pharmaceuticals, adopt effective sales strategies to increase sales of products; promote the market development for special pharmaceuticals and new products to cultivate new growth points; and focus on the sales of the new products of preparations to enhance profitability.2. Increase efforts in scientific research and quicken application of scientific research results. The Company will put more resources in R&D to expedite the R&D of new products. We will ensure that 8 projects are turned into full production in the multi-function industrialization center and that one-site audit and production registration are completed for 13 projects. We will strive to complete mid-scale trial production of 20 projects.3. Further carrying out of the Year of Fundamental Management event to enhance the Companys competitiveness. The Company will continue to carry out technical quality breakthroughs based on the one strategy for one product approach, and commit to lower production costs, control expenditure, boost product quality and increase the acceptance rate. We will seek to improve risk control, execution power and enhance the quality of economic functioning, especially striving for the turnaround of our subsidiaries.4. Accelerate restructuring and cultivate new economic growth points. We will construct parks at high standards, pay attention to industry correlation, steadily press ahead with acquisition and merger of companies, speed up restructuring; vigorously push forward with project construction and relocation, and make good preparation for the certification of the relocation project. 5. Implement international strategies and improve the Companys development level. We will seek to pass the on-site MHRA reexamination, and continually seek exports expansion, in particular exports of preparations. We will aggressively develop strategic collaborative relations with more international enterprises, expedite overseas product registration and accelerate the building of a R&D platform for international cooperation.VI. MANAGEMENT DISCUSSION AND ANALYSISThe Group is mainly engaged in the development, manufacturing and sale of bulk pharmaceuticals, pharmaceutical preparations, chemicals and other products. The profit of the Group is mainly attributable to these businesses.1. LIQUIDITY AND ANALYSIS OF FINANCIAL RESOURCES AND CAPITAL STRUCTURE UNDER HKGAAPAs of 30 June 2012, the liquidity ratio of the Group was 106.96%, the quick ratio was 71.59%, the turnover ratio of account receivables was 410.15% (turnover ratio of account receivables = turnover / average account receivables and net value of bills x 100%) and the turnover ratio of inventory was 285.05% (inventory turnover ratio = cost of sales / average net value of inventory x 100%).There was no significant seasonal effect on the capital demand of the Group.The main source of funds for the Group was loans from financial institutions and funds provided by the medium term note issued by Hualu Holdings Group Limited, the parent companys controlling shareholder. As at 30 June 2012, the total amount of bank loans was RMB480,098,000, which was floating rate loans and was accounted by HIBOR and rates issued by the Peoples Bank of China, and the total amount of medium term note was RMB500,000,000. As at 30 June 2012, cash on hand and in bank amounted to RMB394,346,000 (including bank acceptance drafts deposits of RMB22,281,000).During the Reporting Period, the Groupcharged the land use rights in Hutianzhen,Zhangdian,to a bankforloans. Thebook valueof the land use rightsis RMB68,844,000.There was no charge on the Groups assets except the above charged assets.The Group has stringent internal control systems for cash and fund management in order to strengthen financial management. The Group has sound liquidity and repayment ability.During the Reporting period, the Group invested RMB22,000,000 to purchase all the equity of Shandong Tianda Biology Pharmaceutical Company Limited ( Tianda Biological). As at the time of acquisition, Tianda Biologicals registered capital was RMB6,000,000. Its name was changed to Xinhua Pharmaceutical (Gaomi) Company Limited ( Xinhua Gaomi) in April 2012 after the completion of the acquisition. The Company increased its capital in Xinhua Gaomi by RMB13,000,000 in May 2012 and Xinhua Gaomis registered capital was changed to RMB19,000,000.The clarification of the performance results of the Group is referred to in the section headed Results and Financial Analysis under PRC accounting standards.As at 30 June 2012, the number of employees of the Group was 6,033. The total salaries for employees in the first half of 2012 amounted to RMB120,028,000.The main investment projects in the second half of 2012 will be Hutian Park project and Shouguang Park project.As at 30 June 2012, the capital debt ratio of the Group was 56.06% (capital debt ratio = total borrowings / equity attributable to owners of the Company x 100%).The cash and bank balances of the Company will mainly be used as working capital for production, operation, projects and research development.The assets and debts of the Group were denominated in Renminbi. However, the Group achieved USD94,361,000 in its export for the first half of 2012. Therefore, there was a greater impact from foreign exchange. The Group adopted the following measures to minimise the foreign exchange fluctuation risk: 1. raising the export price in order to minimise foreign exchange fluctuation risk; and 2. when the Group enters into an export contract involving large quantities of products with other parties, the Group shall seek prior consent from the other party that both parties will bear the foreign exchange fluctuation risk should the foreign exchange fluctuation exceed the contractual limit as agreed by both parties.2. RESULTS AND FINANCIAL ANALYSIS UNDER PRC ACCOUNTING STANDARDSIn the first half of 2012, the Group had achieved a turnover of RMB1,537,930,000, representing an increase of 0.99% as compared to the Same Period Last Year. The increase in revenue was mainly attributable to the slight increase in sales and prices of products. The increase in net cash and cash equivalents was RMB101,099,000, while there was a decrease of RMB9,696,000 in the Same Period Last Year. The main reason for the change was due to the increase in net cash flow of RMB204,870,000 from financing activities as compared to the Same Period Last Year. Operating profit amounted to RMB25,525,000, representing a decrease of 67.89% as compared to the Same Period Last Year. The main reason for the decrease was that the costs recorded a larger increase as compared to the Same Period Last Year. Total assets of the Group as at 30 June 2012 amounted to RMB3,398,464,000, representing an increase of RMB394,274,000 or 13.12% as compared to the figure of RMB3,004,190,000 as at the beginning of this year. The increase was mainly due to a newly addition of RMB500,000,000 medium term note from Hualu Holdings Group Company Limited during the Reporting Period. The Groups bank loans as at 30 June 2012 was RMB480,098,000, representing a decrease of RMB208,370,000 from RMB688,468,000 at the beginning of this year. Such decrease was mainly attributable to a newly addition of RMB500,000,000 medium term note from Hualu Holdings Group Company Limited during the Reporting Period. As such, we have sufficient capital. Total equity attributable to equity holders of the Company as at 30 June 2012 increased by RMB30,955,000 or 1.81%, from RMB1,709,932,000 at the beginning of this year to RMB1,740,887,000. This increase was mainly attributable to an increase of RMB31,195,000 from the operating profit of the Group during the Reporting Period.An analysis of the Groups turnover from principal operations is as follows (RMB000):By geographical location of customersFirst half of 2012First half of 2011Total turnoverCostsTotal turnoverCostsPRC (incl. Hong Kong)911,697733,860927,985732,016Europe249,443220,276224,577184,257Americas256,616199,318267,315244,426Others98,98586,11881,68470,984Total1,516,7411,239,5721,501,5611,231,683By industry and By productIncome from principal operationsCosts of sales of principal operationsGross profit margin(%)Bulk pharmaceutical 744,897  603,001  19.05 Preparations 290,644  161,785  44.34 Commercial circulations 385,869  372,171  3.55 Chemical products and other products 95,331  102,615  (7.64) Total 1,516,741  1,239,572  18.27 An analysis of profit as compared to 2011 is as follows:ItemsAmount (RMB000)% of total profitJan.-Jun. 20122011Jan.-Jun. 20122011Operating profit25,52471,92863.8177.17Profit/Loss from non-operation activities14,47821,28436.1922.83Profit before taxation40,00293,212100.00100.003. USE OF PROCEEDSOn 3 September 2001, the Company raised an amount of RMB370,517,000 from the public offer and issue of 33,000,000 A Shares (including the sale of 3,000,000 State-owned shares). As at 30 June 2012, RMB347,238,000 were used in the following projects: Name of projectPlanned investmentRMB000Actual investment Jan.-Jun. 2012RMB000Accumulated amount of investmentRMB000% of the investmentRemarksState-level technical center renovation74,5004,14937,30550.07%-Injection GMP renovation80,000-80,226100.28%completedCaffeine technical renovation160,000-188,201117.63%completedL-350 technical renovation29,980-23,44278.19%completedAnalgin GMP renovation39,800-46,265116.24%completedTotal384,2804,149375,439--(1) Injection GMP renovation project did not reach its profit forecast due to the decrease in pharmaceutical prices.(2) Caffeine technical renovation did not reach its profit forecast because of the effects of the drop in the price and the export tax rebate rate.(3) The principal part of the project of renovation of the state-level technical center has been completed.The remaining proceeds were deposited with banks and will be used in accordance with the Companys project commitments.VII. REVIEW OF MAJOR EVENTSSave as disclosed herein:1. There is no material deviation between the actual corporate governance implemented by the Company and the rules and requirements of corporate governance required to be observed by listed companies in the PRC.2. The Board did not recommend the payment of any interim dividend, nor any transfer from reserves to share capital, for the half year ended 30 June 2012.3. The Group was not involved in any material litigation or arbitration, whether pending or threatened during the reporting period.4. There was no material purchase of assets or disposal of the Companys assets, nor did any material mergers or acquisitions involving the Company occur during the Reporting Period. Similarly, no transactions of such nature occurred during the last reporting period and were carried over to the Reporting Period.5. During the Reporting Period, there was no trust, subcontract and lease of the assets between the Company and other companies.6. The independent non-executive directors special explanation and independent opinions in respect of the use of funds by related parties and external security provided are as follows:During the Reporting Period, there was no non-operational use of the Companys funds by the controlling shareholder and other related parties.During the Reporting Period, save and except the guarantee of bank accepted bills of exchange of RMB14,000,000 provided by the Company in favour of Xinhua Pharmaceutical (Shouguang) Company Limited, its wholly-owned subsidiary, no other material guarantee has been provided by the Company, nor has there been any obligations that have not been performed in full by the Company. There were no guarantees provided in favour of any controlling shareholders, non-legal entities or individuals which were prejudicial to the interests of the Company and its shareholders, in particular the minority shareholders of the Company. As at 30 June 2012, the Company had no overdue external guarantee debts and the Company had no liability arising from any guarantee due to the default of a guaranteed party.7. The Company and its shareholders holding more than 5% of total number of issued shares of the Company have provided undertakings for information disclosure as follows: Nil8. Purchase, Sales and Redemption of the Companys listed securitiesDuring the Reporting Period, neither the Company nor its subsidiaries purchased, sold or redeemed any of its securities.9. Management of FundsDuring the Reporting Period, the Company did not appoint any person to manage the Companys funds. No such appointment was made in the preceding reporting period and carried over to the Reporting Period.10. Information about holding equity in other listed companies (RMB)Stock CodeAbbreviated NameInitial investment amountProportion of equity interest in investeeBook value of end of the Reporting PeriodProfit/loss in the Reporting PeriodChange of shareholders equity in the Reporting PeriodAccounting coursesShare source601601China Pacific Insurance7,000,000.000.06%37,315,168.001,750,000.00493,152.00Available-for-sale financial assetsPurchase601328BANKCOMM14,225,318.000.02%110,900,000.00821,920.0014,850,000.00Available-for-sale financial assetsPurchaseTotal21,225,318.00-148,215,168.002,571,920.0015,343,152.00-11. Index of important information which has been disclosedThe announcement of the 2011 Annual Results Announcement was published on the HKExnews, in the Securities Times C21 in the PRC, on the website: http://www.cninfo.com.cn and on the Companys website on 26 March 2012.The announcement of the The First Quarter Report of 2012 was published on the HKExnews, in the Securities Times D38 in the PRC, on the website: http://www.cninfo.com.cn and on the Companys website on 26 April 2012.The announcement of the The Notice of Annual General Meeting for the 2011 was published on the HKExnews, in the Securities Times D27 in the PRC, on the website: http://www.cninfo.com.cn and on the Companys website on 10 May 2012.The announcement of the Announcement of 2011 Annual General Meeting Resolutions was published on the HKExnews, in the Securities Times D18 in the PRC, on the website: http:// www.cninfo.com.cn and on the Companys website on 27 June 2012.12. Information of reception research, communication and interview during the Reporting Period: NilVIII. CORPORATE GOVERNANCECOMPLIANCE WITH THE CODE ON CORPORATE GOVERNANCE PRACTICESThe Directors confirmed that the Company was in compliance with the Code on Corporate Governance Practices (the Code) and has not deviated from the Code during the six months ended 30 June 2012. The Code includes the provisions contained in Appendix 14 to the Listing Rules.AUDIT COMMITTEEThe Company set up the audit committee under the Board in accordance with Rule 3.21 of the Listing Rules.The audit committee along with the management of the Company has reviewed the accounting standards, principles and methods adopted by the Group, and considered matters regarding auditing, internal control and financial reporting including the unaudited interim accounts for the six months ended 30 June 2012.The audit committee agreed to the accounting standards, principles and methods adopted by the Group for the unaudited interim accounts for the six months ended 30 June 2012, and it has been disclosed fully.INDEPENDENT NON-EXECUTIVE DIRECTORThe Company has complied with Rules 3.10(1) and 3.10(2) of the Listing Rules relating to the appointment of a sufficient number of independent non-executive Directors and at least one independent non-executive Director with appropriate professional qualifications, or accounting or related financial management expertise. The Company has appointed three independent non-executive Directors including one with financial management expertise; details of their biographies were set out in the 2011 Annual Report of the Company.MODEL CODE FOR SECURITIES TRANSACTIONS BY DIRECTORS OF LISTED ISSUERS (MODEL CODE)During the Reporting Period, the Company has adopted a code of conduct regarding transactions by Directors on terms no less exacting than the required standards set out in the Model Code. After having made specific enquiries to the Directors and Supervisors, the Company has confirmed that during the Reporting Period, all Directors and Supervisors have complied with the required standard set out in the Model Code in relation to directors securities transactions and they did not have any non-compliance with the Mode Code. h!. FINANCIAL REPORTS1. Profit and loss account prepared in conformity with PRC accounting standards (Unaudited) Unit: RMBItem First half of 2012First half of 20110ConsolidatedParent companyConsolidatedParent company1.Total operating income1,537,930,023.23908,225,960.781,522,811,524.54957,937,694.81 Includes: Operating income1,537,930,023.23908,225,960.781,522,811,524.54957,937,694.812.Total operating costs1,516,606,553.73873,375,989.931,448,271,735.29928,194,170.01 Includes: Operating cost1,264,175,647.52752,763,409.611,254,708,252.89831,515,794.47 Taxes and surcharges8,253,025.715,078,863.765,697,453.843,781,025.98 Selling expenses117,149,652.7610,309,344.3391,559,028.3612,187,415.31 Administrative expenses99,584,460.2377,135,903.5678,262,015.0864,859,815.91 Financial expenses27,443,767.5128,088,468.6716,245,648.3215,850,118.34 Assets Impairment loss--1,799,336.80- Add: Gain or loss from changes in fair value---- Investment gain or loss4,201,289.544,187,410.094,956,897.334,950,963.06 Includes: Investment gain or loss from related ventures and joint ventures1,615,490.091,615,490.093,200,963.063,200,963.06 Exchange gain or loss----3. Operating profit25,524,759.0439,037,380.9479,496,686.5834,694,487.86 Add: Non-operating income24,632,607.1010,172,180.36778,974.27756,432.66 Less: Non-operating cost10,154,892.498,777,307.262,757,720.092,220,925.97 Includes: Loss from the disposal of non-current assets6,559,471.226,559,471.22539,620.93539,620.934. Profit before taxation40,002,473.6540,432,254.0477,517,940.7633,229,994.55 Less: Income tax expense6,967,721.575,523,789.2215,417,765.134,476,899.965. Profit after taxation33,034,752.0834,908,464.8262,100,175.6328,753,094.59 Includes: Net Profit attributable to the equity holders of the parent company31,195,182.8234,908,464.8260,702,135.8328,753,094.59 Minority interest1,839,569.26-1,398,039.80-6. Earnings per share 1) Basic earnings per share0.070.080.130.06 2) Diluted earnings per share0.070.080.130.067.Other comprehensive income13,318,667.8213,776,885.60(1,101,638.62)(1,786,428.00)8. Total comprehensive income46,353,419.9048,685,350.4260,998,537.0126,966,666.59 Includes: Total comprehensive income attributable to the equity holders of the parent company44,674,226.8648,685,350.4259,360,820.9326,966,666.59 Total comprehensive income attributable to the minority interest1,679,193.04-1,637,716.08-NOTES:xe "s, 1. compared with the latest annual reportA th"1. During the Reporting Period, there was no change in accounting policies and accounting estimates.xe "nfluences, 2. in the range of consolidation as co"2. During the Reporting Period, Xinhua Gaomi was added into the scope of consolidated financial statements of the Company.2. FINANCIAL STATEMENTS PREPARED UNDER HKGAAPCondensed consolidated income statementNotesSix months ended 30 June20122011RMB000RMB000(unaudited)(unaudited)Revenue31,525,0081,509,029Cost of sales(1,247,825)(1,237,382)Gross profit277,183271,647Investment income4,0572,732Other income46,60721,548Distribution and selling expenses(125,417)(99,027)Administrative expenses(103,989)(82,808)Other expenses(32,823)(28,889)Share of profit of an associate1,6153,201Finance costs(28,146)(11,640)Profit before tax439,08776,764Income tax expense5(6,831)(15,305)Profit for the period32,25661,459Profit for the period attributable to:Owners of the Company30,41660,061Non-controlling interests1,8401,39832,25661,459Earnings per share - basic and diluted 6RMB0.067RMB0.131Condensed consolidated statement of comprehensive incomeSix months ended 30 June20122011RMB000RMB000(unaudited)(unaudited)Profit for the period32,25661,459Other comprehensive income (expenses): Exchange differences arising on translation (460)685 Fair value gain (loss) on available-for-sale financial assets15,343(2,101)Income tax relating to components of other comprehensive income (1,566)314Other comprehensive income (expenses) for the period, net of tax13,317(1,102)Total comprehensive income for the period45,57360,357Total comprehensive income attributable to:Owners of the Company43,89458,719Non-controlling interests1,6791,63845,57360,357 Condensed consolidated statement of financial positionNotes30 June 201231 December 2011RMB000RMB000(unaudited)(audited)Non-current assetsTechnical know-how16,126-Property, plant and equipment1,103,0331,065,521Construction in progress488,893363,330Prepaid lease payments on land use rights220,605217,022Investment properties35,51337,142Interest in an associate24,92621,761Available-for-sale investments151,415136,072Deferred tax assets17,23816,588 Prepayments for acquisition of land use rights22,02831,7872,079,7771,889,223Current assetsInventories445,934423,789Trade and other receivables8471,900389,356Prepaid lease payments on land use rights5,9605,711Amount due from an associate63-Amounts due from fellow subsidiaries7,4456,600Tax recoverable1,0033,504Pledged bank deposits25,28131,263Bank balances and cash369,065267,9661,326,6511,128,189Current liabilitiesTrade and other payables9550,591485,119Dividend payable19,03015,111Amounts due to fellow subsidiaries1,3312,835Amount due to an associate-61Tax payable-608Borrowings190,000475,147760,952978,881Net current assets565,699149,308Total assets less current liabilities2,645,4762,038,531Capital and reservesShare capital457,313457,313Reserves1,290,8431,246,949Proposed final dividend-13,719Equity attributable to owners of the Company1,748,1561,717,981Non-controlling interests41,48639,807Total equity1,789,6421,757,788Non-current liabilitiesDeferred tax liabilities6,9995,570Borrowings290,098213,321Loan from ultimate holding company500,000-Deferred income58,73761,852855,834280,7432,645,4762,038,531NOTES TO THE CONDENSED INTERIM FINANCIAL INFORMATION UNDER HKGAAP1. Basis of preparation The Groups unaudited condensed interim financial information has been prepared in accordance with the applicable disclosure provisions of Appendix 16 to the Listing Rules and with Hong Kong Accounting Standard (HKAS) 34, Interim Financial Reporting, issued by the Hong Kong Institute of Certified Public Accountants (HKICPA). The unaudited condensed consolidated interim financial information should be read in conjunction with the annual financial statements for the year ended 31 December 2011.Principal accounting policies The condensed consolidated interim financial information has been prepared on the historical cost basis except for property, plant and equipments and certain financial instruments, which are measured at revalued amounts or fair values, as appropriate. Historical cost is generally based on the fair value of the consideration given in exchange for assets.The accounting policies used in the consolidated condensed interim financial information are consistent with those followed in the preparation of the Groups annual financial statements for the year ended 31 December 2011, except as described below.In the current interim period, the Group has applied the following amendments to Hong Kong Financial Reporting Standards (HKFRSs) issued by the HKICPA.Amendments to HKFRS 1Severe Hyperinflation and Removal of Fixed Dates for First-time AdoptersAmendments to HKFRS 7Disclosures Transfers of Financial AssetsAmendments to HKAS 12Deferred Tax: Recovery of Underlying AssetsThe Group has not early applied the following new and revised standards, amendments or interpretations that have been issued but are not yet effective.Amendments to HKFRSsAnnual Improvements to HKFRSs 2009-2011 Cycle2Amendments to HKFRS 1Government Loans2Amendments to HKFRS 7Disclosure offsetting Financial Assets and Financial Liabilities2Mandatory effective date of HKFRS 9 and Transition Disclosures4HKFRS 9Financial Instruments4HKFRS 10Consolidated Financial Statements2HKFRS 11Joint Arrangements2HKFRS 12Disclosure of Interests in Other Entities2Amendments to HKFRS 10, HKFRS 11 and HKFRS 12Consolidated Financial Statements, Joint Arrangements and Disclosure of Interests in other Entities: Transition Guidance2HKFRS 13Fair Value Measurement2Amendments to HKAS 1Presentation of Items of Other Comprehensive Income1HKAS 19 (as revised in 2011)Employee Benefits2HKAS 27 (as revised in 2011)Separate Financial Statements2HKAS 28 (as revised in 2011)Investments in Associates and Joint Ventures2Amendments to HKAS 32Offsetting Financial Assets and Financial Liabilities3HK(IFRIC) INT 20Stripping Costs in the Production Phase of a Surface Mine21 Effective for annual periods beginning on or after 1 July 2012.2 Effective for annual periods beginning on or after 1 January 2013.3 Effective for annual periods beginning on or after 1 January 2014.4 Effective for annual periods beginning on or after 1 January 2015.The five new or revised standards on consolidation, joint arrangements and disclosures were issued by the HKICPA in June 2011 and are effective for annual periods beginning on or after 1 January 2013. Earlier application is permitted provided that all of the five new or revised standards are applied early at the same time. The directors of the Company anticipate that these new or revised standards will be applied in the Groups consolidated financial statements for financial year ending 31 December 2013 and the potential impact is described below.HKFRS 10 replaces the parts of HKAS 27 Consolidated and Separate Financial Statements that deal with consolidated financial statements. Under HKFRS 10, there is only one basis for consolidation, that is control. In addition, HKFRS 10 includes a new definition of control that contains three elements; (a) power over an investee, (b) exposure, or rights, to variable returns from its involvement with the investee, and (c) ability to use its power over the investee to affect the amount of the investors returns. Extensive guidance has been added in HKFRS 10 to deal with complex scenarios. Overall, the application of HKFRS 10 requires a lot of judgement. The application of HKFRS 10 might result in the Group no longer consolidating some of its investees, and consolidating investees that were not previously consolidated.The amendments to HKAS 1 have been issued to improve the presentation of other comprehensive income. The amendments require entities to group together the items of other comprehensive income that may be reclassified to profit or loss in the future by presenting them separately from those that would never be reclassified to profit or loss.Other than disclosed above, the directors of the Company anticipate that the application of the new or revised standards and interpretations will have no material impact on the result and the financial position of the Group.3. Segment informationDescription of segmentsManagement has determined the operating segments based on the internal reports reviewed by the chief operating decision maker for the purpose of allocating resources to segments and assessing their performance. The Groups operating and reportable segments are as follows:Bulk pharmaceuticals:Development, production and sales of bulk pharmaceuticalsPreparations:Development, production and sales of preparations (e.g. tablets and injections)Commerce circulations:Trading of pharmaceutical products (including retail and wholesale)Chemical and other products:Production and sales of chemical and other products Information regarding the above segments is reported below: Segment turnover and results The following is an analysis of the Groups turnover and results by reportable segment.For the six months ended 30 June 2012Unaudited Bulk pharmaceuticalsPreparationsCommerce circulationsChemical and other products EliminationsTotalRMB 000RMB 000RMB 000RMB 000RMB 000RMB 000REVENUE External sales750,812291,004387,86195,331-1,525,008Inter-segment sales3,758182,7531,301128,972(316,784)-Total 754,570473,757389,162224,303(316,784)1,525,008Segment profit64,5924,495(147)(21,163)47,777Investment and other income 50,664Other expenses(32,823)Finance costs(28,146)Share of profits of an associate1,615Profit before tax 39,087For the six months ended 30 June 2011Unaudited Bulk pharmaceuticalsPreparationsCommerce circulationsChemical and other products EliminationsTotalRMB 000RMB 000RMB 000RMB 000RMB 000RMB 000REVENUE External sales812,608270,361358,68767,373-1,509,029Inter-segment sales4,272160,38543,388154,751(362,796)-Total 816,880430,746402,075222,124(362,796)1,509,029Segment profit 59,21022,1094,1294,36489,812Investment and other income24,280Other expenses(28,889)Finance costs(11,640)Share of profits of an associate3,201Profit before tax 76,764The accounting policies of the reportable segments are the same as the Groups accounting policies. Segment profit represents the profit earned by each segment without allocation of investment and other income, other expenses, finance costs and share of profit of an associate. This is the measure reported to the chief operating decision maker for the purposes of resource allocation and performance assessment.Inter-segment sales are charged at prevailing market rates.Segment assetsThe following is an analysis of the Groups assets by reportable segment.At 30 June 2012Unaudited Bulk pharmaceuticalsPreparationsCommerce circulationsChemical and other products TotalRMB 000RMB 000RMB 000RMB 000RMB 000Segment assets1,471,355527,794176,026606,8122,781,987-Unallocated corporate assets624,441Consolidated assets3,406,428At 31 December 2011Audited Bulk pharmaceuticalsPreparationsCommerce circulationsChemical and other products TotalRMB 000RMB 000RMB 000RMB 000RMB 000Segment assets1,300,312483,372182,817536,6152,503,116Unallocated corporate assets514,296Consolidated assets 3,017,412For the purposes of monitoring segment performances and allocating resources among segments: all assets are allocated to reportable segments other than deferred tax assets, interest in an associate, available-for-sale investments, investment properties, tax recoverable, pledged bank deposits and bank balances and cash. Assets used jointly by reportable segments are allocated on the basis of revenues earned by individual reportable segments.4. Profits before taxProfit before tax has been arrived at after charging (crediting):Six months ended 30 June20122011RMB000RMB000(unaudited)(unaudited)Amortisation of prepaid lease payments on land use rights2,6452,845Amortisation of technical know-how820-Depreciation for property, plant and equipment82,63461,544Depreciation for investment properties1,6291,628Cost of inventories recognised as an expense1,247,8251,237,382Bargain purchase gain in acquisition of a subsidiary(2,094)-Dividends and interest income(4,057)(2,732)Loss on disposal of property, plant and equipment6,300575. Income tax expenseThe major components of income tax expense in the condensed income statement are:Six months ended 30 June20122011RMB000RMB000(unaudited)(unaudited) Current income tax PRC Enterprise Income Tax (EIT)6,96815,350Deferred income tax(137)(45)Income tax expense6,83115,305Under the Law of the PRC on Enterprise Income Tax (the EIT Law) and Implementation Regulation of the EIT Law, the tax rate of the PRC companies is 25% for both periods. Pursuant to the relevant laws and regulations in the PRC, the Company was accredited as a high-tech enterprise. The accreditation is valid for three years. The Company is entitled to the preferential tax rate of 15% for a period of three years commencing from 1 January 2011 to 31 December 2013.Pursuant to the relevant laws and regulations in the PRC, two subsidiaries operating in the PRC are entitled to exemption from the PRC income tax in the first two years from the first profit-making year, followed by a 50% reduction of the PRC income tax for the next three years. During the six months ended 30 June 2012, only one subsidiary operating in the PRC is entitled to exemption from the PRC income tax in the first two years from the first profit-making year, followed by a 50% reduction of the PRC income tax for the next three years.6. Earnings per shareThe calculation of the basic earnings per share is based on the Groups profit attributable to the owners of the Company of RMB30,416,000 (2011: RMB60,061,000) and based on the weighted average of 457,312,830 shares (2011: 457,312,830 shares) in issue during the period.Basic earnings per share and diluted earnings per share for the six months ended 30 June 2012 and 2011 are the same as there were no dilutive events existed during both periods.7. Dividends(a) The Board did not recommend the payment of an interim dividend for the six months ended 30 June 2012 (2011: Nil).(b) Dividends attributable to the previous financial year, approved during the interim period.Six months ended 30 June20122011RMB000RMB000(unaudited)(unaudited) Final dividend in respect of the financial year ended 31 December 2011, approved during the following interim period, of RMB0.03 per share (year ended 31 December 2010: RMB0.05 per share)13,71922,8668. Trade and other receivables30 June 201231 December 2011RMB000RMB000(unaudited)(audited) Trade and bills receivables456,706393,531Less : Allowance for doubtful debts of trade receivables(53,267)(53,328)403,439340,203Other receivables, deposits and prepayments77,70558,397Less : Allowance for doubtful debts of other receivables(9,244)(9,244)68,46149,153Total trade and other receivables471,900389,356Included in the trade and bills receivables are debtors and bills receivables, net of allowance for bad debt and doubtful debts, with the following ageing analysis:30 June 201231 December 2011RMB000RMB000(unaudited)(audited) Within one year394,796335,408More than one year but less than two years7,3723,212More than two years but less than three years1,2101,583Over three years61-403,439340,203The Groups revenue from export sales is on letter of credit or documents against payment. The credit period is agree-p r s t   x z ~ ιΦ}jT94h'hB*CJOJPJQJaJnHo(phtH+hbc]hCJOJPJQJaJnHo(tH%hCJOJPJQJaJnHo(tHhCJQJaJo(h5CJQJaJo( h5CJQJaJnHo(tH$h5CJPJQJaJnHo(tH(jh5CJQJUmHnHo(uh5CJQJo(h5CJOJQJh6KHOJPJQJ]h6KHOJQJ]q r s u v  x 2 X /0GH  $v dWD`v a$$da$^ $dT^a$$a$n<< 2 X \ ^ ` b p  H O P ְs`ZQEQEQEQh>1 h5CJ\h>1 hCJ hCJ$hbc]hB*PJnHo(phtH,h5B*CJPJ\aJnHo(phtH,h5B*CJPJ\aJnHo(phtHh5B*CJ\aJph&hB*CJKHOJQJaJo(ph"hCJOJPJQJaJnHtH%hCJOJPJQJaJnHo(tH+h'hCJOJPJQJaJnHo(tHP T U a b s   #'^ż~k~aWWah>1 hCJo(h>1 h5CJ%h>1 h5CJPJ\nHo(tH"h>1 h5CJPJ\nHtHh>1 hCJPJnHo(tHh>1 hCJPJnHo(tHh>1 h5CJ\h>1 hCJh>1 hua5CJ"h>1 hT5CJPJnHo(tHh>1 hTCJPJnHtHh>1 hTCJPJnHo(tH^_`ghm/023FGHfVZ  pt567[\]lmo䨸䗊zjh>1 hCJUjh>1 hCJU h>1 hCJOJQJ^JaJh>1 hB5CJPJnHo(tHh>1 hCJPJnHo(tHh>1 h5o(h>1 h5h>1 hCJo(h>1 hCJh>1 h h CJo(h>1 h h CJ0 rtnoz{9:uv $rdWD^r`a$gdT,?$~dWD^~`a$gdT,? $d7$a$$da$yz{&'()678߽ﳽufM0h>1 h0J.>*B*CJOJQJ^JaJphh>1 h0J.B*CJphjh>1 hCJUjh>1 hCJUjh>1 hCJU h>1 hCJOJQJ^JaJh>1 hCJo(h>1 hCJh>1 h CJPJnHo(tHh>1 h CJh>1 hT,?CJPJnHo(tHh>1 hCJPJnHo(tH8:KLtv    (*abhlnp￲梲܃yh>1 h5o(+h>1 hCJOJPJQJaJnHo(tHh>1 h h CJjh>1 hCJUjh>1 hCJU h>1 hCJOJQJ^JaJh>1 h5CJ\h>1 hCJo(h>1 hCJh>1 hCJPJnHo(tH,   )*opXZp $$1$Ifa$$da$XZ`b8:<>HɷqdP1 hCJKHaJo('h>1 hwYCJKHPJaJnHo(tH'h>1 h&6CJKHPJaJnHo(tHh>1 hCJKHaJ2h>1 hwY5CJKHOJPJQJaJnHo(tH2h>1 h5CJKHOJPJQJaJnHo(tH#h>1 h5CJKHOJQJaJ#h>1 hCJPJaJnHo(tHh>1 h5CJaJo(h>1 h5CJaJ&h>1 h5CJPJaJnHo(tHh>1 h5HJLXZbdjlp'(^_p󫑫xmYxmPxmh>1 hH>CJ'h>1 hH>CJKHPJaJnHo(tHh>1 hH>CJaJh>1 hH>5CJaJh>1 hH>CJKHaJ2h>1 h5CJKHOJPJQJaJnHo(tH#h>1 h5CJKHOJQJaJh>1 hCJKHaJo(!h>1 h5CJKH\aJo(-h>1 h5CJKHPJ\aJnHo(tHh>1 hCJKHaJp!'{sggg $$Ifa$gdH>$1$Ifxkd$$Ifl\ (#  p(#644 lal $$1$Ifa$'(_p~rrr $$Ifa$gdH>$1$Ifxkd"$$Ifl\ (#  p(#644 lalxlll $$Ifa$gdH>w00$IfXDYDxkd$$Ifl\ (#  p(#644 lal~rrr $$Ifa$gdH>$1$Ifxkdr$$Ifl\ (#  p(#644 lal$%:;<ųxmaOB5h>1 h`nCJKHaJh>1 hKP@CJKHaJ#h>1 hKP@CJPJaJnHo(tHh>1 hKP@CJaJo(h>1 hKP@CJaJh>1 hKP@5CJaJo(h>1 hKP@5CJaJ'h>1 hKP@CJKHPJaJnHo(tHh>1 hH>CJKHaJ#hhH>CJPJaJnHo(tHhCJPJaJnHo(tHh>1 hH>CJaJh>1 hH>5CJaJ'h>1 hH>CJKHPJaJnHo(tH%:~rrd$$4$Ifa$gdKP@ $$Ifa$gdKP@$1$Ifxkd$$Ifl\ (#  p(#644 lal:;<Zf~sssss $$1$Ifa$$1$Ifxkd$$Ifl\ (#  p(#644 lal<WXYZfӹveNeNev-h>1 h`n5CJKHPJ\aJnHo(tH!h>1 h`n5CJKH\aJo(h>1 h`nCJKHaJo('h>1 hH>CJKHPJaJnHo(tH'h>1 h`nCJKHPJaJnHo(tHh>1 h`nCJKHaJ2h>1 hH>5CJKHOJPJQJaJnHo(tH2h>1 h`n5CJKHOJPJQJaJnHo(tH#h>1 h`n5CJKHOJQJaJ !~rrr $$Ifa$gdKP@$1$Ifxkdd$$Ifl\ (#  p(#644 lal !3AOPUWo}"6<DR`aehӯӯӡӯӯӯ+h>1 hH>CJOJPJQJaJnHo(tHh>1 hH>CJKHaJo('h>1 hH>CJKHPJaJnHo(tHh>1 hH>CJOJQJaJo(h>1 hH>CJKHaJh>1 hH>CJOJQJaJh>1 hH>5CJOJQJaJ5!"3AOW~rrr $$Ifa$gdKP@$1$Ifxkd$$Ifl\ (#  p(#644 lalWXo}~rrr $$Ifa$gdKP@$1$Ifxkd$$Ifl\ (#  p(#644 lal~rrr $$Ifa$gdKP@$1$IfxkdV $$Ifl\ (#  p(#644 lalDR`h~rrr $$Ifa$gdKP@$1$Ifxkd $$Ifl\ (#  p(#644 lalhi~rrr $$Ifa$gdKP@$1$Ifxkd $$Ifl\ (#  p(#644 lal~rrr $$Ifa$gdKP@$1$IfxkdN $$Ifl\ (#  p(#644 lal~rrd$$4$Ifa$gdKP@ $$Ifa$gdKP@$1$Ifxkd $$Ifl\ (#  p(#644 lal LPUXZnopƲƢvdTdE5vhhCJOJQJaJo(h>1 hCJOJQJaJh>1 h5CJOJQJaJ"h>1 h5CJOJQJaJo(h>1 hCJKHaJh>1 hH>CJOJQJaJo(h>1 hH>CJOJQJaJh>1 hH>5CJOJQJaJ'h>1 hH>CJKHPJaJnHo(tHh>1 hH>CJKHaJ+h>1 hH>CJOJPJQJaJnHo(tH+h>1 hgCJOJPJQJaJnHo(tHPUZo~rrr $$Ifa$gdKP@$1$Ifxkd $$Ifl\ (#  p(#644 lalop~rrf $$Ifa$gd $$Ifa$gdKP@$1$IfxkdF$$Ifl\ (#  p(#644 lal~rrf $$Ifa$gd $$Ifa$gdKP@$1$Ifxkd$$Ifl\ (#  p(#644 lal  -12?DFٺ|m[m[G3&h>1 hed5B*CJ\aJo(ph&h>1 hF5B*CJ\aJo(ph#h>1 hF5B*CJ\aJphh>1 hFB*CJaJphh>1 hB*CJaJph#h>1 hCJPJaJnHo(tHh>1 hCJKHaJhhCJOJQJaJo(h>1 hCJOJQJaJh>1 h5CJOJQJaJ"h>1 h5CJOJQJaJo('h>1 hCJKHPJaJnHo(tH  -2?zm\F-$00$4$IfXDYDa$gd{/-00$IfXDYDgd{/ -00XDYDgdF -00XDYDxkd$$Ifl\ (#  p(#644 lal?FVWfUI5w$00$IfXDYDa$gd) $$Ifa$gdgw00$IfXDYDgd{/fkd>$$IflF" U t6    44 la-$00$IfXDYD]a$gded-$00$4$IfXDYD]a$gd{/FUVWemn2 ? I W [ \ r s z ñwaaaa*h>1 hgCJPJhmH nHo(sH tH'h>1 hgCJPJhmH nHsH tH h>1 hg&h>1 hgCJhmH nHo(sH tHh>1 hgCJaJ#h>1 hgCJhmH nHsH tHh>1 hFKHPJnHtH&h>1 hF5B*CJ\aJo(ph2h>1 hed5B*CJPJ\aJnHo(phtH&{gw$00$IfXDYDa$gd) $$Ifa$gdgw00$IfXDYDgd{/fkd$$IflF" U t6    44 la2 ? r {gw$00$IfXDYDa$gd) $$Ifa$gdgw00$IfXDYDgd{/fkd4$$IflF" U t6    44 lar s {o $$Ifa$gd) $$Ifa$gdgw00$IfXDYDgd{/fkd$$IflF" U t6    44 la ! ! ! !! !!!"!#!$!&!'!C!G!H!M!N!k!°ɥɥɥnbTbTbTKbh>1 hFCJh>1 hF5CJaJo(h>1 hF5CJaJ#h>1 hFCJPJaJnHo(tH h>1 hgCJKHaJnHtH&h>1 hgCJhmH nHo(sH tHh>1 hgCJaJ#h>1 hgCJhmH nHsH tH h>1 hg+h>1 hgCJOJPJQJaJnHo(tH+h>1 h)CJOJPJQJaJnHo(tHh>1 hgCJaJ ym $$Ifa$gd) $$Ifa$gdgw00$IfXDYDgd{/hkd*$$Ifl\F" U t6    44 la ! !{o $$Ifa$gd) $$Ifa$gdgw00$IfXDYDgd{/fkd$$IflF" U t6    44 la ! !! !"!w $$Ifa$gd) $$Ifa$gdg $Ifgd{/fkd$$$IflF" U t6    44 la"!#!$!M!N!l!m!r!"j"|pp $$Ifa$gd{/ $$Ifa$gd{/ $da$gdFgdFfkd$$IflF" U t6    44 la k!l!m!q!r!!"""N"P"R"T"f"h"j"ªm^O:m:m(h>1 hFCJKHOJPJQJnHtHh>1 h;CJKHOJQJh>1 hFCJKHOJQJ(h>1 hFCJKHOJPJQJnHtH+h>1 hF5CJKHOJPJQJnHtH"h>1 h;5CJKHOJQJo(.h>1 hF5CJKHOJPJQJnHo(tH#h>1 hF5CJKHOJQJaJ&h>1 hF5CJKHOJQJaJo(h>1 hFCJo(h>1 hF5CJaJo(j"l"|"""$$1$Ifa$gdg $Ifgd{/ekd$$Ifl,F3 > O6    44 laj"l"z"|""""""""""" ###.#0#2#\#^#l#x#z#|##ưvh[vh[vh[vG'h>1 h+CJKHPJaJnHo(tHh>1 hgCJKHaJh>1 hgCJKHaJo($h>1 hgCJKHOJQJ^JaJ$h>1 hgCJKHOJQJ^JaJ'h>1 hgCJKHOJQJ^JaJo(*h>1 hg5CJKHOJQJ^JaJo($h>1 hgCJKHPJaJnHtH'h>1 hgCJKHPJaJnHo(tH$h>1 hFCJKHOJQJ^JaJ"""""$$1$Ifa$gdg $Ifgd{/ekd$$Ifl,F3 > O6    44 la""##0#$$1$Ifa$gdg $Ifgd{/ekd$$Ifl,F3 > O6    44 la0#2#^#l#z#$$1$Ifa$gdg $Ifgd{/ekd$$Ifl,F3 > O6    44 laz#|###$vv$$1$Ifa$gdg$IfVDKWDY^`gd (ekd$$Ifl,F3 > O6    44 la###$$$<$H$R$T$V$X$r$$$$$ððk]F2&h>1 hF5CJKHOJQJaJo(,h>1 hFB*CJPJaJnHo(phtHh>1 hF5CJaJo(&h>1 hF5CJPJaJnHo(tHh>1 hF5CJaJ#h>1 hFCJPJaJnHo(tH$h>1 h/CJKHOJQJ^JaJ$h>1 h/CJKHOJQJ^JaJ'h>1 h/CJKHOJQJ^JaJo(*h>1 h/5CJKHOJQJ^JaJo(#h>1 h/CJKHaJnH o(tH $$<$H$T$vv$$1$Ifa$gdg$IfVDKWDY^`gd (ekd$$Ifl,F3 > O6    44 laT$V$X$$$$$zRF: $$Ifa$gd{/ $$Ifa$gd{/(<TPL HD@< ^gdF $da$gdFTQ gdFekd$$Ifl,F3 > O6    44 la$$$$$$$$"%$%&%(%8%<%>%V%X%ñ՛ՅueuPG9,h>1 h&S(CJKHaJh>1 h&S(CJKHaJo(h>1 hFQJ(h>1 hFCJKHOJPJQJnHtHh>1 h;CJKHOJQJo(h>1 hFCJKHOJQJo(+h>1 hFCJKHOJPJQJnHo(tH+h>1 hF5CJKHOJPJQJnHtH"h>1 h;5CJKHOJQJo("h>1 hF5CJKHOJQJo(.h>1 hF5CJKHOJPJQJnHo(tH#h>1 hF5CJKHOJQJaJ$(%<%>%X%l%%{{$$1$Ifa$gdE4 $Ifgd{/`kd$$IflF '!@ @  t!    4 la $$Ifa$gd{/X%l%%%%%%%%%%%%%&ɻꟃiiOAh>1 hf"OCJKHaJo(3h>1 h&S(CJKHOJPJQJ^JaJnHo(tH3h>1 h4CJKHOJPJQJ^JaJnHo(tH6h>1 h&S(5CJKHOJPJQJ^JaJnHo(tH6h>1 h45CJKHOJPJQJ^JaJnHo(tHh>1 h&S(CJKHaJo(h>1 h&S(OJQJaJ'h>1 h&S(CJKHOJQJ^JaJo(*h>1 h&S(5CJKHOJQJ^JaJo(%%%%%$$1$Ifa$gdE4 $Ifgd{/`kd$$IflF '!@ @  t!    4 la%%&&&$$1$Ifa$gd ( $Ifgd{/`kdr$$IflF '!@ @  t!    4 la&&&&&&&&6&7&E&F&P&Z&䰘wiwV@,'h>1 h&S(CJKHOJQJ^JaJo(*h>1 h&S(5CJKHOJQJ^JaJo($h>1 h&S(CJKHPJaJnHtHh>1 h&S(CJKHaJo('h>1 h&S(CJKHPJaJnHo(tHh>1 hf"OOJQJaJ/h>1 hf"OCJKHOJQJ^JaJnH o(tH 3h>1 hf"OCJKHOJPJQJ^JaJnHo(tH2h>1 hf"O5CJKHOJQJ^JaJnH o(tH 6h>1 hf"O5CJKHOJPJQJ^JaJnHo(tH&&F&P&Z&$$1$Ifa$gdE4 $Ifgd{/`kd$$IflF '!@ @  t!    4 laZ&[&\&&&&& '0'C'}}}}} $$Ifa$gd{/gdF $da$gdFgdF`kdX$$IflF '!@ @  t!    4 la Z&[&\&&&&&&&&& ' '/'0'B'C'E'dzwgwSwgwS@$h>1 hFCJOJQJaJnHtH'h>1 hF5CJOJQJaJnHtHh>1 hF5CJKHaJo(*h>1 hF5CJKHPJaJnHo(tHh>1 hF5CJKHaJh>1 hF5CJaJh>1 hFCJaJo(&h>1 hF5CJPJaJnHo(tHh>1 hF5CJaJo(h>1 hF5CJaJ#h>1 hFCJPJaJnHo(tHh>1 h&S(OJQJaJC'D'E'Z'p''' $$Ifa$gd{/ $Ifgd{/`kd$$If4F H&<<d&    4 af4E'Z'_'`'f'g'k'l'p'''''''''''''ڼڅraO@h>1 h{CJOJQJaJ#h>1 h{5CJOJQJ^JaJ h>1 h{CJPJaJnHtH$h>1 hFCJOJQJaJnHtH#h>1 hwCJPJaJnHo(tH h>1 hFCJPJaJnHtH&h>1 hE45CJPJaJnHo(tH#h>1 hF5CJPJaJnHtHh>1 hFCJaJo(#h>1 hFCJPJaJnHo(tH&h>1 hF5CJPJaJnHo(tH'''''''vmaaaa $$Ifa$gd{ $Ifgd{/kdL$$If4rn H&d&4 af4''(((2(3(=(?(@(J(L(Y(g(y(((((((((())))))+)A)O)])n))λxixiixixixixiiih>1 h5CJOJQJaJh>1 h5CJOJQJaJo(h>1 h55CJOJQJaJ"h>1 h55CJOJQJaJo( h>1 h5CJPJaJnHtH$h>1 h{CJOJQJaJnHtH h>1 h{CJPJaJnHtHh>1 h{CJOJQJaJ"h>1 h{5CJOJQJaJo(#'(((2({o7. $Ifgd{/7kdm$$IfH&d&d&4 a $$Ifa$gd{/kd$$Ifrn H&d&4 a2(?(L(Y(f(g(y(((((of $Ifgd{/kd$$Ifrn H&d&4 a $$Ifa$gd5 ((()))*){rffff $$Ifa$gd5 $Ifgd{/kdQ$$Ifrn H&d&4 a*)+)A)O)])n)){rffff $$Ifa$gd5 $Ifgd{/kd$$Ifrn H&d&4 a)))))**++++{vnnbbbYYY $7$8$H$a$ $7$8$H$a$gdF$a$gdFgdFkdi$$Ifrn H&d&4 a ))))))**L*M*N*O*X*e******************0+1++++++++++++++++ָĦָ֛֦Ħָ֦ċyyyyyy#h>1 hOCJPJaJnHo(tHh>1 hFCJaJnHo(tHh>1 hFCJaJ#h>1 h >CJPJaJnHo(tHh>1 hFCJaJo(#h>1 hFCJPJaJnHo(tH h>1 hFCJPJaJnHtH/h>1 hFCJOJPJQJ^JaJnHo(tH/++++++++,,,,-,9,:,;,U,V,W,X,ȼȦwk]K8%h>1 hB*CJOJQJaJph#h>1 hCJPJaJnHo(tHh>1 h5CJaJo(h>1 h5CJaJ9h>1 h5CJKHOJPJQJ\^JaJnHo(tHh>1 h5o(h>1 h5+h>1 hCJOJQJ^JaJnHo(tHh>1 hnHo(tHh>1 hnHtHh>1 hFPJnHo(tHh>1 hFCJaJo(#h>1 hFCJPJaJnHo(tH++++:,;,V,W,X,d,o,$$If^a$ $If^7$8$H$$da$ $7$8$H$a$ X,a,b,c,d,l,m,n,o,p,,,,,,-+-,-@-H-I-e-f-n-o---------..:.^.׿׿ײנ||u|hh\|h>1 hEEnHo(tHh>1 hEEOJQJ^J h>1 hEE h>1 hEEOJQJ^JnHtHh>1 hEECJaJh>1 hEEo(#h>1 h5B*CJaJo(phh>1 hOJQJaJ/h>1 h@ 5B*CJPJaJnHo(phtH/h>1 h5B*CJPJaJnHo(phtH h>1 h5B*CJaJph$o,p,,,,,,,uuuuu$$If^a$$$If^a$okd$$IfTl4TF "$  t1%6    44 laf4T,,-!-#-)-+-i`QQQQ$d$Ifa$gdEE v$$Ifa$kd~$$IfTl4Tr ""$  t1%644 laf4T+-,-@-B-D-F-H-i`QQQQ$d$Ifa$gdEE v$$Ifa$kd3$$IfTl4Tr ""$  t1%644 laf4TH-I-f-h-j-l-n-i`QQQQ$d$Ifa$gdEE v$$Ifa$kd$$IfTl4Tr ""$  t1%644 laf4Tn-o------i^OOOO$d$Ifa$gdEE v$$G$Ifa$kd$$IfTl4Tr ""$  t1%644 laf4T-------i`QQQQ$d$Ifa$gdEE v$$Ifa$kdR $$IfTl4Tr ""$  t1%644 laf4T----...i`QQQQ$d$Ifa$gdEE v$$Ifa$kd!$$IfTl4Tr ""$  t1%644 laf4T..:.F.L.X.^.i`QQQQ$d$Ifa$gdEE v$$Ifa$kd!$$IfTl4r ""$  t1%644 laf4T^._......i`QQQQ$d$Ifa$gdEE v$$Ifa$kdq"$$IfTl4Tr ""$  t1%644 laf4T^._........///,/.///2/3/@/A/K/L/M/f/h/i/l/m///Ͻ{{{ggS{&h>1 h&65CJPJaJnHo(tH&h>1 hu/ 5CJPJaJnHo(tHh>1 h5CJaJo(&h>1 hEE5CJPJaJnHo(tH&h>1 h5CJPJaJnHo(tHh>1 h5CJaJ#h>1 hCJPJaJnHo(tHh>1 hEEOJQJ^Jh>1 hEECJaJh>1 hEEo( h>1 hEEOJQJ^JnHtH.......i`QQQQ$d$Ifa$gdEE v$$Ifa$kd&#$$IfTl4Tr ""$  t1%644 laf4T...////"060ig_g_gYL$$If^a$^$da$kd#$$IfTl4Tr ""$  t1%644 laf4T////////000"0#0$0%0&0İĞrWrE-E-/h>1 h5B*CJPJaJnHo(phtH#h>1 h5B*CJaJo(ph4h>1 hGB*CJOJPJQJaJnHo(phtH(h>1 hB*CJOJQJaJo(ph,h>1 hB*CJPJaJnHo(phtH#h>1 hCJPJaJnHo(tH&h>1 hu/ 5CJPJaJnHo(tH&h>1 h5CJPJaJnHo(tHh>1 h5CJaJ5h>1 h5CJOJPJQJ\^JaJnHo(tH&05060a0b00000 11K1L1Q1R1111112 22*2+282G2Y2Z2`2g2v222222222ĭppeepepepeeh>1 hCJaJ'h>1 hCJKHPJaJnHo(tH h>1 hh>1 h5CJKHaJh>1 hCJKHaJ h>1 h,h>1 h5B*CJPJaJnHphtH/h>1 h5B*CJPJaJnHo(phtH h>1 h5B*CJaJph#h>1 h5B*CJaJo(ph'60L0b000001^Ld$1$7$8$H$Ifgd_kd$$$IfTֈ ~4 T$ p T$aT$$If^a$151A1G1I1K1L1AkdI%$$IfTֈ ~4 T$ p T$aT$d$1$7$8$H$Ifa$gdt $d$1$7$8$H$Ifa$gdL1e1u11111$d$1$7$8$H$Ifa$gdt $d$1$7$8$H$Ifa$gdd$1$7$8$H$Ifgd_11$kd&$$IfTֈ ~4 T$ p  <T$ap<T1111111$d$1$7$8$H$Ifa$gdt $d$1$7$8$H$Ifa$gdd$1$7$8$H$Ifgd_11$kdT'$$IfTֈ ~4 T$ p  <T$ap<T1 22!2&2(2*2$d$1$7$8$H$Ifa$gdt $d$1$7$8$H$Ifa$gdXd$1$7$8$H$Ifgd_*2+2$kd($$IfTֈ ~4 T$ p  <T$ap<T+282H2P2U2W2Y2$d$1$7$8$H$Ifa$gdt $d$1$7$8$H$Ifa$gdXd$1$7$8$H$Ifgd_Y2Z2$kd)$$IfTֈ ~4 T$ p  <T$ap<TZ2g2w22222$d$1$7$8$H$Ifa$gdt $d$1$7$8$H$Ifa$gdd$1$7$8$H$Ifgd_22$kd8+$$IfTֈ ~4 T$ p  <T$ap<T2222222$d$1$7$8$H$Ifa$gdt $d$1$7$8$H$Ifa$gdd$1$7$8$H$Ifgd_22$kd,$$IfTֈ ~4 T$ p  <T$ap<T2222222$d$1$7$8$H$Ifa$gdt $d$1$7$8$H$Ifa$gdd$1$7$8$H$Ifgd_22223!3"3Z3[34446484444444F5H55555ʸ씈t`RtA h>1 h5B*CJaJphh>1 h5CJaJo(&h>1 h85CJPJaJnHo(tH&h>1 h5CJPJaJnHo(tHh>1 h5CJaJ#h>1 hCJPJaJnHo(tH#h>1 hlCJPJaJnHo(tH#h>1 hCJPJaJnHo(tH'h>1 hCJKHPJaJnHo(tHh>1 hCJKHaJo( h>1 hh>1 hCJKHaJ22$kd-$$IfTֈ ~4 T$ p  <T$ap<T2[34$4.42464$d$1$7$8$H$Ifa$gdt $d$1$7$8$H$Ifa$gdd$1$7$8$H$Ifgdm6484$kd/$$IfTֈ ~4 T$ p  <T$ap<T84P4p44444$d$1$7$8$H$Ifa$gdt $d$1$7$8$H$Ifa$gdd$1$7$8$H$Ifgd_444$"kdh0$$IfTֈ ~4 T$ p  <T$ap<T45556666*636{fW$d,$Ifa$gdV$d$1$7$8$H$Ifa$gdVd$1$7$8$H$Ifgd_]kd1$$IflFP" "    4 la $If^$da$ 566*63646Y6b6c666666666666667 7 777&7'7<7=7E7F7]7t7777777777777ɾɾɾɾɾԪɾɾԘɾԊԊԊɾԘɾx#h>1 hCJPJaJnHo(tHh>1 h8CJKHaJo(#h>1 h8CJPJaJnHo(tH'h>1 h8CJKHPJaJnHo(tHh>1 h8OJQJh>1 h8CJaJh>1 h8CJKHaJh>1 h5OJQJ#h>1 h5B*CJaJo(ph.3646M6Y6b6zk$d,$Ifa$gdV$d$1$7$8$H$Ifa$gdVd$1$7$8$H$Ifgd_]kd)2$$IflFP" "    4 lab6c6666zk$d,$Ifa$gdV$d$1$7$8$H$Ifa$gdVd$1$7$8$H$Ifgd_]kd2$$IflFP" "    4 la66666zk$d,$Ifa$gdV$d$1$7$8$H$Ifa$gdVXd$1$7$8$H$Ifgdkp]kd+3$$IflFP" "    4 la66666zk$d,$Ifa$gdV$d$1$7$8$H$Ifa$gdVXd$1$7$8$H$Ifgdkp]kd3$$IflFP" "    4 la6667 7zk$d,$Ifa$gdV$d$1$7$8$H$Ifa$gdVd$1$7$8$H$Ifgdkp]kd-4$$IflFP" "    4 la 7 777&7zk$d,$Ifa$gdV$d$1$7$8$H$Ifa$gdVd$1$7$8$H$Ifgdkp]kd4$$IflFP" "    4 la&7'747<7E7zk$d,$Ifa$gdV$d$1$7$8$H$Ifa$gdVd$1$7$8$H$Ifgdkp]kd/5$$IflFP" "    4 laE7F7777zk$d,$Ifa$gdV$d$1$7$8$H$Ifa$gdVd$1$7$8$H$Ifgdm]kd5$$IflFP" "    4 la77777xg$d,$4$Ifa$gdV$d$1$7$8$H$Ifa$gdVd$1$7$8$H$Ifgdkp_kd16$$Ifl8FP" "    4 la7777799&;';;;;;??B?C?7$8$H$$da$]kd6$$IflFP" "    4 la777.8/8f8g8888899Y9Z99999993:4:k:l:::::;;%;';`;a;;;;;;@<A<B<<<<<<<<<>!>t>u>>>??ݯ%h>1 h5CJPJ\nHo(tH"h>1 h5CJPJ\nHtHh>1 h5CJ\h>1 hCJPJnHo(tHh>1 hCJPJnHo(tHh>1 hCJo(h>1 hCJ:??A?B?C?D?o?p????????????????۾}kZkZBkB/h>1 hm5B*CJPJaJnHo(phtH h>1 hm5B*CJaJph#h>1 hm5B*CJaJo(ph(h>1 hB*CJOJQJaJo(phh>1 h-CJh>1 hCJPJnHo(tHh>1 hCJh>1 hCJo(9h>1 h5CJKHOJPJQJ\^JaJnHo(tHh>1 h5o(h>1 h5#h>1 hCJPJaJnHo(tHC??????@3@4@Rkd77$$Iflr4{"7m t64 la$If^gd7 $If^^$da$?????@@@ @!@0@1@2@3@4@9@:@E@I@J@K@ϽϽϽϽϡoZG%h>1 hB*CJOJQJaJph(h>1 hB*CJOJQJaJo(ph#h>1 h5B*CJaJo(phh>1 hOJQJ(h>1 hB*CJOJQJaJo(phh>1 hmOJQJ h>1 hm5B*CJaJph#h>1 hm5B*CJaJo(ph/h>1 hm5B*CJPJaJnHo(phtH/h>1 h@ 5B*CJPJaJnHo(phtH4@5@6@7@8@9@:@E@F@G@H@I@`kd7$$Iflr4{"7m t64 la $If^$$If^a$ I@J@\@e@i@m@q@wjj]]]$If^gd$$If^a$kd8$$Iflr4{"7m t64 laK@L@N@[@\@d@e@h@i@m@p@q@r@@@@@@@@@@@ҢwaVҢ;ҢaV4h>1 hyhB*CJOJPJQJaJnHo(phtHh>1 hOJQJ+h>1 h5B*CJOJQJaJo(ph+h>1 hl&5B*CJOJQJaJo(ph(h>1 hl&B*CJOJQJaJo(ph(h>1 hB*CJOJQJaJo(ph4h>1 hB*CJOJPJQJaJnHo(phtH%h>1 hB*CJOJQJaJph4h>1 hl&B*CJOJPJQJaJnHo(phtHq@r@@@@@@wjj]]]$If^gd$$If^a$kd;9$$Iflr4{"7m t64 la@@@@@@@@wjZZMMM$If^gd$$If^a$gdl&$$If^a$kd9$$Iflr4{"7m t64 la@@@@@@@@@@@ A A8A=A@AAAEAFAQAgAiAmApAqAuAvAAAAAAAAAAAAAAAAAAA׼צ׼צ׼צ׼צ׼צh>1 hl&OJQJnHtHh>1 hl&OJQJ+h>1 hl&5B*CJOJQJaJo(ph4h>1 hl&B*CJOJPJQJaJnHo(phtH(h>1 hl&B*CJOJQJaJo(ph%h>1 hl&B*CJOJQJaJph,@@@ AA9A=AAAEAwjjjj]]]$If^gd$$If^a$kd:$$Iflr4{"7m t64 laEAFAQAiAmAqAuAwjj]]]$If^gd$$If^a$kdK;$$Iflr4{"7m t64 lauAvAAAAAAwjj]]]$If^gd$$If^a$kd;$$Iflr4{"7m t64 laAAAAAAAwjj]]]$If^gd$$If^a$kd<$$Iflr4{"7m t64 laAAAB B$B(Bwjj]]]$If^gd$$If^a$kd[=$$Iflr4{"7m t64 laAAAB B#B$B(B)BCBfBjBmBnBrBsBwBxByBBBBBBBBBBBBBBBBBBBʷʢ}ʷʢrr]rʢʢr(h>1 hl&5B*CJOJQJaJphh>1 hl&OJQJh>1 hl&OJQJnHtH+h>1 hl&5B*CJOJQJaJo(ph(h>1 hl&B*CJOJQJaJo(ph%h>1 hl&B*CJOJQJaJph4h>1 hl&B*CJOJPJQJaJnHo(phtH4h>1 h@ B*CJOJPJQJaJnHo(phtH$(B)BCBfBjBnBrBwjj]]]$If^gd$$If^a$kd >$$Iflr4{"7m t64 larBsBtBuBvBwBxBwjj]]]$If^gd$$If^a$kd>$$Iflr4{"7m t64 laxByBBBBBBwjj]]]$If^gd$$If^a$kdk?$$Iflr4{"7m t64 laBBBBBBBwjj]]]$If^gd$$If^a$kd@$$Iflr4{"7m t64 laBBBBBBCwjj]]]$If^gd$$If^a$kd@$$Iflr4{"7m t64 laBBBCCCC'C,C/C0C4C5C6C7C9CCCLCVC[C^C_CкМкnnS>n>(h>1 hyhB*CJOJQJaJo(ph4h>1 hYB*CJOJPJQJaJnHo(phtH4h>1 hyhB*CJOJPJQJaJnHo(phtH%h>1 hyhB*CJOJQJaJph%h>1 hl&B*CJOJQJaJphh>1 hl&OJQJ+h>1 hl&5B*CJOJQJaJo(ph(h>1 hl&B*CJOJQJaJo(ph4h>1 hl&B*CJOJPJQJaJnHo(phtHCCC(C,C0C4Cwjj]]]$If^gd$$If^a$kd{A$$Iflr4{"7m t64 la4C5CCCWC[C_CcCwggZZZ$If^gd$$If^a$gdL]kd+B$$Iflr4{"7m t64 la_CcCdChCiCjCzC{C~CCCCCCCCCCCCCCCCCCCC DDDDDD+D,D=D?D@DGDHD޸ޓxxxxixxiɓɓxh>1 hyhOJQJnHtH4h>1 hyhB*CJOJPJQJaJnHo(phtH%h>1 hyhB*CJOJQJaJph#h>1 hyh5B*CJaJo(ph h>1 hyh5B*CJaJph(h>1 hyhB*CJOJQJaJo(phh>1 hyhOJQJ+h>1 hyh5B*CJOJQJaJo(ph(cCdCeCfCgChCiCwjj]]]$If^gd$$If^a$kdB$$Iflr4{"7m t64 laiCjC{C|C}C~CCwjj]]]$If^gd$$If^a$kdC$$Iflr4{"7m t64 laCCCCCCCwjj]]]$If^gd$$If^a$kd;D$$Iflr4{"7m t64 laCCCCCCCwjj]]]$If^gd$$If^a$kdD$$Iflr4{"7m t64 laCCCDDDDwjj]]]$If^gd$$If^a$kdE$$Iflr4{"7m t64 laDD,D>DDDHDNDwjj]]]$If^gd$$If^a$kdKF$$Iflr4{"7m t64 laHDIDKDNDODZD[DlDqDtDuDyDzDDDDDDDDDDDDDDDD㾫{;{{i`P`P`P`h>1 hCJPJnHo(tHh>1 hCJ#h>1 hCJPJaJnHo(tH4h>1 hyhB*CJOJPJQJaJnHo(phtH(h>1 hyhB*CJOJQJaJo(ph%h>1 hyhB*CJOJQJaJphh>1 hyhOJQJnHtH+h>1 hyh5B*CJOJQJaJo(ph7h>1 hyh5B*CJOJPJQJaJnHo(phtHNDOD[DmDqDuDyDwjj]]]$If^gd$$If^a$kdF$$Iflr4{"7m t64 layDzDDDDDDwjj]]]$If^gd$$If^a$kdG$$Iflr4{"7m t64 laDDD[E\EIIOIPIIIIwummmummmum$da$kd[H$$Iflr4{"7m t64 la DDDDD/ESEYE[E\EuEvE|E}EEEEEEEEEEEEEEEEE F FjFkFFFFF)G*GGGGG@HAHHHHHIIIIINI̽ܭܛh>1 h5CJaJ#h>1 hCJPJaJnHo(tHh>1 h.CJPJnHo(tHh>1 hBCJPJnHtHh>1 hBCJPJnHo(tHh>1 hCJPJnHo(tHh>1 hCJh>1 hCJo(7NIOIPIIIIIIIIIJJ1 h$CJaJo(#h>1 h$CJPJaJnHo(tHh>1 h$CJaJh>1 h.CJPJnHo(tHh>1 hCJo(h>1 hCJ9h>1 h5CJKHOJPJQJ\^JaJnHo(tHh>1 h5o(h>1 h5#h>1 hCJPJaJnHo(tHh>1 hBCJPJnHo(tHh>1 hCJPJnHo(tHh>1 h5CJaJo(IIIICJDJKKLL#M$M4M5M_O`OOOQQZS[SSS$U $da$gd>d\gd$gd$ $da$gd$$da$7$8$H$JJJJJJJKK KKKKKK8K1 h$CJo(h>1 h$CJPJnHo(tHh>1 h$CJ#h>1 h$CJPJaJnHo(tHh>1 h$CJaJo(h>1 h$CJaJ h>1 h$CJPJaJnHtH'h>1 h$CJPJQJaJnHo(tH8sLxLLLLLLLLLLLMMM!M"M#M$M-M3M4M5MTNUNVNYNeNiNNNNNNNNN_O`OOOOOFPJPPPPP*Qʼ܀h>1 h$5CJ#h>1 h$CJOJQJ^JaJo(&h>1 h$5CJPJaJnHo(tHh>1 h$5CJaJh>1 h$5CJaJo(#h>1 h$CJPJaJnHo(tHh>1 h$CJo(h>1 h$CJh>1 h$CJPJnHo(tH1*Q+Q.QgQhQlQmQnQtQQQQQQQQQRRNRQRdReRkRRRSS"SWSZS[SSS$U%UUUUUɿɿɿ{qeɿɿqh>1 h$5CJo(h>1 h$5CJhKUlh$CJo(hKUlh>0JCJo(hKUlh>0JCJhKUlh>CJPJnHo(tHhKUlh>CJo(hKUlh>CJh>1 h$CJo(h>1 h$CJhKUlh&A5CJ\hKUlh&ACJPJnHo(tHhKUlh&ACJhKUlh$CJ'$U%UUUUUXX6Z7ZZZ\\^^^^D_E___4a5a6agahad\gd$ $da$gd> $da$gd$UVVVVVVWW^WqWtW}WWWWWWWXXZ#Z6Z7Z`ZjZZZ[[[[\\]\^\~\\\\\\] ]Z][]`]]]]]]]*^+^hKUlh>CJPJnHo(tHhKUlh>CJhKUlh>CJo(h1CJPJnHo(tHh$CJPJnHo(tHjh>1 h$CJUh>1 h$5CJo(h>1 h$5CJh>1 h$CJo(h>1 h$CJ7+^9^:^^^^^^^^^^^^^D_E_J_K_______4a5a6a@aAadaga¸wi]wh>1 h$5CJaJh>1 h$5CJaJo(&h>1 h$5CJPJaJnHo(tH&h>1 he95CJPJaJnHo(tHh>1 h$CJPJnHo(tHh>1 h$CJh>1 h$CJo(h>1 h$5CJhKUlh$CJPJnHo(tHhKUlh>CJPJnHo(tHhKUlh>CJhKUlh>CJo(gaha{a~abbbbrcscd!d#d$dXd]dnezeee~gggglhvhhhhhhhiiViYiiiiijjkk$k'kUk]keknkvkkkkkkkkkkkkkkkǾhKUlhZyCJPJnHo(tHhKUlhZyCJo(hKUlhZyCJhKUlh$CJhKUlh$CJo(h>1 h$CJo(h>1 h$CJ#h>1 h$CJKHOJQJaJo(@ha#d$dee~ggiikkllllmmnnoooo&r $da$gd=q7$8$H$ ^`$da$ $da$gdeR $da$gd$kOlWlllllll9m:mVmWm_m`mmmmmmmmnnnn¸ym_m_m_h>1 h5CJaJo(h>1 h5CJaJ3h>1 hCJKHOJ PJQJ ^J aJnHo(tHh>1 hCJo(h>1 hCJ#h>1 hCJPJaJnHo(tHh>1 h5o(h>1 h5h>1 h5|CJPJnHo(tHh>1 h$CJo(h>1 h$CJhKUlh$CJo(hKUlh$CJnnn n!nHnNnQnUndnenjnpnqnnnnn o ooo9o:o@oooooooop1pFpHpgpppppppppppppɹ٩ُُٙ٩ُُُُُ|||||||||h>1 h=qCJo(h>1 h=qCJh>1 hCJo(h>1 h*@CJPJnHo(tHh>1 hVCJQJ]aJo(h>1 hVCJPJnHo(tHh>1 hCJPJnHo(tHh>1 hCJ9h>1 h5CJKHOJPJQJ\^JaJnHo(tH0ppqqQqRqqqqqqqqqrr#r%r&r'r2r3r1 hCJh>1 hc!CJPJnHo(tHh>1 hZ6CJo(h>1 hZ6CJPJnHtHh>1 h!CJPJnHo(tHh>1 h!CJh>1 hZ6CJPJnHo(tHh>1 hZ6CJh>1 h=qCJPJnHo(tHh>1 h=qCJo(h>1 h=qCJ+&r'rssssuuvv1w2wwwExFxxx{{{{ $da$gd67$8$H$^ $da$gd2 $da$gd=q$da$ $da$gdZ6sssssssstttt tt*t;t1 h=qCJPJnHtHh>1 h=qCJo(h>1 h=qCJPJnHo(tHh>1 h=qCJh>1 hCJPJnHo(tHh>1 hCJo(Fuuuuuuuuuuuuusvtvvvvvvvvvvvwwwww$w/w0w1w2wOwVw潴zjah>1 h2CJh>1 h2CJPJnHo(tHh>1 hd9CJPJnHo(tHh>1 h`(CJPJnHo(tHh>1 hmCJPJnHo(tHh>1 hCJo(h>1 hCJh>1 hCJPJnHo(tHh>1 h=qCJPJnHtHh>1 h=qCJo(h>1 h=qCJh>1 h=qCJPJnHo(tH$Vwgwhwiwjwwwwwwwwwwwwx xx,x-x;xCxFxxxxxxxx(y)y5y6y7yճzjZh>1 h k`CJPJnHo(tHh>1 hCJPJnHo(tHh>1 hp"CJPJnHo(tHh>1 hCJPJnHo(tHh>1 hCJh>1 hCJPJnHo(tHh>1 hCJo(h>1 h2CJh>1 h2CJPJnHtHh>1 hmCJPJnHo(tHh>1 h2CJPJnHo(tHh>1 h2CJo(#7y8y;y?yByCyfygyhyyyyyyyyy1z2z3z4zDzEzVz[zzzG{H{{{{{{{{{ؾؾؾصؾΠi`h>1 h6CJ9h>1 h5CJKHOJPJQJ\^JaJnHo(tHh>1 h5CJaJo(h>1 h5CJaJ(h>1 hB*CJOJQJaJo(phh>1 hp"CJh>1 hCJPJnHo(tHh>1 hCJo(h>1 hCJh>1 hCJPJnHo(tHh>1 h=2CJPJnHtH${{'|4|E|F|R|S|T|V|k|l|p|q|w|x|||}|||||||||||||}"}#}&}<}>}@}I}J}M}N}O}R}^}_}c}d}j}k}o}p}}}}}}}}}}}}}}~3~5~6~9~M~N~P~Y~\~]~_~t~u~y~z~~h>1 hB9CJPJnHo(tHh>1 h6CJPJnHo(tHh>1 h6CJh>1 h6CJo(P~~~~~~~~~~~~~~~~~~02BCDGHO_`acpstw{| ()SZ_hityz|ʿʿh>1 h6CJaJ#h>1 h6CJPJaJnHo(tHh>1 h6CJPJnHo(tHh>1 h6CJh>1 h6CJo(KrsЃփvn$1$Ifhkd I$$Ifl4?F  6    44 la]f4 $$1$Ifa$$da$ $da$gd6 ̀πЀӀ$6DEHWhҁԁ!"$2458@ABDOQTUX\] ݱh>1 h6CJPJnHtH#h>1 h6CJPJaJnHo(tHh>1 h6CJaJh>1 h6CJPJnHo(tHh>1 h6CJo(h>1 h6CJFfklpqrsŷŷŷkQ9/h>1 h5CJKHOJPJQJaJnHtH2h>1 h_ 5CJKHOJPJQJaJnHo(tH2h>1 h5CJKHOJPJQJaJnHo(tH#h>1 h5CJKHOJQJaJ&h>1 h5CJKHOJQJaJo(h>1 hQJ]o(h>1 h5CJaJo(h>1 h5CJaJh>1 hCJPJnHo(tHh>1 h6CJnH o(tH h>1 h6CJPJnHo(tHσЃՃփ"#*JKTtu|ð밥l_Pl_Pl_Pl_h>1 hs'VCJKHnHtHh>1 hs'VCJKHaJ$h>1 hs'VCJKHPJaJnHtH&h>1 h5CJKHOJQJaJo(#h>1 h5CJKHOJQJaJh>1 hCJKH$h>1 hCJKHPJaJnHtH'h>1 h_ CJKHPJaJnHo(tH'h>1 h@uCJKHPJaJnHo(tH'h>1 hCJKHPJaJnHo(tHփ e]QQC$$1$Ifa$gdkp $$Ifa$gdkp$1$IfkdI$$Ifl4?r)A644 la]f4 $$1$Ifa$"#*2:BJe]QQ $$Ifa$gdkp$1$IfkdJ$$Ifl?r)A644 la]$$1$Ifa$gdkpJKT\dltsk__QQ$$1$Ifa$gdkp $$Ifa$gdkp$1$IfkdJ$$Ifl?r)A644 la]tu|sk__QQ$$1$Ifa$gdkp $$Ifa$gdkp$1$IfkdK$$Ifl?r)A644 la]DŽsk__QQ$$1$Ifa$gdkp $$Ifa$gdkp$1$IfkdK$$Ifl?r)A644 la]DŽȄɄ+,BCDWXąЅх JKPQz{ɵvbv'h>1 h/<CJKHPJaJnHo(tHh>1 h/<CJKHaJo('h>1 hs'VCJKHPJaJnHo(tHh>1 hCJKH#h>1 h5CJKHOJQJaJ&h>1 h5CJKHOJQJaJo(h>1 hQJ]o(h>1 hs'VCJKHaJ$h>1 hs'VCJKHPJaJnHtHh>1 hs'VCJKH$DŽȄɄ,Cse]RRR $$1$Ifa$$1$IfVDWD^`kdL$$Ifl?r)A644 la]CDXhx~ppp$$1$Ifa$gdkp$1$IfxkdL$$Ifl?\644 la]~ppp$$1$Ifa$gdkp$1$Ifxkd M$$Ifl?\644 la]х~ppp$$1$Ifa$gdkp$1$IfxkdM$$Ifl?\644 la] 0@J~ppp$$1$Ifa$gdkp$1$IfxkdM$$Ifl?\644 la]JKQaqz~ppp$$1$Ifa$gdkp$1$IfxkdqN$$Ifl?\644 la]z{|͆߆~~~sss $$1$Ifa$$da$xkdN$$Ifl?\644 la]{|džȆ̆͆ކ߆ྴpV<2h>1 h}=5CJKHOJPJQJaJnHo(tH2h>1 h5CJKHOJPJQJaJnHo(tH$h>1 hCJKHOJQJ^JaJh>1 hCJKH#h>1 h5CJKHOJQJaJ&h>1 h5CJKHOJQJaJo(h>1 hCJo(h>1 h5CJaJo(&h>1 h@u5CJPJaJnHo(tHh>1 h5CJaJ&h>1 hs'V5CJPJaJnHo(tH߆ $$1$Ifa$$1$IfhkdaO$$Ifl4?Fq && &  6    44 la]f4 ͳlR8ͳ-h>1 hCJKH2h>1 h}=5CJKHOJPJQJaJnHo(tH2h>1 h5CJKHOJPJQJaJnHo(tH&h>1 h5CJKHOJQJaJo(0h>1 hCJKHOJPJQJ^JaJnHtH3h>1 hs'VCJKHOJPJQJ^JaJnHo(tH3h>1 h@uCJKHOJPJQJ^JaJnHo(tH3h>1 hCJKHOJPJQJ^JaJnHo(tH/h>1 h5CJKHOJPJQJaJnHtH ")/5phZLZL$$1$Ifa$gdIi$$1$Ifa$gdkp$1$IfkdO$$Ifl4?rq &&&'& 644 la]f4 "(/456_`gmtyz{ÇćŇ˽˽˲˽˽˲˽˽˲vYPh>1 hCJ9h>1 h5CJKHOJPJQJ\^JaJnHo(tHh>1 h5CJaJo(h>1 h5CJaJ&h>1 h|F85CJPJaJnHo(tHh>1 hPJnHo(tHh>1 h}=CJKHh>1 h}=CJKHaJo(h>1 h}=CJKHaJ$h>1 h}=CJKHPJaJnHtH'h>1 h}=CJKHPJaJnHo(tH56`gntzsk]O]O$$1$Ifa$gdIi$$1$Ifa$gdkp$1$IfkdP$$Ifl?rq '''''' 644 la]z{sk]O]O$$1$Ifa$gdIi$$1$Ifa$gdkp$1$IfkdMQ$$Ifl?rq '''''' 644 la]ćŇЈskkkek_VV $$Ifa$^7$8$H$$da$kdQ$$Ifl?rq '''''' 644 la] 89`a ̼̼ܧgMg2h>1 h4$.5CJKHOJPJQJaJnHo(tH2h>1 h5CJKHOJPJQJaJnHo(tH#h>1 h5CJKHOJQJaJ&h>1 h5CJKHOJQJaJo((h>1 hB*CJOJQJaJo(phh>1 h k`CJPJnHo(tHh>1 hDCJPJnHo(tHh>1 hCJPJnHo(tHh>1 hCJh>1 hCJo( 5=QYZ^U $$Ifa$kdR$$Iflֈh  ^"9U{!64 la $$Ifa$ 89YZ‰ɉщۉ܉ ʶyj`M$h>1 hDCJKHPJaJnHtHh>1 hDQJ\h>1 hDB*CJo(phh>1 hDOJQJ\nHtH&h>1 hDCJPJ\aJnHo(tHh>1 hDCJKHaJh>1 hDCJ\aJ'h>1 hDCJKHPJaJnHo(tHh>1 hOJQJ\nHtH#h>1 h5CJKHOJQJaJ&h>1 h5CJKHOJQJaJo(DkddS$$Iflֈh  ^"9U{!64 la$$1$Ifa$gdkp $$Ifa$gdkp $$Ifa$‰ɉщۉ y$$Ifa$$$1$Ifa$gdkp $$Ifa$gdkp $$Ifa$ $$Ifa$ۉ܉ g^UI;U$$1$Ifa$gdkp $$Ifa$gdkp $$Ifa$ $$Ifa$kd!T$$Iflֈh  ^"9U{!64 la:ACJ^UI;$$1$Ifa$gdkp $$Ifa$gdkp $$Ifa$kdT$$Iflֈh  ^"9U{!64 la $$Ifa$$:CJQ[\s|݊+3DEOryËċ̣qqhh>1 h2CJh>1 hCJPJnHtHh>1 hCJo(h>1 hCJh>1 hCJPJnHo(tHh>1 hDOJQJ\nHtHh>1 hDCJKHaJh>1 hDCJ\aJ'h>1 hDCJKHPJaJnHo(tH$h>1 hDCJKHPJaJnHtHh>1 hDOJQJ\%JQ[\sz|^UI $$Ifa$gdkp $$Ifa$kdU$$Iflֈh  ^"9U{!64 la $$Ifa$|PG $$Ifa$kdXV$$Iflֈh  ^"9U{!64 la $$Ifa$$$1$Ifa$gdkp6kdW$$Iflֈh  ^"9U{!64 la$$4$Ifa$gd $$Ifa$$$1$Ifa$gdkp $$Ifa$gdkp-.‹Ë/0ŌƌQR֎׎ ^`$da$$da$gd2 $da$ċŋƋNjʋڋ-./0ČŌƌߌWX+23úä}qc}úúZPh>1 h` CJo(h>1 h` CJh>1 h5CJaJo(h>1 h5CJaJ)h>1 h5CJPJ\aJnHo(tHh>1 h5o(h>1 h5+h>1 hCJOJPJQJaJnHo(tHh>1 hCJh>1 hCJo(h>1 h2CJPJnHtHh>1 h2CJo(h>1 h2CJh>1 h2CJPJnHo(tH3JMOPRՎ֎׎&'SUx}Џя #,MOlrvyݑߑ<@CEFŵŵŵŵŵŵ||h>1 h4$.CJPJnHtHh>1 h4$.CJo(h>1 h4$.CJPJnHo(tHh>1 h}CJPJnHo(tHh>1 hCJPJnHo(tHh>1 hCJh>1 hCJo(h>1 h` CJPJnHo(tHh>1 h` CJh>1 h` CJnH o(tH 0NOޑߑklPQ͗!E $$1$Ifa$7$8$H$$da$ $7$8$H$a$gd4$. $7$8$H$a$FIJMsÒ̒ޒ7@{L]_ؔrsjklmǽǽǴǴǴh>1 hAoCJPJnHo(tHh>1 h)5CJPJnHo(tHh>1 hCJh>1 hCJo(h>1 hCJPJnHo(tHh>1 h4$.CJo(h>1 h4$.CJPJnHo(tHh>1 h4$.CJPJnHtH:ȖҖ&*:?HIOUnox-0dgȘɘΘϘ٘vi^i^ih>1 hCJaJh>1 hCJPJaJh>1 hCJKHaJh>1 hCJKH'h>1 h5CJKHPJaJnHtHh>1 h5CJKHaJ3h>1 hCJKHOJ PJQJ ^J aJnHo(tHh>1 h4$.CJo(h>1 h4$.CJh>1 hCJPJnHo(tHh>1 hCJo(h>1 hCJE| $$1$Ifa$)!!$1$IfkdW$$Ifl %;IFC!%F1C*ppp$$$$44 laɘϘݘ" $$Ifa$ $$Ifa$gdkp $$Ifa$gd_٘ݘ"#3@AFGRV]ako™˙ϙٙݙޙ:;ȻȻȒoh>1 h@uCJPJnHo(tHh>1 hCJh>1 hCJo($h>1 hCJKHPJaJnHtHh>1 hCJaJh>1 hCJaJh>1 hCJKHaJh>1 hCJKH h>1 hCJPJaJnHtHh>1 hCJPJaJh>1 hCJPJaJo(&"#*3)!!$1$IfkdX$$IflY %;IFC!%F1C*ppp$$$$44 la3AGVao $$Ifa$ $$Ifa$gdkp $$Ifa$gd_) $$1$Ifa$kdZ$$IflY %;IFC!%F1C*ppp$$$$44 la™ϙݙޙ $$Ifa$ $$Ifa$gdkp $$Ifa$gd_<6...$da$7$8$H$kd?[$$IflYִ%;IFC!%wC*ppp    44 la;<123koƛǛЛћқӛ՛W[HL̼̼欜̜̜||h>1 h9CJPJnHo(tHh>1 hCJPJnHo(tHh>1 hleCJPJnHo(tHh>1 hvhCJPJnHo(tHh>1 hU0CJPJnHo(tHh>1 hCJo(h>1 h@uCJPJnHo(tHh>1 hCJh>1 h" CJPJnHo(tH0ԛ՛12mn67*+897$8$H$$da$012lmnߞܼ̬tfI=h>1 h5CJ\9h>1 h5CJKHOJPJQJ\^JaJnHo(tHh>1 h5CJaJo(h>1 h5CJaJ3h>1 hCJKHOJ PJQJ ^J aJnHo(tHh>1 h5o(h>1 h5h>1 hKHPJnHo(tHh>1 h{_CJPJnHo(tHh>1 hCJPJnHo(tHh>1 hCJo(h>1 hCJh>1 h9CJPJnHo(tH/012JU̟Пڟ.=@A23457;<AB|9h>1 h5CJKHOJPJQJ\^JaJnHo(tHh>1 h5CJaJo(h>1 h5CJaJ3h>1 hCJKHOJ PJQJ ^J aJnHo(tHh>1 hoCJPJnHo(tHh>1 hCJPJnHo(tHh>1 hCJo(h>1 hCJ0)*+/6Ȣɢ3478¶{{{kh>1 h-8CJPJnHo(tHh>1 h*1CJPJnHo(tH9h>1 h5CJKHOJPJQJ\^JaJnHo(tHh>1 h5CJaJo(h>1 h5CJaJ3h>1 hCJKHOJ PJQJ ^J aJnHo(tHh>1 hCJo(h>1 hCJh>1 hoCJPJnHo(tH 89~fp¦Ȧ>@BDlnˮoe]F,h>1 h5;CJPJ\aJnHo(tHh>1 h5h>1 h5o(h>1 hj5PJnHo(tHh>1 ho}_o(h>1 ho}_CJo(h>1 ho(h>1 hPJnHo(tH h>1 h9h>1 h5CJKHOJPJQJ\^JaJnHo(tHh>1 h5CJaJo(h>1 h5CJaJ3h>1 hCJKHOJ PJQJ ^J aJnHo(tH>@Bln&:` $$1$Ifa$$7$8$H$]a$ ^`$da$ $da$gdo}_7$8$H$ $&|~468ҷr`rF,2h>1 hk 5CJKHOJPJQJaJnHo(tH2h>1 h5CJKHOJPJQJaJnHo(tH#h>1 h5CJKHOJQJaJ&h>1 h5CJKHOJQJaJo(h>1 hPJnHo(tHh>1 hCJh>1 hCJPJnHo(tHh>1 hCJo(4h>1 h5;@KHOJPJQJ\nHo(tH&h>1 h5CJPJaJnHo(tHh>1 h5CJaJh>1 h5CJaJo(8:VZ\^`bdf~ԩ֩ةű{gUgUgUӊӊ{=/h>1 hk CJKHOJPJQJaJnHo(tH#h>1 h5CJKHOJQJaJ&h>1 h5CJKHOJQJaJo(h>1 hCJKHOJQJ$h>1 hCJKHPJaJnHtH'h>1 hk CJKHPJaJnHo(tH'h>1 h| CJKHPJaJnHo(tHh>1 hCJKHaJo('h>1 hCJKHPJaJnHo(tH/h>1 h5CJKHOJPJQJaJnHtH`bf֩ $$1$Ifa$$1$IfekdD\$$IflF"&J &&J%6    44 la5֩ة%6Esk__QQ$$1$Ifa$gd $$Ifa$gd$1$Ifkd\$$Iflr>"&J &&&&%644 la5%EFcܪ8XYst«߫9UVpqŬƬʬ٬ڬ ־֞֞֞֞֞֞֞}֞h>1 hk CJKHaJo($h>1 hk CJKHPJaJnHtH'h>1 hk CJKHPJaJnHo(tHh>1 hk 5CJaJ/h>1 hk CJKHOJPJQJaJnHo(tHh>1 hk CJKHOJQJh>1 hk CJKHaJh>1 hk 5CJ\aJ1EFctsaUUGG$$1$Ifa$gd $$Ifa$gdL$1$IfWD^L`kd\]$$Iflr>"&J ''''%644 la5ͪܪsk__QQ$$1$Ifa$gd $$Ifa$gd$1$Ifkd]$$Iflr>"&J ''''%644 la5)8IXsk__QQ$$1$Ifa$gd $$Ifa$gd$1$Ifkd^$$Iflr>"&J ''''%644 la5XYtsk__QQ$$1$Ifa$gd $$Ifa$gd$1$Ifkd*_$$Iflr>"&J ''''%644 la5«ѫ߫sk__QQ$$1$Ifa$gd $$Ifa$gd$1$Ifkd_$$Iflr>"&J ''''%644 la5+9GUsk]QQCC$$1$Ifa$gd $$Ifa$gd $1$IfWD` $1$Ifkd^`$$Iflr>"&J ''''%644 la5UVqsaUUGG$$1$Ifa$gd $$Ifa$gd $1$IfWDp^ `kd`$$Iflr>"&J ''''%644 la5ƬȬʬ׬٬sk__QQ$$1$Ifa$gd $$Ifa$gd$1$Ifkda$$Iflr>"&J ''''%644 la5٬ڬ saUUGG$$1$Ifa$gd $$Ifa$gd $1$IfWDp^ `kd,b$$Iflr>"&J ''''%644 la5/<IVcsk__QQ$$1$Ifa$gd $$Ifa$gd$1$Ifkdb$$Iflr>"&J ''''%644 la5./Icdopͭ !=YZuvîĮ߮23Mcd}~үӯ ̿̿̿ؔ̿̿̿ؔ̿$h>1 hk CJKHOJQJnHtHh>1 hk 5CJ\aJh>1 hk CJKHaJo(h>1 hk CJKHOJQJh>1 hk CJKHaJh>1 hk 5CJaJ$h>1 hk CJKHPJaJnHtH'h>1 hk CJKHPJaJnHo(tH2cdͭڭsaUUGG$$1$Ifa$gd $$Ifa$gd $1$IfWDp^ `kd`c$$Iflr>"&J ''''%644 la5 smaaSS$$1$Ifa$gd $$Ifa$gd$Ifkdc$$Iflr>"J ''''%644 la5 !/=KYsk__QQ$$1$Ifa$gd $$Ifa$gd$1$Ifkdd$$Iflr>"&J ''''%644 la5YZvsaUUGG$$1$Ifa$gd $$Ifa$gdD$1$IfWD^`Dkd.e$$Iflr>"&J ''''%644 la5ĮҮ߮saUUGG$$1$Ifa$gd $$Ifa$gd $1$IfWDp^ `kde$$Iflr>"&J ''''%644 la53@MXcsaUUGG$$1$Ifa$gd $$Ifa$gd $1$IfWD^` kdbf$$Iflr>"&J ''''%644 la5cd~sk__QQ$$1$Ifa$gd $$Ifa$gd$1$Ifkdf$$Iflr>"&J ''''%644 la5ӯsk__QQ$$1$Ifa$gd $$Ifa$gd$1$Ifkdg$$Iflr>"&J ''''%644 la5 "0>LZsk__QQ$$1$Ifa$gd $$Ifa$gd$1$Ifkd0h$$Iflr>"&J ''''%644 la5 !">Z[degkǰ23578UV`jkٱ2NOʽʽymymmmʽʽh>1 hk 5CJaJh>1 hk CJKHOJQJ'h>1 hbCJKHPJaJnHo(tHh>1 hk CJKHaJo($h>1 hk CJKHOJQJnHtHh>1 hk CJKHaJh>1 hk 5CJ\aJ$h>1 hk CJKHPJaJnHtH'h>1 hk CJKHPJaJnHo(tH*Z[ǰհsaUUGG$$1$Ifa$gd $$Ifa$gd$1$IfWD ^`kdh$$Iflr>"&J ''''%644 la5 sk__QQ$$1$Ifa$gd $$Ifa$gd$1$Ifkddi$$Iflr>"&J ''''%644 la534567sk__QQ$$1$Ifa$gd $$Ifa$gd$1$Ifkdi$$Iflr>"&J ''''%644 la578V[`ejsaUUGG$$1$Ifa$gd $$Ifa$gd $1$IfWD^` kdj$$Iflr>"&J ''''%644 la5jksaUUGG$$1$Ifa$gd $$Ifa$gd $1$IfWD^` kd2k$$Iflr>"&J ''''%644 la5˱ٱsaUUGG$$1$Ifa$gd $$Ifa$gd $1$IfWD^` kdk$$Iflr>"&J ''''%644 la5$2@NsaUUGG$$1$Ifa$gd $$Ifa$gd $1$IfWD^` kdfl$$Iflr>"&J ''''%644 la5NO˲ٲsaUUGG$$1$Ifa$gd $$Ifa$gd $1$IfWD^` kdm$$Iflr>"&J ''''%644 la5O˲.=LMNOVWXóƳٳ޳ҿҿkXkOEOEOEOh>1 hCJo(h>1 hCJ$h>1 hCJfHq &-jh>1 hCJUfHq &h>1 hCJaJnHtHh>1 h5CJaJ'h>1 h56PJ\]nHo(tHh>1 hPJnHo(tH$h>1 hk CJKHOJQJnHtHh>1 hk CJKHaJh>1 hk 5CJaJ'h>1 hk CJKHPJaJnHo(tH.;=JLsaUUGG$$1$Ifa$gd $$Ifa$gd $1$IfWD^` kdm$$Iflr>"&J ''''%644 la5LMNOVW״sqg_q___q_$da$ T^kd4n$$Iflr>"&J ''''%644 la5 ,-0MTYijmv״شλβ墒maMaBh>1 hCJaJ&h>1 h5CJPJaJnHo(tHh>1 h5CJaJ#h>1 hCJPJaJnHo(tHh>1 h CJh>1 h CJo(h>1 h,~CJPJnHo(tHh>1 h CJPJnHo(tHh>1 hCJ$h>1 hCJfHq &-jh>1 hCJUfHq &h>1 hCJo(h>1 hCJPJnHo(tH״ش!"R]kdn$$IfFrp#n0 .$    4 a%$!d$4$Ifa$gdFm%$!d$Ifa$gdFmd$If^`gdFmdgd2$da$ش !"&'()ϼrf]M?5h>1 h2>*CJh>1 h2CJnH o(tH h>1 h2CJPJnHo(tHh>1 h2CJh>1 h2>*CJaJ&h>1 h2>*CJOJQJnHo(tH'h>1 h2CJOJPJQJnHo(tHh>1 h2>*CJOJQJ'h>1 h2CJOJPJQJnHo(tH$h>1 h2CJOJPJQJnHtHh>1 h2CJaJh>1 h25CJo(h>1 h5CJaJo(h>1 h5CJo("#$)./01SpkdRo$$If\rp#n.$4 a$d$&dIfPa$gdFm$d$Ifa$gdFmZd$If^Z`gdFm)-./01ABQZ\]abijlvx{|ĵŵǵȵ̵͵ߵ +,-79:àڱ!h>1 h2hQCJnH o(tH #h>1 h2CJPJaJnHo(tHh>1 h2CJnH o(tH h>1 h2CJh>1 h2CJaJh>1 h2CJPJnHo(tHh>1 h2CJo(?19ABCDP\k\$d$Ifa$gdFmZd$If^Z`gdFmpkdo$$If\rp#n.$4 a$d$Ifa$gdFm\]^_`azk\\$d$Ifa$gdFm$d$Ifa$gdFmZd$If^Z`gdFmpkdjp$$If\rp#n.$4 aabjlvzk\\$d$Ifa$gdFm$d$Ifa$gdFmZd$If^Z`gdFmpkdp$$If\rp#n.$4 azkSS$d$&dIfPa$gdFm$d$Ifa$gdFmZd$If^Z`gdFmpkdq$$If\rp#n.$4 azk\\$d$Ifa$gdFm$d$Ifa$gdFmZd$If^Z`gdFmpkdr$$If\rp#n.$4 aĵ̵zk\\$d$Ifa$gdFm$d$Ifa$gdFmZd$If^Z`gdFmpkdr$$If\rp#n.$4 a̵͵ߵzk\K$d$4$Ifa$gdFm$d$Ifa$gdFm$d$Ifa$gdFmZd$If^Z`gdFmpkd&s$$If\rp#n.$4 a zk\\$d$Ifa$gdFm$d$Ifa$gdFmZd$If^Z`gdFmpkds$$If\rp#n.$4 a ,-7@zk\\$d$Ifa$gdFm$d$Ifa$gdFmZd$If^Z`gdFmpkd>t$$If\rp#n.$4 a:;>?@AXYZdeghklmntu|~ζ׶ضڶ۶ݶ߶ &(ñh>1 h2h,*NCJ#h>1 h2CJPJaJnHo(tHh>1 h2CJh>1 h2CJaJh>1 h2CJo(h>1 h2CJnH o(tH h>1 h2CJPJnHo(tHA@AYZdmzk\\$d$Ifa$gdFm$d$Ifa$gdFmZd$If^Z`gdFmpkdt$$If\rp#n.$4 amn}~zk\\$d$Ifa$gdFm$d$Ifa$gdFmZd$If^Z`gdFmpkdVu$$If\rp#n.$4 azk\\$d$Ifa$gdFm$d$Ifa$gdFmZd$If^Z`gdFmpkdu$$If\rp#n.$4 aͶζ׶zkSS$d$&dIfPa$gdFm$d$Ifa$gdFmZd$If^Z`gdFmpkdnv$$If\rp#n.$4 azk\\$d$Ifa$gdFm$d$Ifa$gdFmZd$If^Z`gdFmpkdv$$If\rp#n.$4 azk\\$d$Ifa$gdFm$d$Ifa$gdFmZd$If^Z`gdFmpkdw$$If\rp#n.$4 a &/zkSS$d$&dIfPa$gdFm$d$Ifa$gdFmZd$If^Z`gdFmpkdx$$If\rp#n.$4 a()*+,-./045CJKLSTUVZ[_`ouwʷ˷̷ӷԷطٷݷ޷߷ׯÛ&h>1 h25CJPJaJnHo(tH'h>1 h2CJOJPJQJnHo(tHh>1 h2CJh>1 h2CJaJh>1 h2CJo(h>1 h2CJPJnHo(tHh>1 h2CJnH o(tH 9/01234zk\\$d$Ifa$gdFm$d$Ifa$gdFmZd$If^Z`gdFmpkdx$$If\rp#n.$4 a45KLSZxiQQ$d$&dIfPa$gdFm$d$Ifa$gdFmXd$IfWD^X`gdFmpkd*y$$If\rp#n.$4 aZ[\]^_zk\\$d$Ifa$gdFm$d$Ifa$gdFmZd$If^Z`gdFmpkdy$$If\rp#n.$4 a_`xiZZ$d$Ifa$gdFm$d$Ifa$gdFmZd$If^Z`gdFmrkdBz$$IfG\rp#n.$4 a|m^^$d$Ifa$gdFm$d$Ifa$gdFmd$IfVDG^gd2pkdz$$If\rp#n.$4 a˷̷ҷط|mUU$d$&dIfPa$gdFm$d$Ifa$gdFmd$IfVDG^gd2pkd^{$$If\rp#n.$4 aطٷڷ۷ܷݷ|m^^$d$Ifa$gdFm$d$Ifa$gdFmd$IfVDG^gd2pkd{$$If\rp#n.$4 aݷ޷߷zkSS$d$&dIfPa$gdFm$d$Ifa$gdFmZd$If^Z`gdFmpkdv|$$If\rp#n.$4 azk\\$d$Ifa$gdFm$d$Ifa$gdFmZd$If^Z`gdFmpkd}$$If\rp#n.$4 a'0zkNN'$ d$&dIfPa$gdFm$d$Ifa$gdFmZd$If^Z`gdFmpkd}$$If\rp#n.$4 a&*,.012jklmnƲƔmSG9h>1 h2>*CJOJQJh>1 h25CJo(3h>1 h5B*CJOJPJQJnHo(phtH'h>1 h5B*CJOJQJo(ph$h>1 hB*PJnHo(phtHh>1 h2CJaJ$h>1 h2CJOJPJQJnHtH'h>1 h2CJOJPJQJnHo(tH'h>1 h2CJOJPJQJnH o(tH h>1 h2CJo(h>1 h2CJ#h>1 h2CJPJaJnHo(tH012klmngg_K7%$!d$Ifa$gdFmd$If^`gdFmdgd2&9TPL HD@<+{d<^pkd~$$If\rp#n.$4 an~¸øǸȸ׸޸߸ ÷{{{{{{o_o{oh>1 h2CJaJnH o(tH h>1 h2CJaJo(h>1 h2CJaJh>1 h2CJnH o(tH h>1 h2CJPJnHo(tHh>1 h2CJo(h>1 h2CJh>1 h2>*CJaJ&h>1 h2>*CJOJQJnHo(tH'h>1 h2CJOJPJQJnHo(tH'h>1 h2CJOJPJQJnHo(tH%nyjRR$d$&dIfPa$gdFm$d$Ifa$gdFmZd$If^Z`gdFm]kd~$$IfFrp#n0 .$    4 a%$!d$Ifa$gdFmzk\\$d$Ifa$gdFm$d$Ifa$gdFmZd$If^Z`gdFmpkd*$$If\rp#n.$4 a¸zk\\$d$Ifa$gdFm$d$Ifa$gdFmZd$If^Z`gdFmpkd$$If\rp#n.$4 a¸øĸŸƸǸzk\\$d$Ifa$gdFm$d$Ifa$gdFmZd$If^Z`gdFmpkdB$$If\rp#n.$4 aǸȸ޸߸xiQQ$d$&dIfPa$gdFm$d$Ifa$gdFmXd$IfWD^X`gdFmpkd΀$$If\rp#n.$4 azk\\$d$Ifa$gdFm$d$Ifa$gdFmZd$If^Z`gdFmpkdZ$$If\rp#n.$4 azk\\$d$Ifa$gdFm$d$Ifa$gdFmZd$If^Z`gdFmpkd$$If\rp#n.$4 aMZ`dxl]]$d$Ifa$gdFm d$IfgdFmd$IfWD^`gdFmpkdr$$If\rp#n.$4 a !MZdefghswx 09?KMTUVWZ[\]øьrᖸьh>1 h2h[CJaJh>1 hM/CJaJo(h>1 h2CJo(h>1 h2CJaJnH o(tH #h>1 h4CJPJaJnHo(tHh>1 h2CJaJh>1 h2CJnH o(tH h>1 h2CJPJnHo(tHh>1 h2CJaJo(#h>1 h2CJPJaJnHo(tH+dexiZZ$d$Ifa$gdFm$d$Ifa$gdFmd$IfWD^`gd4pkd$$If\rp#n.$4 av];;!$d$&dIfPWD^`a$gdFm$d$IfWD^`a$gdFm8d$IfVDuWD^8`gdxpkd$$If\rp#n.$4 a zk\\$d$Ifa$gdFm$d$Ifa$gdFmZd$If^Z`gdFmpkd$$If\rp#n.$4 a LMT\xiQQ$d$&dIfPa$gdFm$d$Ifa$gdFmd$IfWD^`gdFmpkd$$If\rp#n.$4 a\]^_`azk\\$d$Ifa$gdFm$d$Ifa$gdFmZd$If^Z`gdFmpkd.$$If\rp#n.$4 a]ab̺кѺߺ !"#$%&/013459:웇'h>1 h2CJOJPJQJnHo(tHh>1 h2CJo(h>1 h2CJPJnHo(tHh>1 h2CJnH o(tH h>1 h2CJnH tH h>1 h2CJaJnH o(tH h>1 h2CJaJo(h>1 h2CJaJh>1 h2CJ0abzkSS$d$&dIfPa$gdFm$d$Ifa$gdFmZd$If^Z`gdFmpkd$$If\rp#n.$4 azk\\$d$Ifa$gdFm$d$Ifa$gdFmZd$If^Z`gdFmpkdF$$If\rp#n.$4 aͺκϺкzk\\$d$Ifa$gdFm$d$Ifa$gdFmZd$If^Z`gdFmpkd҆$$If\rp#n.$4 aкѺ|m^^$d$Ifa$gdFm$d$Ifa$gdFmd$IfVDG^gd2pkd^$$If\rp#n.$4 a|mUU$d$&dIfPa$gdFm$d$Ifa$gdFmd$IfVDG^gd2pkd$$If\rp#n.$4 a !"#|m^^$d$Ifa$gdFm$d$Ifa$gdFmd$IfVDG^gd2pkdv$$If\rp#n.$4 a#$%&-4xiQQ$d$&dIfPa$gdFm$d$Ifa$gdFmZd$If^Z`gdFmrkd$$If \rp#n.$4 a456789zk\\$d$Ifa$gdFm$d$Ifa$gdFmZd$If^Z`gdFmpkd$$If\rp#n.$4 a9:<stu{g\\SG $$Ifa$gd $Ifgd $da$gdFJ`&9TPL HD@<+{d<^pkd$$If\rp#n.$4 a:;<rstuvz{~hRh~Rh@#h>1 h}j>*CJPJaJnHtH+h>1 h}jCJOJPJQJaJnHo(tH+h>1 h}jCJOJPJQJaJnHo(tH(h>1 h}jCJOJPJQJaJnHtHh>1 h}jCJo(h>1 h}jCJh>1 h}jCJaJh>1 h5PJnHo(tHh>1 h}j5PJnHo(tHh>1 h5o(/h>1 h5B*CJPJaJnHo(phtHh>1 h5B*ph{PG; $$Ifa$gd $Ifgdpkd$$If\rY#F$4 a"%$!xd0$&dIfPUD2]xa$gd}j%$!d8$&dIfPa$gdĻŻȻʻ˻ݻ߻лۻлЭТzdN+h>1 h$ >*CJOJPJQJaJnHtH+h>1 h$ CJOJPJQJaJnHo(tH+h>1 h$ CJOJPJQJaJnHo(tH#h>1 h$ CJPJaJnHo(tHh>1 h$ CJaJh>1 h}j5CJ\aJ(h>1 h}jCJOJPJQJaJnHtHh>1 h}jCJaJ+h>1 h}j>*CJOJPJQJaJnHtHh>1 h}jCJOJQJaJŻtk_ $$Ifa$gd $Ifgdpkd<$$If\rY#F$4 a%$!xd0$IfUD2]xa$gd}jŻƻǻȻɻʻyZZ%$!xd0$IfUD2]xa$gd}job& $$Ifa$gd $Ifgdpkdȋ$$If\rY#F$4 aʻ˻޻߻y__%$!xd0$IfUD2]xa$gd}j $$Ifa$gd $IfgdpkdT$$If\rY#F$4 asY@~$xd0$IfUD2]x`a$gd$ %$!xd0$IfUD2]xa$gd$ $$Ifa$gd$IfWDd`gdpkd$$If\rY#F$4 a%()234MNUV]^_ȶt_Nȶ8Nȶ+h>1 h$ >*CJOJPJQJaJnHtH h>1 h$ CJPJaJnHtH(h>1 h$ CJOJPJQJaJnHtH+h>1 h$ >*CJOJPJQJaJnHtH+h>1 h$ CJOJPJQJaJnHo(tH+h>1 h$ CJOJPJQJaJnHo(tH#h>1 h$ CJPJaJnHo(tHh>1 h$ CJaJ+h>1 h$ >*CJOJPJQJaJnHtH+h>1 h$ CJOJPJQJaJnH o(tH )3sY?%$!xd0$IfUD2]xa$gdoP%$!xd0$IfUD2]xa$gd$ $$Ifa$gd$IfWDd`gdpkdl$$If\rY#F$4 a34MNV^sY@~$xd0$IfUD2]x`a$gd$ %$!xd0$IfUD2]xa$gd$ $$Ifa$gd$IfWDd`gdpkd$$If\rY#F$4 a^_sY@~$xd0$IfUD2]x`a$gd$ %$!xd0$IfUD2]xa$gd$ $$Ifa$gd$IfWDd`gdpkd$$If\rY#F$4 aͼмۼ 0=>?ƶ{eTIIeTIIeTIeTh>1 h}jCJaJ h>1 h}jCJPJaJnHtH+h>1 h}j>*CJOJPJQJaJnHtH1h>1 h}jhCJOJPJQJaJnH o(tH +h>1 h}jCJOJPJQJaJnH o(tH h>1 h}jCJaJo(h>1 h}jCJaJnH o(tH #h>1 h}jCJPJaJnHo(tH h>1 h$ CJPJaJnHtH+h>1 h$ >*CJOJPJQJaJnHtHsYY%$!xd0$IfUD2]xa$gd}j $$Ifa$gd$IfWDd`gdpkd$$If\rY#F$4 aڼۼsYY%$!xd0$IfUD2]xa$gd}j $$Ifa$gd$IfWDd`gdpkd$$If\rY#F$4 a sYY%$!xd0$IfUD2]xa$gd}j $$Ifa$gd$IfWDd`gdpkd($$If\rY#F$4 a/07>sYY%$!xd0$IfUD2]xa$gd}j $$Ifa$gd$IfWDd`gdpkd$$If\rY#F$4 a>?pqxyWW"%$!xd0$&dIfPUD2]xa$gd}j $$Ifa$gd $Ifgdpkd@$$If\rY#F$4 a?Apqнѽҽ+,78ԾԩԾԩԇԩԾvdRvR#h>1 h}jCJPJaJnHo(tH#h>1 hkCJPJaJnHo(tH h>1 h}jCJPJaJnHtHh>1 h}j5CJaJ+h>1 h}j>*CJOJPJQJaJnHtH(h>1 h}jCJOJPJQJaJnHtH+h>1 h}jCJOJPJQJaJnH o(tH h>1 h}jCJaJh>1 h}jCJaJnH o(tH h>1 hJmCJaJnH o(tH y__%$!xd0$IfUD2]xa$gd}j $$Ifa$gd $Ifgdpkd̑$$If\rY#F$4 ayWW"%$!xd0$&dIfPUD2]xa$gd}j $$Ifa$gd $IfgdpkdX$$If\rY#F$4 ay__%$!xd0$IfUD2]xa$gd}j $$Ifa$gd $Ifgdpkd$$If\rY#F$4 ay__%$!xd0$IfUD2]xa$gd}j $$Ifa$gd $Ifgdpkdp$$If\rY#F$4 aɽѽsYY%$!xd0$IfUD2]xa$gd}j $$Ifa$gd$IfWDd`gdpkd$$If\rY#F$4 aѽҽsYY%$!xd0$IfUD2]xa$gd}j $$Ifa$gd$IfWDd`gdpkd$$If\rY#F$4 a+,28sYY%$!xd0$IfUD2]xa$gd}j $$Ifa$gd$IfWDd`gdpkd$$If\rY#F$4 a89VWZ\sYY%$!xd0$IfUD2]xa$gd}j $$Ifa$gd$IfWDd`gdpkd$$If\rY#F$4 a89IVW[\]ľžҾӾԾ34侨侏侨䃾䃾n侨nbnh>1 h}j5CJaJ(h>1 h}jCJOJPJQJaJnHtHh>1 h}jCJaJo(1h>1 h}jhBCJOJPJQJaJnH o(tH +h>1 h}j>*CJOJPJQJaJnHtH+h>1 h}jCJOJPJQJaJnH o(tH h>1 h}jCJaJnH o(tH h>1 h}jCJaJ h>1 h}jCJPJaJnHtH%\]sYY%$!xd0$IfUD2]xa$gd}j $$Ifa$gd$IfWDd`gdpkd,$$If\rY#F$4 asYY%$!xd0$IfUD2]xa$gd}j $$Ifa$gd$IfWDd`gdpkd$$If\rY#F$4 aľž̾ӾsYY%$!xd0$IfUD2]xa$gd}j $$Ifa$gd$IfWDd`gdpkdD$$If\rY#F$4 aӾԾsQQ"%$!xd0$&dIfPUD2]xa$gd}j $$Ifa$gd$IfWDd`gdpkdЗ$$If\rY#F$4 ay__%$!xd0$IfUD2]xa$gd}j $$Ifa$gd $Ifgdpkd\$$If\rY#F$4 ayWW"%$!xd0$&dIfPUD2]xa$gd}j $$Ifa$gd $Ifgdpkd$$If\rY#F$4 ay__%$!xd0$IfUD2]xa$gd}j $$Ifa$gd $Ifgdpkdt$$If\rY#F$4 a2345y__%$!xd0$IfUD2]xa$gd}j $$Ifa$gd $Ifgdpkd$$If\rY#F$4 a456OPQ`abstϿпԿտѿp`p`T;pT1h>1 h}jhBCJOJPJQJaJnH o(tH h>1 h}jCJaJo(h>1 h}jCJaJnH o(tH h>1 h}jCJPJaJnHtH+h>1 h}j>*CJOJPJQJaJnHtH+h>1 h}jCJOJPJQJaJnH o(tH #h>1 h}jCJPJaJnHo(tH#h>1 hkCJPJaJnHo(tHh>1 h}jCJaJh>1 h}j5CJaJ.h>1 h}j5>*CJOJPJQJaJnHtH56OQYasYY%$!xd0$IfUD2]xa$gd}j $$Ifa$gd$IfWDd`gdpkd$$If\rY#F$4 aabst{sYY%$!xd0$IfUD2]xa$gd}j $$Ifa$gd$IfWDd`gdpkd$$If\rY#F$4 asYY%$!xd0$IfUD2]xa$gd}j $$Ifa$gd$IfWDd`gdpkd$$If\rY#F$4 aϿпҿտsYY%$!xd0$IfUD2]xa$gd}j $$Ifa$gd$IfWDd`gdpkd0$$If\rY#F$4 aտֿsYY%$!xd0$IfUD2]xa$gd}j $$Ifa$gd$IfWDd`gdpkd$$If\rY#F$4 aտֿ !"#$78GHIKLMNtuθΔθ~rθ]rθ(h>1 h}jCJOJPJQJaJnHtHh>1 h}j5CJaJ+h>1 h}jCJOJPJQJaJnHo(tH.h>1 h}j>*CJOJPJQJaJnHo(tHh>1 h}jCJaJo(+h>1 h}j>*CJOJPJQJaJnHtH+h>1 h}jCJOJPJQJaJnH o(tH h>1 h}jCJaJ h>1 h}jCJPJaJnHtH#sQQ"%$!xd0$&dIfPUD2]xa$gd}j $$Ifa$gd$IfWDd`gdpkdH$$If\rY#F$4 a thNN%$!xd0$IfUD2]xa$gd}j $$Ifa$gda$IfVDnWDc^a`gd}joB=pkdԝ$$If\rY#F$4 a yWW"%$!xd0$&dIfPUD2]xa$gd}j $$Ifa$gd $Ifgdpkd`$$If\rY#F$4 a !"#y__%$!xd0$IfUD2]xa$gd}j $$Ifa$gd $Ifgdpkd$$If\rY#F$4 a#$78@HyWW"%$!xd0$&dIfPUD2]xa$gd}j $$Ifa$gd $Ifgdpkdx$$If\rY#F$4 aHIJKLMy__%$!xd0$IfUD2]xa$gd}j $$Ifa$gd $Ifgdpkd$$If\rY#F$4 aMNtuyWW"%$!xd0$&dIfPUD2]xa$gd}j $$Ifa$gd $Ifgdpkd$$If\rY#F$4 ay__%$!xd0$IfUD2]xa$gdk $$Ifa$gd $Ifgdpkd$$If\rY#F$4 a &+=PQRlmz{uufh>1 h}j5CJ\aJo(#h>1 h}jCJPJaJnHo(tHh>1 h}jCJaJnH o(tH h>1 h}jCJPJaJnHtHh>1 h}jCJaJh>1 h}j5CJ\aJ h>1 hkCJPJaJnHtH+h>1 hkCJOJPJQJaJnH o(tH h>1 hkCJaJh>1 hk5CJaJ#zk\\$d$Ifa$gd$d$Ifa$gdZd$If^Z`gdpkd$$If\rY#F$4 a|m^^$d$Ifa$gd$d$Ifa$gdd$IfWDd`gdpkd4$$Ifl\Y#0$4 lavgXX$d$Ifa$gd$d$Ifa$gdnd$IfVDGWD2^`ngd}jpkd$$Ifl\Y#0$4 la vgOO$d$&dIfPa$gd$d$Ifa$gdnd$IfVDGWD2^`ngd}jpkdD$$Ifl\Y#0$4 la zk\\$d$Ifa$gd$d$Ifa$gdZd$If^Z`gdpkḍ$$Ifl\Y#0$4 la<=GQzk\\$d$Ifa$gd$d$Ifa$gdZd$If^Z`gdpkdT$$Ifl\Y#0$4 laQRlmt{zkSS$d$&dIfPa$gd$d$Ifa$gdZd$If^Z`gdpkdܤ$$Ifl\Y#0$4 la{|}~zk\\$d$Ifa$gd$d$Ifa$gdZd$If^Z`gdpkdd$$Ifl\Y#0$4 lazkSS$d$&dIfPa$gd$d$Ifa$gdZd$If^Z`gdpkd$$Ifl\Y#0$4 lazk\\$d$Ifa$gd$d$Ifa$gdZd$If^Z`gdpkdt$$Ifl\Y#0$4 lazk\\$d$Ifa$gd$d$Ifa$gdZd$If^Z`gdpkd$$Ifl\Y#0$4 lavgXX$d$Ifa$gdFm$d$Ifa$gdFmnd$IfVDGWD2^`ngd$ pkd$$Ifl\Y#0$4 la ,-78@HIVWY\]^_nopqrsw·zzi h>1 h}jCJPJaJnHtHh>1 h}jCJOJQJaJh>1 h}jCJaJnH o(tH #h>1 h}jCJPJaJnHo(tHh>1 h}jCJaJo(h>1 h}jCJaJh>1 h$ CJaJ#h>1 h$ CJPJaJnHo(tHh>1 h$ CJaJnH o(tH h>1 h$ CJPJaJnHtH"vgXX$d$Ifa$gdFm$d$Ifa$gdFmnd$IfVDGWD2^`ngd$ pkd $$Ifl\Y#0$4 la ,-57vgXX$d$Ifa$gdFm$d$Ifa$gdFmnd$IfVDGWD2^`ngd$ pkd$$Ifl\Y#0$4 la78HIPWvgOO$d$&dIfPa$gd$d$Ifa$gdnd$IfVDGWD2^`ngd}jpkd$$Ifl\Y#0$4 laWXYZ[\|m^^$d$Ifa$gd$d$Ifa$gdd$IfVDG^gd}jpkd$$Ifl\Y#0$4 la\]^_goufNN$d$&dIfPa$gd$d$Ifa$gd%!Zd$If^Z`gdpkd,$$Ifl\Y#0$4 laopqrstufWW$d$Ifa$gd$d$Ifa$gd%!Zd$If^Z`gdpkd$$Ifl\Y#0$4 latuvwzkSS$d$&dIfPa$gd$d$Ifa$gdZd$If^Z`gdpkd<$$Ifl\Y#0$4 latk\T$da$$d^a$gdCicd^ d^`^gdFJ`rkdī$$Ifl?\Y#0$4 laƮƔtƮ]O@O@5h>1 hCJaJh>1 h5CJ\aJo(h>1 h5CJ\aJ,h>1 hB*CJPJaJnHo(phtH>h>1 hY5B*CJKHOJPJQJ\aJnHo(phtH2h>1 hFJ`5B*CJKHOJQJ\aJo(ph/h>1 hY5B*CJKHOJQJ\aJph/h>1 hFJ`5B*CJKHOJQJ\aJphA *h>1 hK5@B*CJOJPJQJ\aJnHo(phtH+gt*145}kYJh>1 h5CJ\aJo(#h>1 hyCJPJaJnHo(tH#h>1 h,CJPJaJnHo(tHh>1 hCicCJaJnH o(tH h>1 hCic5CJaJ#h>1 hY!CJPJaJnHo(tHh>1 hFJ`CJaJnH o(tH h>1 hFJ`CJaJh>1 hCicCJaJo( h>1 hCicCJPJaJnHtH#h>1 hCicCJPJaJnHo(tHh>1 hCicCJaJef`a[$c$7$8$H$IfWD^c`a$gdFm$$7$8$H$Ifa$gdFm $da$gd$ $d^a$gd$ d & Fd1$ tefACDEXY_`ap~ غ̺غتتتxj]h>1 h$ CJPJ aJh>1 h$ CJPJ aJo( h>1 h$ CJPJaJnHtH"h>1 h$ 5CJaJnH o(tH h>1 h$ CJaJnH tH h>1 h$ CJaJnH o(tH #h>1 h$ CJPJaJnHo(tHh>1 h$ CJaJo(h>1 h$ CJaJh>1 h5CJ\aJo(h>1 h5CJ\aJ$FGZ[\jr{|ȻȻn\D\\.h>1 h$ CJH*OJ QJ ^J aJnH o(tH #h>1 h$ CJPJ aJnH o(tH h>1 h$ CJPJaJnHtHh>1 h$ CJaJ+h>1 h$ CJOJ QJ ^J aJnH o(tH h>1 h$ CJPJ aJh>1 h$ CJPJ aJo(h>1 h$ CJPJ aJ(h>1 h$ CJOJ QJ ^J aJnH tH #h>1 h$ CJOJ QJ ^J aJo( h>1 h$ CJOJ QJ ^J aJ[\r}'Ukd$$If0"0 t644 la$c$7$8$H$IfWD^c`a$gdFm$$7$8$H$Ifa$gdFmUkdP$$If0"0 t644 la{|ujTd$IfWD^`gdFm $da$gd$ $d^a$gd$ $d7$8$H$a$gd$ Zkd $$If0"0 t644 lagb=$$7$8$H$Ifa$gdFm}d$IfWD^`gdFmUkd$$If0@p#0 t!644 la$d$IfWD^`$gdFm BCDE$%&'ѿфssѿѲbb h>1 h$ CJPJ aJnHtH h>1 h$ CJOJ QJ ^J aJ1h>1 h$ hCJOJ QJ ^J aJnH o(tH (h>1 h$ CJOJ QJ ^J aJnH tH h>1 h$ CJPJ aJ#h>1 h$ CJPJ aJnH o(tH .h>1 h$ CJH*OJ QJ ^J aJnH o(tH +h>1 h$ CJOJ QJ ^J aJnH o(tH &DE}'Ukdb$$If0@p#0 t!644 la$d$IfWD^`$gdFmd$IfWD^`gdFmUkd$$If0@p#0 t!644 laEF}Ukdʮ$$If0@p#0 t!644 la$d$IfWD^`$gdFmd$IfWD^`gdFmBUkd$$If0@p#0 t!644 la$$7$8$H$Ifa$gdFmUkd2$$If0@p#0 t!644 la&'=Zkdj$$If0@p#0 t!644 lagb=$$7$8$H$Ifa$gdFmUkd$$If0@p#0 t!644 la'U}xgg$$7$8$H$Ifa$gdFmgd$ Ukdܰ$$If0@p#0 t!644 la$d$IfWD^`$gdFmd$IfWD^`gdFm;<=>GUZ[lmno*-CDEFPսս՘լսլլսս՘ս՘p+h>1 h:8CJOJ QJ ^J aJnH o(tH #h>1 h$ CJOJ QJ ^J aJo(h>1 h$ CJPJ aJ h>1 h$ h>1 h$ CJOJ QJ ^J aJ.h>1 h$ CJH*OJ QJ ^J aJnH o(tH +h>1 h$ CJOJ QJ ^J aJnH o(tH (h>1 h$ CJOJ QJ ^J aJnH tH (=>[n8Zkd$$If0@p#0 t!644 lagb=$$7$8$H$Ifa$gdFmZkdD$$If0@p#0 t!644 lagb=no8Zkd$$If0@p#0 t!644 lagb=$$7$8$H$Ifa$gdFmZkd($$If0@p#0 t!644 lagb=EF8Zkd~$$If0@p#0 t!644 lagb=$$7$8$H$Ifa$gdFmZkd $$If0@p#0 t!644 lagb=PQX_`abcտxdWEWEWdWEWEdWEWEd#h>1 h$ OJ QJ ^J nH o(tH h>1 h$ OJ QJ ^J &h>1 h$ H*OJ QJ ^J nH o(tH h>1 h$ CJPJaJnHtHh>1 h$ CJPJ aJ h>1 h$ CJOJ QJ ^J aJ.h>1 h$ CJH*OJ QJ ^J aJnH o(tH +h>1 h$ CJOJ QJ ^J aJnH o(tH +h>1 h:8CJOJ QJ ^J aJnH o(tH (h>1 h:8CJOJ QJ ^J aJnH tH FYbxcTTTT7$8$H$VD^gd$ $d7$8$H$VD^a$gd$ Zkd$$If0@p#0 t!644 lagb=$d$IfWD^`$gdFmd$IfWD^`gdFmcd&)UV qt+.hsV[9<DEH\ʼznah>1 h5CJ\o(h>1 h5CJ\,h>1 hB*CJPJaJnHo(phtHh>1 h$ CJaJh>1 h$ CJaJo(&h>1 h$ H*OJ QJ ^J nH o(tH h>1 h$ OJ QJ ^J o(#h>1 h$ OJ QJ ^J nH o(tH h>1 h$ OJ QJ ^J nH tH #h>1 h$ H*OJ QJ ^J nH tH # bcDE\]uv,VD]^gd,,BVD]^Bgd,$d^a$gd, & FH7$8$H$^`Hgd, $d^a$ d^`^$d^a$gd$ \]uvRS;<>SVao./012ɿɛɛɊɛ~~ɛɊɊɛ~ɛɛɊ~nh>1 h59PJaJnHo(tHh>1 h,CJ]aJ h>1 h,CJPJaJnHtHh>1 h,CJaJh>1 h,PJaJnHo(tHh>1 h,aJh>1 h,aJo(#h>1 h,CJPJaJnHo(tH#h>1 h,5CJPJaJnHtH#h>1 hCJPJaJnHo(tH):JLkdӴ$$If0p#/ !4 a8Lkdb$$If0p#/ !4 a8$d$Ifa$gd d$Ifgd:;<=>UVYJ$d$Ifa$gdLkd$$If0p#/ !4 a8 d$IfgdLkdD$$Ifq0p#/ !4 a8EQkd$$If0p#/ !4 a8gc&$d$Ifa$gd d$IfgdLkd8$$If0p#/ !4 a812YJJ,BVD]^Bgd,Lkd$$If0p#/ !4 a8 d$IfgdLkd0$$If0p#/ !4 a82PQHJLfhrrrrrr$d$$&dIfPa$gdFm&d$$If^`&gdFm$\d$VDQ^\`a$gd+`$\#d$VDQ^\`#a$gd59A7$8$H$VD^`Agd597$8$H$VD^gd59 & FH7$8$H$^`Hgd592PQ LNh`bprѿp_p_p_UJJh>1 h+`CJaJh>1 h+`>*CJ h>1 h+`CJPJaJnHtH#h>1 h+`CJPJaJnHo(tHh>1 h+`CJaJh>1 h+`>*CJaJ#h>1 h59>*CJPJaJnHtH&h>1 h59>*CJPJaJnHo(tH"h>1 h59>*CJaJnH o(tH h>1 h59CJPJaJnHtHh>1 h59CJaJ#h>1 h595CJPJaJnHtHh$d$$&dIfPa$gdFm,&d$$If^`&gdFmkd$$$If֞ ^:!%nnnn0p#4 a8 0@P`$d$$Ifa$gdFmoԦ$d$$Ifa$gdFm`bd,&d$$If^`&gdFmkd $$If֞ ^:!%nnnn0p#4 a8dfhjlnp$d$$Ifa$gdFmoԦ$d$$Ifa$gdFmpr,&d$$If^`&gdFmkd$$If֞ ^:!%nnnn0p#4 a8r>?ABCDIJLQz{Ѿѳььььььѳсьѳၳm&h>1 h+`hewCJPJaJnHtHh>1 h+`CJaJ%h>1 h+`hewCJaJnH o(tH &h>1 h+`CJPJ]aJnHo(tHh>1 h+`CJaJ%h>1 h+`h CJaJnH o(tH h>1 h+`CJaJnH o(tH h>1 h+`CJ]aJ#h>1 h+`CJPJ]aJnHtH*$d$$Ifa$gdFmoԦ$d$$Ifa$gdFm,&d$$If^`&gdFmkd$$If֞ ^:!%nnnn0p#4 a8$d$$Ifa$gdFmoԦ,qd$$IfVD&WD^`qgd+`kdл$$If֞ ^:!%nnnn0p#4 a8'-5?A$d$$&dIfPa$gdFmoԦ$d$$&dIfPa$gdFmABC,&d$$If^`&gdFmkd$$If֞ ^:!%nnnn0p#4 a8CDEFGHI$d$$Ifa$gdFmoԦ$d$$Ifa$gdFmIJQ,qd$$IfVDWD^`qgd+`kd$$If֞ ^:!%nnnn0p#4 a8QYaiq{$d$$&dIfPa$gdFm,&d$$If^`&gdFmkd$$If֞ ^:!%nnnn0p#4 a8$d$$Ifa$gdFmoԦ$d$$Ifa$gdFm,qd$$IfVDWD^`qgd+`kd$$If֞ ^:!%nnnn0p#4 a8$d$$Ifa$gdFm$d$$Ifa$gdFmoԦ$d$$&dIfPa$gdFm,&d$$If^`&gdFmkdv$$If֞ ^:!%nnnn0p#4 a8 $%./8?BFOPTU[\]acdkw{|黧黧黧q黧޻̻"h>1 h+`CJ]aJnH o(tH &h>1 h+`CJPJ]aJnHo(tHh>1 h+`CJaJnH o(tH &h>1 h+`hewCJPJaJnHtH h>1 h+`CJPJaJnHtH#h>1 h+`CJPJ]aJnHtHh>1 h+`CJaJh>1 h+`CJ]aJh>1 h+`CJaJ)$d$$Ifa$gdFmoԦ$d$$Ifa$gdFm,&d$$If^`&gdFmkdd$$If֞ ^:!%nnnn0p#4 a8$d$$Ifa$gdFmoԦ$d$$Ifa$gdFm,&d$$If^`&gdFmkdR$$If֞ ^:!%nnnn0p#4 a8$d$$Ifa$gdFmoԦ$d$$Ifa$gdFm ,&d$$If^`&gdFmkd@$$If֞ ^:!%nnnn0p#4 a8 !"#$%.$d$$Ifa$gdFmoԦ$d$$Ifa$gdFm./P,&d$$If^`&gdFmkd.$$If֞ ^:!%nnnn0p#4 a8PQRSTU[$d$$&dIfPa$gdFm$d$$Ifa$gdFmoԦ$d$$Ifa$gdFm[\],&d$$If^`&gdFmkd$$If֞ ^:!%nnnn0p#4 a8]^_`abc$d$$Ifa$gdFmoԦ$d$$Ifa$gdFmcdw,&d$$If^`&gdFmkd $$If֞ ^:!%nnnn0p#4 a8wxyz{|$d$$&dIfPa$gdFm$d$$Ifa$gdFm,$\#d$VDQ^\`#a$gd59kd$$If֞ ^:!%nnnn0p#4 a8 LNh`bprȼyygYDy)h>1 h+`h CJPJaJnHo(tHh>1 h+`CJ]aJo(#h>1 h+`CJPJ]aJnHtHh>1 h+`CJaJh>1 h+`>*CJ h>1 h+`CJPJaJnHtH#h>1 h+`CJPJaJnHo(tHh>1 h+`CJaJh>1 h+`>*CJaJ#h>1 h59>*CJPJaJnHtH&h>1 h59>*CJPJaJnHo(tH"h>1 h59>*CJaJnH o(tH HJLfh$d$$&dIfPa$gdFm&d$$If^`&gdFm$\d$VDQ^\`a$gd+`A7$8$H$VD^`Agd59,&d$$If^`&gdFmkd$$If֞ ^:!%nnnn0p#4 a8 0@P`$d$$Ifa$gdFmoԦ$d$$Ifa$gdFm`bd,&d$$If^`&gdFmkd$$If֞ ^:!%nnnn0p#4 a8dfhjlnp$d$$Ifa$gdFmoԦ$d$$Ifa$gdFmpr,&d$$If^`&gdFmkd$$If֞ ^:!%nnnn0p#4 a8$d$$Ifa$gdFmoԦ$d$$Ifa$gdFm,&d$$If^`&gdFmoԦkd$$If֞ ^:!%nnnn0p#4 a8 "#&'(ɷɤɷɷɤɷɷɤɷɤxɷiɷih>1 h+`CJaJnH tH h>1 h+`CJ]aJh>1 h+`CJaJ)h>1 h+`hewCJPJaJnHo(tH%h>1 h+`hewCJaJnH o(tH #h>1 h+`CJPJaJnHo(tHh>1 h+`CJaJnH o(tH &h>1 h+`CJPJ]aJnHo(tH#h>1 h+`CJPJ]aJnHtH)$d$$Ifa$gdFmoԦ$d$$Ifa$gdFm,qd$$IfVDWD^`qgd+`kd$$If֞ ^:!%nnnn0p#4 a8'.6@B$d$$&dIfPa$gdFm()*,-14568:<>?@BCDJKMRUVYZ\]^abdfmoqrtvxz{|~ݺݯݺί#h>1 h+`CJPJ]aJnHtHh>1 h+`CJaJh>1 h+`CJ]aJh>1 h+`CJaJ&h>1 h+`hewCJPJaJnHtHh>1 h+`CJaJnH tH #h>1 h+`CJPJaJnHo(tHh>1 h+`CJaJnH o(tH 4BCD,&d$$If^`&gdFmkd$$If֞ ^:!%nnnn0p#4 a8DEFGHIJ$d$$Ifa$gdFmoԦ$d$$Ifa$gdFmJKR,qd$$IfVDWD^`qgd+`kd|$$If֞ ^:!%nnnn0p#4 a8RZbjr|$d$$&dIfPa$gdFm,&d$$If^`&gdFmkdj$$If֞ ^:!%nnnn0p#4 a8$d$$Ifa$gdFmoԦ$d$$Ifa$gdFm,qd$$IfVDWD^`qgd+`kdX$$If֞ ^:!%nnnn0p#4 a8ɷɨɷɷɷɷɨɷɨxgS&h>1 h+`hewCJPJaJnHtH h>1 h+`CJPJaJnHtHh>1 h+`CJaJh>1 h+`CJ]aJh>1 h+`CJaJh>1 h+`hewCJaJh>1 h+`CJaJnH tH #h>1 h+`CJPJaJnHo(tHh>1 h+`CJaJnH o(tH &h>1 h+`CJPJ]aJnHo(tH#h>1 h+`CJPJ]aJnHtH $d$$Ifa$gdFm$d$$Ifa$gdFmoԦ$d$$&dIfPa$gdFm,&d$$If^`&gdFmkdF$$If֞ ^:!%nnnn0p#4 a8$d$$Ifa$gdFmoԦ$d$$Ifa$gdFm,&d$$If^`&gdFmkd4$$If֞ ^:!%nnnn0p#4 a8$d$$Ifa$gdFmoԦ$d$$Ifa$gdFm #$%'(+,-.7>AENOSïxlxllZl"h>1 h+`CJ]aJnH o(tH h>1 h+`CJ]aJ&h>1 h+`hewCJPJaJnHtH h>1 h+`CJPJaJnHtH#h>1 h+`CJPJ]aJnHtH&h>1 h+`CJPJ]aJnHo(tHh>1 h+`CJaJh>1 h+`CJaJnH tH h>1 h+`CJaJnH o(tH #h>1 h+`CJPJaJnHo(tH ,&d$$If^`&gdFmkd"$$If֞ ^:!%nnnn0p#4 a8$d$$Ifa$gdFmoԦ$d$$Ifa$gdFm,&d$$If^`&gdFmkd$$If֞ ^:!%nnnn0p#4 a8 !"#$-$d$$Ifa$gdFmoԦ$d$$Ifa$gdFm-.O,&d$$If^`&gdFmkd$$If֞ ^:!%nnnn0p#4 a8OPQRSTZ$d$$&dIfPa$gdFm$d$$Ifa$gdFmoԦ$d$$Ifa$gdFmSTUVYZ[\`bcjvz{|}~^|hⶪTGh>1 h+`PJnHtH&h>1 h+`>*CJPJaJnHo(tH&h>1 h+`hewCJPJaJnHtH#h>1 h+`CJPJ]aJnHtH h>1 h+`CJPJaJnHtHh>1 h+`CJaJh>1 h+`CJ]aJh>1 h+`CJaJh>1 h+`CJaJnH tH #h>1 h+`CJPJaJnHo(tHh>1 h+`CJaJnH o(tH h>1 h+`hewCJaJZ[\,&d$$If^`&gdFmkd$$If֞ ^:!%nnnn0p#4 a8\]^_`ab$d$$Ifa$gdFmoԦ$d$$Ifa$gdFmbcv,&d$$If^`&gdFmkd$$If֞ ^:!%nnnn0p#4 a8vwxyz{$d$$&dIfPa$gdFm$d$$Ifa$gdFm,&d$$If^`&gdFmkd$$If֞ ^:!%nnnn0p#4 a8$d$$Ifa$gdFmoԦ$d$$Ifa$gdFm,$\#d$VDQ^\`#a$gd+`kd$$If֞ ^:!%nnnn0p#4 a8^_muv|(*fghvƴm[m[G[Gm&h>1 hP>*CJPJaJnHo(tH"h>1 hP>*CJaJnH o(tH #h>1 hP>*CJPJaJnHtHh>1 hPCJaJnH o(tH h>1 hPCJPJaJnHtH&h>1 hP5CJPJaJnHo(tH#h>1 hP5CJPJaJnHtH#h>1 hPCJPJaJnHo(tHh>1 h+`PJnHtHh>1 h+`PJnHo(tHh>1 h+`nH o(tH )*fgvwqlgd+`$d$`a$gdP$\d$VDQ^\`a$gdP$d$WD`a$gdP $d$a$gdP & FH7$8$H$^`HgdP$d$^a$gd59$7$8$H$WD`a$gd+`$7$8$H$UD,VD]^a$gd+` FHb$d$$&dIfPa$gdFm&d$$If^`&gdFmDFHJ`b*,.8:VX"$<Lhjlźźź󦖺ŖŖ󄦄źth>1 h+`CJaJnH o(tH #h>1 h+`CJPJ]aJnHtHh>1 h+`CJaJnH o(tH &h>1 h+`CJPJ]aJnHo(tHh>1 h+`CJaJh>1 h+`CJaJ h>1 h+`CJPJaJnHtH#h>1 h+`CJPJaJnHo(tHh>1 h+`CJ]aJ+ *fRCCCCC$d$$Ifa$gdFm&d$$If^`&gdFmkd$$Ifֈq mG$ nt"4 a8*,.02468fRCCCCC$d$$Ifa$gdFm&d$$If^`&gdFmkd$$Ifֈq mG$ nt"4 a88:Xl|fRCCCCC$d$$Ifa$gdFm&d$$If^`&gdFmkdB$$Ifֈq mG$ nt"4 a8fRCCCCC$d$$Ifa$gdFm&d$$If^`&gdFmkd$$Ifֈq mG$ nt"4 a8fRCCCC$d$$Ifa$gdFm&d$$If^`&gdFmkd$$Ifֈq mG$ nt"4 a8N:+$d$$Ifa$gdFm&d$$If^`&gdFmkd$$Ifֈq mG$ nt"4 a8$d$$&dIfPa$gdFm "$LNWC&d$$If^`&gdFmkdF$$Ifֈq mG$ nt"4 a8$d$$Ifa$gdFmNPRThj?kd$$Ifhֈq mG$ nt"4 a8$d$$&dIfPa$gdFm$d$$Ifa$gdFmjlVXd$d$$&dIfPa$gdFm&d$$If^`&gdFmgd+`$d$`a$gd+`$\d$VDQ^\`a$gd+` lprTdfhϻϻtttititiW#h>1 h+`CJPJ]aJnHtHh>1 h+`CJaJh>1 h+`CJaJ h>1 h+`CJPJaJnHtH#h>1 h+`CJPJaJnHo(tHh>1 h+`CJ]aJh>1 h+`PJnHtH&h>1 h+`>*CJPJaJnHo(tH"h>1 h+`>*CJaJnH o(tH h>1 h+`>*CJaJ#h>1 h+`>*CJPJaJnHtHdfhxfRCCCCC$d$$Ifa$gdFm&d$$If^`&gdFmkd$$Ifֈq mG$ nt"4 a8fRCCCCC$d$$Ifa$gdFm&d$$If^`&gdFmkd$$Ifֈq mG$ nt"4 a8fRCCCCC$d$$Ifa$gdFm&d$$If^`&gdFmkdJ$$Ifֈq mG$ nt"4 a8 !&'3<CDFHOPQRWXlos|}~ɾժsɾ՘aQh>1 h+`CJ]aJnH tH "h>1 h+`CJ]aJnH o(tH h>1 h+`CJPJaJnHtH& *h>1 h+`CJPJ]aJnHtH#h>1 h+`CJPJ]aJnHtH&h>1 h+`CJPJ]aJnHo(tHh>1 h+`CJaJh>1 h+`CJ]aJh>1 h+`CJaJh>1 h+`CJaJnH tH h>1 h+`CJaJnH o(tH  !"#$%&fRCCCCC$d$$Ifa$gdFm&d$$If^`&gdFmkd $$Ifֈq mG$ nt"4 a8&'DEFGHfRCCCC$d$$Ifa$gdFm&d$$If^`&gdFmkd$$Ifֈq mG$ nt"4 a8HPQRSN:+$d$$Ifa$gdFm&d$$If^`&gdFmkd$$Ifֈq mG$ nt"4 a8$d$$&dIfPa$gdFmSTUVWXlWC&d$$If^`&gdFmkdN$$Ifֈq mG$ nt"4 a8$d$$Ifa$gdFmlpqrs}$&d$$&dIfP^`&a$gdFm$&d$$If^`&a$gdFm}~<=SfWB=0 d^`d$d$UDs]^a$gd+`$d$`a$gd+`kd$$Ifֈq mG$ nt"4 a8~,8;EFYcf:<=@RSTfɹɹۧɖɃwjw`Th>1 hPCJ\o(h>1 hCJ\h>1 h5CJ\o(h>1 h5CJ\%h>1 h5>*CJPJnHo(tH h>1 h<CJPJaJnHtH#h>1 h<CJPJaJnHo(tHh>1 h+`CJaJnH o(tH #h>1 h+`CJPJaJnHo(tH h>1 h+`CJPJaJnHtH&h>1 h+`>*CJPJaJnHo(tHSTkU#qd$IfWD^`qgdFmOkd$$If440B# T"4 a8f4$d$Ifa$gdFm d$IfgdFm$d`a$gd-$d`a$gdP $d^a$fn'(+145WX\^_kƻ~~~nnnnnh>1 h-CJaJnH o(tH h>1 h-#h>1 h-CJPJaJnHo(tHh>1 h-CJaJnH tH h>1 h-CJh>1 h-CJaJo(h>1 h-CJaJ"h>1 h-CJPJ\nHo(tHh>1 hPCJ\h>1 hPCJ\o("h>1 hPCJPJ\nHo(tH+o``$d$Ifa$gdFm#qd$IfWD^`qgdFmbkdF$$If44FBY#T"    4 a8f4$d$&dIfPa$gdFmxx$d$Ifa$gdFm#qd$IfWD^`qgdFmbkd$$If44FBY#T"    4 a8f4xx$d$Ifa$gdFm#qd$IfWD^`qgdFmbkdd$$If44FBY#T"    4 a8f4(.4xx$d$Ifa$gdFm#qd$IfWD^`qgdFmbkd$$If44FBY#T"    4 a8f445X\^xx$d$Ifa$gdFm#qd$IfWD^`qgdFmbkd$$If44FBY#T"    4 a8f4^_xx$d$Ifa$gdFm#qd$IfWD^`qgdFmbkd$$If44FBY#T"    4 a8f4xx$d$Ifa$gdFm#qd$IfWD^`qgdFmbkd$$If44FBY#T"    4 a8f4 HRSqxz{|оооТоооvj`h>1 hCJ\h>1 hCJ\o(h>1 h5CJ\o(h>1 h5CJ\%h>1 h t5CJPJ\nHo(tHh>1 h-CJnH tH h>1 h-CJaJnH tH #h>1 h-CJPJaJnHo(tHh>1 h-CJaJnH o(tH h>1 h-CJaJo(h>1 h-CJaJh>1 h-CJ$sb$d$4$Ifa$gdFm$d$Ifa$gdFm#qd$IfWD^`qgdFmgkd&$$If44FBY#T"    4 a8f4gc&HPRxg$d$4$Ifa$gdFm$d$Ifa$gdFm#qd$IfWD^`qgdFmbkd$$If44FBY#T"    4 a8f4RSqyxx$d$Ifa$gdFm#qd$IfWD^`qgdFmbkdH$$If44FBY#T"    4 a8f4yy$d$&dIfPa$gdFm #d$IfgdFmbkd$$If44FBY#T"    4 a8f4()*|jXL d$IfgdFmVdUD]V^gdVdUD]V^gdRQ $d^a$ d^`dgdKUlbkd`$$If44FBY#T"    4 a8f4&'()=CDEIJNOPQabc|}~ź}}}}q_q_K&h>1 h5CJPJ]aJnHtH#h>1 hCJPJ]aJnHtHh>1 hCJ]aJ h>1 h#h>1 hCJPJaJnHo(tHh>1 hCJaJnH tH h>1 hCJh>1 hCJaJo(h>1 hCJaJ"h>1 hCJPJ\nHo(tH"h>1 hRQCJPJ\nHo(tHh>1 hRQCJ\o(h>1 hRQCJ\*CDEJOss$d$&dIfPa$gdFm#qd$IfWD^`qgdFmOkd$$If440B# T"4 a8f4$d$Ifa$gdFmOPQYaxx$d$Ifa$gdFm#qd$IfWD^`qgdFmbkdb$$If44FBY#T"    4 a8f4abco|xx$d$Ifa$gdFm#qd$IfWD^`qgdFmbkd$$If44FBY#T"    4 a8f4|}~ss$d$Ifa$gdFmo[c&#qd$IfWD^`qgdFmbkd$$If44FBY#T"    4 a8f4ss$d$Ifa$gdFm#qd$IfWD^`qgdFmgkd$$If44FBY#T"    4 a8f4g[c& IJIJIJIJIJwwwIJIJIJj]h>1 h5CJ\o(h>1 hCJnH tH h>1 hCJaJo(h>1 hCJaJnH tH h>1 hCJ]aJh>1 hCJh>1 hCJaJ#h>1 hCJPJaJnHo(tHh>1 hCJaJnH o(tH h>1 h5CJaJ#h>1 hCJPJ]aJnHtHh>1 h5CJ]aJ#oo$d$&dIfPa$gdFm#qd$IfWD^`qgdFmbkd$$If44FBY#T"    4 a8f4xx$d$Ifa$gdFm#qd$IfWD^`qgdFmbkd:$$If44FBY#T"    4 a8f4 jR$d$&dIfPa$gdFm$}d$&dIfPa$gdFm#qd$IfWD^`qgdFmbkd$$If44FBY#T"    4 a8f4 zma $d^a$ d^`^$VdUD]V^a$gddgdbkdR$$If44FBY#T"    4 a8f4 !$DGKNRkzWXv?@cg:JKOQmqIJh>1 h5CJ\o(,h>1 hB*CJPJaJnHo(phtH"h>1 h:8CJPJ\nHo(tHh>1 h:8CJ\o(h>1 h5CJ\h>1 h5CJ\o(h>1 hCJ\o(h>1 hCJ\4 15}.jŻŻŎŻŻŻ|ŻŻ|q|q`| h>1 hRQCJPJaJnHtHh>1 hRQCJaJ#h>1 hRQCJPJaJnHo(tHh>1 hRQCJnH o(tH h>1 hRQCJPJnHtHh>1 hRQCJPJnHo(tHh>1 hRQCJo(h>1 hRQCJh>1 hCJo(h>1 hCJ%h>1 h5CJPJ\nHo(tHh>1 h5CJ\#-.fg$d$Ifa$gd d$Ifgd$HdVDWD8^`Ha$gdRQd^ d^`^ d^gdRQ$d^a$gdRQ *1TXYefнyyiyWyWWL@h>1 hRQCJaJo(h>1 hRQCJaJ"h>1 hRQCJPJ\nHo(tHh>1 hRQCJ\nH o(tH h>1 hRQCJ\"h>1 hfCJPJ\nHo(tHh>1 hRQCJ\o(h>1 h5>*CJh>1 hCJPJnHo(tH%h>1 h5CJPJ\nHo(tHh>1 h5CJ\h>1 h5CJ\o(,h>1 hB*CJPJaJnHo(phtH$d$&dIfPa$gd#qd$IfWD^`qgdOkd$$If440B# T"4 a8f4 !#$ܨܨܗv_,h>1 hB*CJPJaJnHo(phtHh>1 hRQCJnH tH 'h>1 hRQCJPJQJaJnHo(tH h>1 hRQCJPJaJnHtHh>1 hRQCJaJnH o(tH h>1 hRQCJaJ h>1 hRQ#h>1 hRQCJPJaJnHo(tHh>1 hRQCJaJo(h>1 hRQCJaJnH tH h>1 hRQCJ!xx$d$Ifa$gd#qd$IfWD^`qgdbkdT$$If44FBY#T"    4 a8f4xx$d$Ifa$gd#qd$IfWD^`qgdbkd$$If44FBY#T"    4 a8f4xx$d$Ifa$gd#qd$IfWD^`qgdbkdr$$If44FBY#T"    4 a8f4 !"#xx$d$Ifa$gd#qd$IfWD^`qgdbkd$$If44FBY#T"    4 a8f4#$oooooooo$d$&dIfPa$gd#qd$IfWD^`qgdbkd$$If44FBY#T"    4 a8f4  %7~rZZZ$d$&dIfPa$gdFm d$IfgdFm d^gd'M d^`^bkd$$If44FBY#T"    4 a8f4  $%'(2678tctcQtctc#h>1 h'MCJPJaJnHo(tH h>1 h'MCJPJaJnHtHh>1 h'MCJaJnH o(tH #h>1 h'M>*CJPJaJnHtH&h>1 h'M>*CJPJaJnHo(tHh>1 h'MCJaJo(h>1 h'MCJaJh>1 h'MCJh>1 hCJh>1 h5CJ\o(h>1 h5CJ\%h>1 h5CJPJ\nHo(tH789AI$d$Ifa$gdFm d$IfgdFm]kd$$IflF#&T"    4 laIJKWb#$d$Ifa$gdFm d$IfgdFm]kd$$IflF#&T"    4 labcdef#$d$Ifa$gdFm d$IfgdFm]kd$$IflF#&T"    4 lafg#$d$Ifa$gdFm d$IfgdFmbkd$$IflF#&T"    4 lagFuu#$d$&dIfPa$gdFmd$If^`gdFm]kdb$$IflF#&T"    4 la#$d$Ifa$gdFm d$IfgdFm]kd$$IflF#&T"    4 laxx$d$&dIfPa$gdFm%!d$IfgdFm]kd:$$IflF#&T"    4 la&,-35nuv}oqrt{ŲŜЊ~thhh>1 h'MCJaJo(h>1 h'MCJ\h>1 h'MCJ\o("h>1 h'MCJPJ\nHo(tH+h>1 h'MCJOJPJQJaJnHo(tH$h>1 h'MCJOJQJaJnHtHh>1 h'MCJaJ h>1 h'MCJPJaJnHtHh>1 h'MCJaJnH o(tH h>1 h'MCJOJQJaJ& $$Ifa$gdFm%!$IfgdFm]kd$$IflF#&T"    4 la&-4 $$Ifa$gdFm%!$IfgdFm]kd$$IflF#&T"    4 la45nv~uu#$d$&dIfPa$gdFmd$If^`gdFm]kd~$$IflF#&T"    4 la~ $$Ifa$gdFm%!$IfgdFm]kd$$IflF#&T"    4 la~~$$&dIfPa$gdFm%!$IfgdFm]kdV$$IflF#&T"    4 la $$Ifa$gdFm%!$IfgdFm]kd$$IflF#&T"    4 la~~$$&dIfPa$gdFm%!$IfgdFm]kd.$$IflF#&T"    4 lapqr{qqq$d$&dIfPa$gdFm d$IfgdFm d^gd'M]kd$$IflF#&T"    4 laHNOTUVfglmnpqryz;ⷾⷾ⾧֧⾧֧֧ͧ;;֧͛h>1 h'MCJ\o(h>1 h'MCJaJnH o(tH h>1 h'Mh>1 h'MCJaJnH tH h>1 h'MCJh>1 h'MCJaJo(h>1 h'MCJaJ#h>1 h'MCJPJaJnHo(tH7||$d$Ifa$gdFm#qd$IfWD^`qgdFm]kd$$IfF#&U"    4 a8||$d$Ifa$gdFm#qd$IfWD^`qgdFm]kd$$IfF#&U"    4 a8||$d$Ifa$gdFm#qd$IfWD^`qgdFm]kd $$IfF#&U"    4 a8||$d$Ifa$gdFm#qd$IfWD^`qgdFm]kd$$IfF#&U"    4 a8||$d$Ifa$gdFm#qd$IfWD^`qgdFm]kd$$IfF#&U"    4 a8IOU||$d$Ifa$gdFm#qd$IfWD^`qgdFm]kd$$IfF#&U"    4 a8UVgjlss$d$&dIfPa$gdFm#qd$IfWD^`qgdFm]kd$$IfF#&U"    4 a8lmnop||$d$Ifa$gdFm#qd$IfWD^`qgdFm]kd$$IfF#&U"    4 a8pqrzss$d$&dIfPa$gdFm#qd$IfWD^`qgdFm]kd$$IfF#&U"    4 a8wj^OO$d^a$gd0vS $d^a$ d^`$d^a$gdg$d^a$gd'M d^gd'M]kd$$IfF#&U"    4 a8d upon in the sales contract. Except for some particular customers where payment in advance is normally required, the Group allows an average credit period of 30 days to its local trade customers and 180 days for local hospital customers. 9. Trade and other payablesThe following is an aged analysis of accounts payable presented based on the invoice date at the end of the reporting period.30 June 201231 December 2011RMB000RMB000(unaudited)(audited)Within one year406,956346,815More than one year but less than two years1,8013,986More than two years but less than three years487601Over three years3,8653,809413,109355,211Other payables and accrued charges137,482129,908550,591485,11910. Related party transaction Significant related party transactions, which were carried out in the normal course of the Groups business are as follows:Six months ended 30 June20122011RMB000RMB000(unaudited) (unaudited)SXPGC - Payment of annual trademark license fee (Note)3,7501,100- Rental expense500500- Acquisition of land use rights8,399-Fellow subsidiaries :- Sale of water, electricity, steam and waste materials6,3085,379- Sale of bulk pharmaceuticals and chemical rawMaterials31,963-- Purchase of raw materials29,82325,137- Design fee income6110Associates- Sale of water, electricity and steam271-- Purchase of raw materials410-Non-controlling interest shareholders:- Sale of bulk pharmaceuticals and chemical raw materials73,20573,797- Purchase of raw materials-309Note:Pursuant to a trademark license agreement dated 7 December 1996 (Agreement), the Group was granted the exclusive right to use the trademark Xinhua (Trademark) by SXPGC for its existing and future products in and outside the PRC at an initial annual fee of RMB600,000 increasing at the rate of an extra RMB100,000 per year until the annual fee reaches the cap amount of RMB1,100,000, which shall stay as such until the Agreement is terminated. The terms of the Agreement shall continue to have effect during the validity period of the Trademark, being until 28 February 2013, subject to further renewal of the registration of the Trademark. On 23 March 2012, in order to amend and supplement the Agreement, the Company and SXPGC entered into a supplemental trademark license agreement, pursuant to which the Group was required to pay SXPGC an annual fee of RMB10,000,000 from 1 April 2012 to 31 December 2014. Other terms of the Agreement remain unchanged. During the six months ended 30 June 2012, the annual fee paid by the Group was RMB3,750,000 (2011 : RMB1,100,000). As at 30 June 2012, Hualu Holdings Company Limited provide guarantee to the Group amounted to RMB230,000,000 (2011: RMB230,000,000). Compensation of key management personnelSix months ended 30 June20122011RMB000RMB000(unaudited) (unaudited)Short-term benefits916898Post-employment benefits1261201,0421,018i!. DOCUMENTS FOR INSPECTION AND PLACE FOR INSPECTION(1) DOCUMENTS FOR INSPECTION1. The original copy of the Company s 2012 Interim Report signed by the Chairman of the Board.2. Financial statements for the six months ended 30 June 2012 signed by the Chairman of the Board, the financial controller and the chief of the accounting department of the Company.(2) PLACE FOR INSPECTIONOffice of the Secretary to the Board of the Company.By Order of the BoardShandong Xinhua Pharmaceutical Company LimitedZhang DaimingChairman23 August 2012, Zibo, PRCAs at the date of this announcement, the Board comprises: Executive Directors:Mr. Zhang Daiming (Chairman)Mr. Du DepingMr. Zhao SongguoIndependent Non-executive Directors:Mr. Zhu BaoquanMr. .psôȴ˴ԴE۳}qd}dZOh>1 h0vSCJaJh>1 hCJ\h>1 h5CJ\o(h>1 h5CJ\%h>1 h5CJPJ\nHo(tH"h>1 hCJPJ\nHo(tH h>1 hh>1 h'MCJ\h>1 h'Mh (CJ\h>1 h'MCJaJnH o(tH h>1 h'MCJaJ#h>1 h'MCJPJaJnHo(tHU h>1 h'MCJPJaJnHtHE{µõٵڵ۵ݵ޵)/0567dhilmn~ʿ h>1 h0vSh>1 h0vSCJaJnH tH h>1 h0vSCJh>1 h0vSCJaJnH o(tH h>1 h0vSCJaJo(h>1 h0vSCJaJ"h>1 h0vSCJPJ\nHo(tH h>1 h0vSCJPJaJnHtH#h>1 h0vSCJPJaJnHo(tH4}gXX$d$Ifa$gd#qd$IfWD^`qgd]kd$$$IfFBY#T"    4 a8$d$&dIfPa$gd d$Ifgdµõϵٵ||$d$Ifa$gd#qd$IfWD^`qgd]kd$$IfFBY#T"    4 a8ٵڵ۵ܵݵ||$d$Ifa$gd#qd$IfWD^`qgd]kd*$$IfFBY#T"    4 a8ݵ޵||$d$Ifa$gd#qd$IfWD^`qgd]kd$$IfFBY#T"    4 a8*06||$d$Ifa$gd#qd$IfWD^`qgd]kd0$$IfFBY#T"    4 a867eim||$d$Ifa$gd#qd$IfWD^`qgd]kd$$IfFBY#T"    4 a8mnss$d$&dIfPa$gd#qd$IfWD^`qgd]kd6$$IfFBY#T"    4 a8||$d$Ifa$gd#qd$IfWD^`qgd]kd$$IfFBY#T"    4 a8||$d$Ifa$gd#qd$IfWD^`qgd]kd<$$IfFBY#T"    4 a8ĶŶ̶ͶԶնֶ׶ضٶڶ۶   ʺʺ䗋xkaUh>1 h5>*CJh>1 hCJ\h>1 h5CJ\o(%h>1 h5CJPJ\nHo(tHh>1 h5CJ\,h>1 hB*CJPJaJnHo(phtHh>1 h0vSCJaJo(h>1 h0vSCJaJnH o(tH h>1 h0vSCJaJnH tH h>1 h0vSCJaJh>1 h0vSCJ#h>1 h0vSCJPJaJnHo(tHŶͶնss$d$&dIfPa$gd#qd$IfWD^`qgd]kd$$IfFBY#T"    4 a8նֶ׶ضٶ||$d$Ifa$gd#qd$IfWD^`qgd]kdB$$IfFBY#T"    4 a8ٶڶ۶ss$d$&dIfPa$gd#qd$IfWD^`qgd]kd$$IfFBY#T"    4 a8  maUF$d$Ifa$gdFm d$IfgdFm d^gdC$ & FSWd1$^S`Wa$gdCd^ d^`^]kdH$$IfFBY#T"    4 a8 ikŷƷǷ %&,=>ABE͐͐͸t͸ͩd͗dh>1 hCCJaJnH o(tH h>1 hC5CJaJnH tH h>1 hC5CJaJ h>1 hC#h>1 hCCJPJaJnHo(tHh>1 hCCJaJnH tH h>1 hCCJh>1 hCCJaJo(h>1 hCCJaJh>1 hCCJ\o(h>1 hCCJ\"h>1 hCCJPJ\nHo(tH'$d$&dIfPa$gdFm#qd$IfWD^`qgdFmOkd$$If440B#} 9!4 aSf4ŷxx$d$Ifa$gdFm#qd$IfWD^`qgdFmbkdA$$If44FBY#}9!    4 aSf4ŷƷǷԷ||$d$Ifa$gdFm#qd$IfWD^`qgdFm]kd$$IfFBY#}9!    4 aS||$d$Ifa$gdFm#qd$IfWD^`qgdFm]kdP$$IfFBY#}9!    4 aS||$d$Ifa$gdFm#qd$IfWD^`qgdFm]kd$$IfFBY#}9!    4 aS &,xx$d$Ifa$gdFm#d$IfVDF^`gdC]kdV $$IfFBY#}9!    4 aS,->BFzz$d$Ifa$gdFm#fd$IfVDG^gdC]kd $$IfFBY#}9!    4 aSEFGIghnpqrtuŸƸ˸̸ҸӸ ʺ쮖uj^j^jN^h>1 hi}CJaJnH o(tH h>1 hi}CJaJo(h>1 hi}CJaJh>1 hCCJaJnH tH #h>1 hCCJPJaJnHo(tH.h>1 hC5CJOJPJQJaJnHo(tHh>1 hC5CJaJh>1 hCCJaJnH o(tH +h>1 hCCJOJPJQJaJnHo(tHh>1 hCCJaJo(h>1 hCCJh>1 hCCJaJFGhnp$d$Ifa$gdFm#d$IfVDG^gdC]kd\ $$IfFBY#}9!    4 aSpqrst{{$d$Ifa$gdFm#d$IfVDG^gdCo{L]kd $$IfFBY#}9!    4 aStu||$d$Ifa$gdFm#qd$IfWD^`qgdFm]kdb $$IfFBY#}9!    4 aSƸ̸Ҹ||$d$Ifa$gdFm#d$IfVDF^`gdC]kd $$IfFBY#}9!    4 aSҸӸ}nn$d$Ifa$gdi}#d$IfVD^gdC#d$IfVDG^gdC]kdh $$IfFBY#}9!    4 aS3:Azz$d$Ifa$gdFm#d$IfVDF^`gdC_kd $$IfFBY#}9!    4 aS239:ABDVX\]^`aklnoq¹ùĹܹ)/ͻͯݯ쯚ͯͻzzh>1 hC5CJaJo("h>1 hC5CJaJnH o(tH h>1 hC5CJaJh>1 hCCJh>1 hCCJaJo(#h>1 hCCJPJaJnHo(tHh>1 hCCJaJnH o(tH h>1 hCCJaJnH tH h>1 hCCJaJh>1 hi}CJ+ABVX\||$d$Ifa$gdFm#d$IfVDF^`gdC]kdx$$IfFBY#}9!    4 aS\]^_`||$d$Ifa$gdFm#d$IfVDg^`gdC]kd$$IfFBY#}9!    4 aS`almn$d$Ifa$gdFm #d$IfgdFm]kd~$$IfFBY#}9!    4 aSno$d$Ifa$gdFm#d$IfVDG^gdC]kd$$IfFBY#}9!    4 aS||$d$Ifa$gdFm#d$IfVDF^`gdC]kd$$IfFBY#}9!    4 aS¹ù||$d$Ifa$gdFm#d$IfVDg^`gdC]kd$$IfFBY#}9!    4 aSùĹ$d$Ifa$gdFm#d$If`gdFm]kd$$IfFBY#}9!    4 aS)07zz$d$Ifa$gdFm#QWd$IfVDFWD?^Q`WgdC]kd$$IfFBY#}9!    4 aS/0678;UVW[\]bd  Ƚ୛ȏymcmcWcmcMcAch>1 hnVCJ\aJh>1 hnV5CJh>1 hnV5CJo(h>1 hnVCJ\h>1 hnVCJ\o(h>1 hCCJ\o(h>1 hCCJ\h>1 hC5>*CJ#h>1 hCCJPJaJnHo(tHh>1 hCCJaJnH o(tH h>1 hCCJaJh>1 hCCJh>1 hCh3CJaJo(h>1 hCCJaJo(%h>1 hCh3CJaJnH o(tH 78UW[qq$d$&dIfPa$gdFm#QWd$IfVDFWD?^Q`WgdC]kd$$IfFBY#}9!    4 aS[\]cd#qbW?$ & FSWd1$^S`Wa$gd $da$gdC$>d^>a$gdnV$d^a$gdC$ndWD2^`na$gdC d^gdC]kd$$IfFBY#}9!    4 aS 78Yx'2<KOyz{}Ͼؾ  ~thtththth>1 hCCJ\o(h>1 hCCJ\h>1 hCCJ\aJo(&h>1 hCCJPJ\aJnHo(tHh>1 hCCJ\aJ"h>1 hCCJPJ\nHo(tH"h>1 hnVCJPJ\nHo(tHh>1 hnVCJ\aJo(h>1 hjPCJ\o(h>1 hnVCJ\h>1 hnVCJ\o(( !"$&NOPdjklpquvwxмzkYYRkRkRkz h>1 hC#h>1 hCCJPJaJnHo(tHh>1 hCCJaJnH tH h>1 hCCJh>1 hCCJaJo(h>1 hCCJaJ*h>1 hCCJOJPJQJ\nHo(tHh>1 hCCJ\aJ&h>1 hCCJPJ\aJnHo(tH"h>1 h CJPJ\nHo(tHh>1 hCCJ\o("h>1 hCCJPJ\nHo(tH#$OPQjklhR#qd$IfWD^`qgdFmOkd$$If440B#} 9!4 aSf4$d$Ifa$gdFm d$IfgdFm~`gdC$ & FSWd1$^S`Wa$gdC $d1$a$gd lqvwxo``$d$Ifa$gdFm#qd$IfWD^`qgdFmbkd$$If44FBY#}9!    4 aSf4$d$&dIfPa$gdFm||$d$Ifa$gdFm#qd$IfWD^`qgdFm]kd$$IfFBY#}9!    4 aS||$d$Ifa$gdFm#qd$IfWD^`qgdFm]kd'$$IfFBY#}9!    4 aSĿ||$d$Ifa$gdFm#qd$IfWD^`qgdFm]kd$$IfFBY#}9!    4 aSÿĿſݿ޿TVjlúӎïӯӎïsiaiaih>1 h5h>1 h5o(4h>1 hB*CJOJPJQJaJnHo(phtH#h>1 hCCJPJaJnHo(tHh>1 hCCJaJnH tH h>1 hCCJaJh>1 hCCJh>1 hCCJaJnH o(tH h>1 hCCJaJo(h>1 hCCJaJnH o(tH h>1 hC5CJaJnH tH Ŀſ޿}}$d$&dIfPa$gdFm #d$IfgdFm]kd-$$IfFBY#}9!    4 aS$d$Ifa$gdFm#d$IfgdFmoc&]kd$$IfFBY#}9!    4 aSxx$d$&dIfPa$gdFm#d$IfgdFmoc&]kd3$$IfFBY#}9!    4 aSlnhjlmk$7$8$H$WD^`a$gd{u $7$8$H$a$gd{u7$8$H$$da$^]kd$$IfFBY#}9!    4 aS lnJLfj  BFbcklmо~~rо[,h>1 hB*CJKHOJQJ\aJphh>1 h{uCJ\o("h>1 h5TCJPJ\nHo(tH"h>1 h3ACJPJ\nHo(tH"h>1 h{uCJPJ\nHo(tHh>1 h{uCJ\"h>1 hCJPJ\nHo(tHh>1 h5o(h>1 h59h>1 h5CJKHOJPJQJ\^JaJnHo(tH34op< $$G$Ifa$$G$a$$^a$ $ ^ a$gd7"$0TPL HD@< ^ a$$ ^ a$ ^ gd}^нoY81h>1 hB*CJOJPJQJaJnHphtH@h>1 h56B*CJOJPJQJ\]aJnHo(phtH+h>1 h6B*CJOJQJ]aJph7h>1 h5B*CJOJPJQJ\aJnHphtH7h>1 hG5B*CJOJPJQJ\aJnHphtH+h>1 h5B*CJOJQJ\aJph%h>1 hB*CJOJQJaJph,h>1 hB*CJPJaJnHo(phtH/h>1 hB*CJKHOJQJ\aJo(ph '234< <<B<C<Q<R<V<\<]<ҹzzzllzj\llO\lh>1 h]={PJnHtHh>1 h]={PJnHo(tHUh>1 hPJnHo(tHh>1 hGPJnHo(tHh>1 hGPJnHtHh>1 hPJnHtH,h>1 hB*CJPJaJnHo(phtH1h>1 hB*CJOJPJQJaJnHphtH%h>1 hB*CJOJQJaJph4h>1 h3AB*CJOJPJQJaJnHo(phtHBai HuiliangMr. Kwong Chi Kit, VictorNon-executive Directors: Mr. Ren FulongMr. Xu Lie Mr. Zhao BinPAGE PAGE 27<'<(<)<C<R<^<k<l<m<n<fagd7Gkd$$If0!64 aGkd9$$If0!64 a $$G$Ifa$ ]<j<k<m<n<o<q<r<t<u<w<x<z<{<<<<<<<<<<<<<<<ĺ hZyCJ hKUl0J$mHnHuhZy hZy0J$jhZy0J$Uh6jh6UhU4hnHo(tHh>1 hPJnHtHh>1 hPJnHo(tHh>1 ho(n<p<q<s<t<v<w<y<z<<<<<<<<<gd7#$a$##&`#$/0P/ =!"H#$n% nu*l?xK-PNG  IHDRryJzgAMA pHYsLLXtcPLTE#$ 84*&'"51;7.*?;2-2./+40)%(#,(=9950,+'=83.627383B>B?A=C?@=QNUQNJFBJFXU\Y^[DAZWIF]ZOKHDWSQMMJKHSOD@YUVSLISPFCYV[W^ZROLHOLWTb_`\a^b^`]iftrfc}pn|ymjxupmvtywc`li~{}{wt}{rogdvsda~{xuebnkkgkholtqheqnpnspzw{x~}ƵG'IDATx}|yNg˲$Dz6d[r^ 8&!iP*`Ԙ˒lbh^ZQ@!M#'MI4mt/kvӦMO$nwvgyfgwgt7<3(Z8˱!}t%O_dKU}*meDW܇lL7{]+>IcMC|l4IzO̚*Irìi.! gKz8T*%,佫X ˏ<&K$]vUtɑ,VEzIyH.#Ϛ!tifPIѳf$]Nfx$]F䜳fX$]>.fpHl]Κatg&o#K>k.8ietgƾUFI9|֌4&(D2I$ʴ[K\Co~$]YgȎ*FC$A#eY/c#"OFj+ <#۠1kZǮWM?f5$=Y!R+K.>k*qبPެM`$oY _&I1k̊/ 6/~"G̚J]Y͠E-%B$cJME.s`SϒrĬ9ö"^}2JOfdGʶ*Fwt%YSYw-V21 1y oU2l"lJK=G5ڠ}>i&{1kF%03%)Iy?|Tjzώ|vK{Áw돳L&)sI:i<";ZKܔ{< 5$1FT=twLW|^2? 6{) _%R;I1fI~3Dv F)+I3kFf4b[jNv)I3k* 5lc557{"bcfMsWz_&[lJ@E"̚ K,iM%]r̬IUlr̙p +颐cfM ߽٨Ɇ7t1QQai˿.9fdUll)] @5mB*ëN* tQ~͗26w_pS Iw5km{ޕCL3u B]!G͚,6gt9fִ: qsѪ”%(Y(iD TW#fMA$)/pY AA8z=CfMQ`J/{]MYS:Naq&(D08J;0tCfMQ@ "4\ҝfȶsidz?t;"G͚DtGaJJrܬs"paL IE5yBRlLB ͚.BSl鱊1;K;O9kz~"bsz s[QG#gMe~6iDjcLI!GΚ~ؤS\m%]Κ~$N#)}BܬQ`]j]|sa\Q#y0Y >/ <ʔ>&FzQœt/8EXlFt<ʔ_k=+= 071ox ɕpAqQj] *>~.6Q,tzM (Q_6\#frRLQB]uIRvpzM eۣ|mwJ63;VVX RԣLQ']iѧ3O޵ˍznq(ybE>)ΉFIX88S:U ,U3sdθT`"NBBonaEBORVV+x2j ' s%NR08E=ƓGVhbf#i+zbiӪ8SR"DKnb5rSWMu;6rH[!V#3S0Ow.Bd.A#[̕`XPg #ȂE#/93fZeɌ\S{<03Ol#4 2)J{d<=`[Sԗ ˀ\S%-x,-|@u=݅}55FJ77(\dcs'`}IIFKgnFmNڳw8B?Hz,s-ډ-}ֽ-V,a \954O|\*Kѹ\nW"ZO_^6MSa&y <07t|-s<7{<2*C6m,^YZ=@9Q(iE0b+ANlzQ~O9Q_\jVv^X !*y{F0DiR#ϲӓO5||@c|ȋA^Ɍ=t*"GIgPݙ-M> 9RP86uimڰJsp>/;|(|=i :\2noi@ Wߍ}kj qg@>a19i?K]~되>>7xlgߗ@g sh.~K|~ xs>"¹7U­Ůһ4vvg^i4so8xgkSdpG+'rmS}̈́ð)wh39jkku?ʒa@VfN6:%BwSTjc9u h5#p%k _=ANWvm)eͯlW+RuKw)]zYv})K-_%)kxb[nZ TVdxN~Uwjb;? bPVWȵ!|,<}qP ~9kZgL/g}lIV6z tNyPw\ܵ!1[gtwA[h%#N0y@d z|+C ŕ5G.Yn1<'`MMM7}dy(B#,yKg\7S;w²n r<0w :ҹ0)oux9֖~e⯖gs4[_Sۿ[ rf;G^8}EO{뢂G\Y/XId(Wp=Lh+ve7(so+}Gi'Mp_kk'KD74mфG-1 >cUƱe9 +5?r/:i@~D Gu݅fIZ`UEN 'D%=u\ 3A~ YoaEٷs7Dޠ_E8@-J1|s )rOAO.мE%!185<Ӧi_r`/qc/*!wR?̱+[=aǎ0{̱~}ee];Mf-nz1_W<o5O_cc>YF3>xפ@r.GΏcM]G}EuT)My+78ϻﵱ7Wa=U=_sYjr uK7xCuQ_?Yf n% ؜G-Y`n9 R9؆۳˔F„܀?mG^ {:Fߘ2C7CTk=\@pFk}j&'jv r5qC[:+@ުv߈MarCij BNԓ~P-w9j| 4E"G9 eljUc9!~sS̊PSFF:"YeSC\yHf GL2;6h3c&TiWyf|;tk$o59Yh{w{QȉJN,tΐH#\2*ّ$ʥ ~G0M}"'߇ǽ#FCx#;]vkr"']yVjMN\wn^ZǡWZ#Oo3w,J1G%EBOM_!X#ׯͦۡ"'rLQ5r})mx }M(%r3>QH}/yfN^܌ur"ȹOf5Z.\F|ߩch !~ kn*e#7vReUS8%!G~e`[pCheeAUsn+dz.~#GF3ܟ 9fu<' tW:H<:Kg I;N]:֜op?vԼ,Bkm܍VE8'w c$a_SPTVn58pi.7Ȋ|֜N)meX>wK*)07f^xz)G4w0oVjtP\RQ^so= PկMAwoIң_:û]ul#t0tHq}g:v.;'ѻ\^Vz9WʽRm5ݪ~yv N}Y!Pr&lj&(9f4@k|9!KE\oEqo*<#Z8kcu#QMe"w,:p/ė%"'W+S3'rN"Cr{\]^-P:~pOqL /r[+:@0#ֳ!9bb0,~[;|oB-l$rS't| !G4>ޱ ANg\RSVtDåZ-rTuif=˿1ȭ$K!O8f;`ŽsݦFvzozpWލ+++^=aG>@W2۱ή^=":۷{Eeu}sǂX>h#'Jg 3'U y>K ;rMyUQ v77- ?r*3arCޛ}u7^=n^n7]Vjz~T,PT|' %zo^ IL]" *^e6rg2OCy|l oPVmR rK?1f>B7pvk^77eT$r*gFE/AFj69iF= )N75u cy~iFƧ s|n14#kꑎ,EwA"^(m<x$|Drn=2P Wʻ Sp J<񉲋Jܔ3U=F/5>JtM"@4j|:@ !,rE/*քU5lώU}Mmy=wMu%{nA܇+ߒnzkݼhMBt#`+iyWw T?%EeM}'jӖb76f5`D<$Z $}7uQdk"%Z CrŃ⏤79#㦪5ǥDxOQEWaTnePu}?L(*hc^*R^QbEP/{ |%.#;f?d ?iKz $"l+is=x(J|kc.85`(hJ(l_sY^c%NQHiЕĶXĻCY#+=raDF+CBb~X?ĉx >< ptAwEԜӇjZRI7f. qmZ8CbeA!x%%p/ =K5Q$ݴkG\#^UC6I7rfU;o6n^6 _)ꊝeml 1vi,w.x4̉J.8IoIýlw'kmb JSQ>c釐<7 HһGGZSKG{WD{s{i\^6 <$=ߍq3htcS<W} 4|lMbϛvU*=8N1g,3{6]"Iqԋ[$|V'[g 4rgrH:X^6rWoqH8*n+t0E}hW f%&PQ U籤CE<L%.Iq`JmDCBO> NotesdB*CJaJphHOH Subhead 1Td^T ;CJaJ~O~ Subhead 2B$'PL HD@<Q^`a$5B*\phO Body textc$>TPL HD@<Td1$7$8$H$^Ta$-B*CJOJQJ_HaJmH nHphsH tHDZ@D ~e,g$a$CJOJPJQJaJnHtH<O< write $a$CJPJnHtHpOpChar Char Char Char!d1$CJKHPJaJmHnHtHu.". yblFhe,g"CJaJ6 @26 u#9r G$CJaJ)@A uxP@RP u w%!d1$CJKHOJPJQJaJtH 0b0 le,g&G$CJaJPOrP Anrede' 1$KHOJPJQJaJtH VOV W[CQ W[CQ(d1$CJKHPJaJmHnHtHuPQ@P ckee,g 3)$a$!B*CJOJPJaJnHphtHBL@B eg*$a$CJOJPJQJaJnHtHvOv Report Text-+$d1$5$7$8$9DH$^a$KHPJaJmH sH tH VT@V e,gWW!,$:d1$]:^a$CJKHPJaJtH `O` Default-1$7$8$H$)B*CJPJ_HaJmH nHphsH tH*U@* c >*B*phXOX xl137/dd1$[$\$ CJKHOJPJQJaJnHtHpOp Body Single0$ (1$a$$B*CJPJ_HhmH phsH tH 2V@2 ]vc >*B* ph0`@"0 HTML 0W@W26]Be@2B  HTML @BP h4$<@&a$5CJ OJPJQJ\^JaJ K@ y|T5([@b( 5uP[N~{T6\J@r\ oRh7$d8<@&a$"5CJ KHOJPJQJ\^JaJ - [e,g48 ` @ 1$3$5$7$8$G$0CJKHOJPJQJ^J_HaJmH nHsH tH6%@6 [ON0W@W9G$ OJQJ^J.?@. ~_g:dVD4^d4/@4 Rh;8WD8^`8<2@< Rh 2<d8VDWD8^d`8<3@< Rh 3=d8VDWD8^d`8<4@< Rh 4>d8VDXWD8^d`8<5@< Rh 5?d8VD WD8^d`8,1@, RhS @ & F 0:@0 RhS 2 A & F 0;@"0 RhS 3 B & F 0<@20 RhS 4 C & F0=@B0 RhS 5 D & F4D@R4 Rhc~ExVD^8E@b8 Rhc~ 2FHxVD^H8F@r8 Rhc~ 3GxVDX^8G@8 Rhc~ 4HxVD ^8H@8 Rhc~ 5I4xVD^400@0 Rhyv&{S J & F46@4 Rhyv&{S 2 K & F47@4 Rhyv&{S 3 L & F48@4 Rhyv&{S 4 M & F49@4 Rhyv&{S 5 N & F$$vU_ 1O00vU_ 2PVD^00vU_ 3QHVD^H00vU_ 4RVDX^00vU_ 5SVD ^00vU_ 6T4VD^400vU_ 7U VD^ 00vU_ 8V| VDx^| 00vU_ 9W VD@^ $@$ ybleW[X*j* ybl;NY5\(^@( nf(Qz)Z,@@, ~{T[dVD4^dX$@X 6eON0W@W(\d&+D/G$VDx^d OJQJ^J$ $"}_ 1]0 0"}_ 2^VD^0 0"}_ 3_VD^00"}_ 4`XVDX^X00"}_ 5a VD ^ 00"}_ 6bVD^00"}_ 7cVD^00"}_ 8dxVDx^x00"}_ 9e@VD@^@6!6 "}_hf5OJQJ\^J8"8 lgCJOJPJ QJ^JaJ4#4 VhvU_h8VDWD8`8(+( >\le,giG$8Y8 ech~gVj-D M I@ Oo`hok8$d%d&d'd-DM NOPQVDWD ^8` OJQJ^J0,0 _evU_lVD^<.< _evU_hmxOJPJQJ^J(B@( ckee,gnx4M@4 ckeL)ۏoWDd`8C@8 ckee,g)ۏpxVD^8N@8 ckeL)ۏ 2qWD`0@"0 cke)ۏrWD`2P@22 ckee,g 2 sdxBR@BB ckee,g)ۏ 2tdxVD^DS@RD ckee,g)ۏ 3uxVD^CJaJ*O@* lʑhv$a$TOrT 7h_1wdd1$XDdCJKHPJaJhmH sH tH 6O6 short_text1CJaJZOZ Table Texty$a$$B*CJPJ_HhmH phsH tH ZOZ Table Text Char$B*CJPJ_HhmH phsH tH JOJ body text{xx1$CJKHaJtH VOV RQk=|d1$WD`CJKHOJPJQJaJtH <O< tw4winMark<B* H*phVOV gnUk=~d1$WD`CJKHOJPJQJaJtH 8O8 c!apple-style-spanO c!hpsBOB c!apple-converted-space:O!:  highlight1q PO1P #- Char Char$CJKHPJ_HaJmH nHsH tH&OA& 1hps atn$OQ$ >st1d D 45PQ+q.YmK00)0 K00@)@0K00PX=@0 K00X=@ OJQJo(K00X=@&K00X=@0K00 0Y=B2FGafkst.38MNv $45hwPQ+,JKPy#*+bipq  #-.@LXYs|<=Bex.<J[lm cp}=>abGHIJKL_$=Z[ "$&(*+\ho{     5 A H T [ \ ] D!E!!!!!!"@"A"""""""""""""""/#T#_#d#f#h#i#v#####################$$$$$!$"$/$?$G$L$N$P$Q$$$$$$$$$% %%%%%%%%%%%%%%%&&%&.&/&e&p&y&z&&&&&&&&&&&&&&&&&'''''''''''''''))**Z+[+++..//{/|//////0000000000000(0105090=0>0M0d0h0l0p0q000000000001 111115191=1A1B1O1g1k1o1s1t111111111111122262:2>2?2@2A2B2C2D2E2R2S2T2U2V2W2h2222222222222222333#3'3+3/303132333435363G3H3I3J3K3L3[3r3v3z3~333333333333333 44444'494=4A4E4F4L4M4S4W4]4^4_4'5(58899~999999::c;d;<<<<==+?,?n?o?AA&C'C_C`CDDfEgEEECHDHIITIUIKKNMOMMMNNNNPPP3P4PRRTTJVKVNXOXYY}[~[[[\\\\b^c^^^``aabbddaebeeenfofggggmjnjjjmmqq>r?rerxrrrrrrrrrrrrrrrrrssss s(s0s8s@sAsHsOsVs]sdsesksussssssssstt$t4tDtMtNt[tkt{tttttttttt uuuu-u=uFuGuHuuuuuuuuuuuuuuuuuvv,v3v:v@vFvGv^vevlvsvzv{v|v}vvvwwwwwwwx xx%x&xNxUx[xbxixkxlxxxxxxxxxxxxxxxyyyyy'y(y?yFyHyOyWyaybyhypyvy~yyyyyyyzzzzt{u{{{{{||}}}}~~_`ǃȃwx78OPbcnÆH[hip"-;_hio}ʼnƉ|}9:PQab͎̎ҐӐZ[klmߕ OPVi|}і/@O`opȗɗ$%@MZgtuǘȘ!"=KYguvՙיٙۙݙޙ"/0КҚԚؚ֚ٚ %&BP^ituśƛ $/0JXftǜԜ՜ &'wʝםٝ"',167W\afklÞĞ { "#tu̡͡Ρԡ()*+,-.68BLM[\htuvwxyzƢǢ΢բ֢ %&09:IJS\]}~ģƣͣԣգ&'()*+,STUVWmnu|}789:STUV[`abckstuv&,01rszĦŦͦѦҦӦԦզ֦צ ()*+,-.XY`ghijklm§çݧާ?@AGTefghpxyz{¨ɨ˨̨"*+UV^fg}~թ֩ީ <=DKLMNOPQRS]ghijklm|}~Ī̪ͪ"#&()NOU[\lmsyzȫɫʫ˫̫ͫΫϫЫګ%-.?@GNOrsy¬ʬҬӬԬլ֬׬ج٬ڬ @AKUVWXYZ[pqrst˭̭έխ֭׭ح٭ڭۭ 89@GHIJKLMZ[eopqrstuîĮ̮Ԯծ#$%&'()*+3;<=>?@ABCMWXY˱ͱ12,-Ǵȴ޴'(>jkGH]̶RS[rs|Ƿ!Ը ':;XwxùĹڹ%`ab.st./()ABSTj !"fghijuv#+3;CKLMNOPQRST\]^_`abct|  !"#$%&'()8?EKTU\]^_`abcde QRSTijkxy &.6=?IJ^dls{ +,-./078GHIJKLUVdefghirsno"#$9:G]z{ !"#$%&'(<=>?@JKLijk #+56789:;<=Z[\]^fghijklmnRSij>DJKnrtu()^fhi>?@YZ[`efgowxy !"34CD|}$123456789: +,-6;MNOW_`amxyz{|} <CJK$*01_ekl}:@FGuy}~06<=NRVWx~$&'CJQRfhlmnopq|}~9@GHegklmst34_`az{| @A^_vw #=>yz,-.HWcpqrsuvxy{|~00000000000000000000000000000000000000000000000000000000000000000 00 00 0 0 0 0 0 0 0 0 0 0 0 0 w 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 00 00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0--- - -- 0 w 0 w 0 w 0 w 0 w 0 w 0 w 0 0 0 w 0 0 0 w 0 0 0 0 0 0 0 000000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0  0 0 0 0000 0 00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0000 00 00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 00000000000000000 0 0 0 0 00 0 0 0 0 v0 0 0 0 0 0 v0 0 0 0 0 0 v0 0 0 0 0 0 v0 0 0 0 0 0 v0 0 0 0 0 0 v0 0 0 0 0 0 v0 0 0 0 0 0 v0 0 0 0 0 0 v0 0 0 0 0 0 0000000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 X0 0 0 0 0 0 0 X0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 X0 0 0 0 X0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 000000000000000000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 00 0 0 0 0 0 000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0000000 00 00 00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 y0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 000000000000000000000000000000000000000000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0000000000000000000000000000000000000000000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0 0000000000000 %0 %0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0  0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 '0 '0 0 0000 %0 %0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0  0 0 0 0     0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0  0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0000 0 %0 % 0 0 0 % % 0 0 0 % % 0 0 0 % % 0 0 0 % % 0  0 % ~ 0  0 % % 0  0 % ~ 0  0 % ~ 0  0 % % 0  0 % % 0  0 % % 0  0 % % 0 0 0 % % 0 0 0 % % 0 0 0 % % 0 0 0 % % 0 0 0 % % 0  0 % % 0  0 % % 0  0 % % 0  0 % % 0  0 % % 0  0 % % 0  0 % % 0  0 % % 0 0 0 % % 0 0 0 % % 0 0 0 % % 0 0 0 % % 0  0 % % 0  0 % % 0  0 % % 0  0 % % 0  0 % % 0  0 % % 0  0 % % 0 0 0 % % 0 0 0 % % 0 0 0 % % 0 0 0 % % 0 0 0 % % 0 0 0 % % 0 0 0 0 0 0  0 0 0 0  0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0  0 0 0 0  0 0 0 0  0 0 0 0  0 0 0 0 %0 0 0 0 0 %0 0 0 0 0 0 0 0 0 0 0000000 000000000  0 0  0 0 0 0 000  0   0   0   0   0 0 0 0 0 0 0 0 0 0   0 00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0   0 00000000000 00,,0 0 0 0 0 0 0 0 0 0 0 0 00 0 0 0 0 0 0 0 0 0 0 0 ,, 00 00 000 00 0 000 000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 00 000 00 0 000 000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 00000 0 00 0 0 00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 000 0 00 0 0 00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0000000 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 #0 0 0 0 0000 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 000000000000 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0000 0000 0 0000 00 0 0 0 0 0 0 0 #0 #0 0 0 #0 #0 0 0 #0 #0 0 0 #0 #0 0 0 #0 #0 0 %0 0 0 0 %0 0 0 0 %0 0 0 0 0 #0 #0 0 %0 0 0 0 %0 0 0 0 %0 0 0 0 %0 0 0 0 0000 00 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 00000000 00 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 000 000 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 ## 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 #0 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 #0 0 0 0 # 0 0 0 # 0 0 0 0000 00 0~0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 #0 0 0 0 #0 0 0 0 #0 0 0 0 0000000000000000000000000 00000 0 0000 0 0 0@0I00@0I00@0I00@0I00@#0@#0@0@#0@#0@0I00qrsuv"DE*:;cdLMXYmn  S T   M N p q A B G Z f   = N _ d e m | 8D-56M[iqr"0>FGafkst.38MNv 45hwPQ+,JKPy#*+ipq  #-.@LXYs<=Bex.<J[lm cp}=>abGHIJKL_$=Z[ "$&(*+\ho{     5 A H T [ \ ] D!E!!!!!!"@"A"""""""""""""""/#T#_#d#f#h#i#v#####################$$$$$!$"$/$?$G$L$N$P$Q$$$$$$$$$% %%%%%%%%%%%%%%%&&%&.&/&e&p&y&z&&&&&&&&&&&&&&&&&'''''''''''''''))**Z+[+++..//{/|//////0000000000000(0105090=0>0M0d0h0l0p0q000000000001 111115191=1A1B1O1g1k1o1s1t111111111111122262:2>2?2@2A2B2C2D2E2R2S2T2U2V2W2h2222222222222222333#3'3+3/303132333435363G3H3I3J3K3L3[3r3v3z3~333333333333333 44444'494=4A4E4F4L4M4S4W4]4^4_4'5(58899~999999::UIKKOXYY}[~[[[\\\\b^c^^^aabbdaebeeenfofggggmjnjjjq>r?rerxrrrrrrrrrrrrrrrrrssss s(s0s8s@sAsHsOsVs]sdsesksussssssssstt$t4tDtMtNt[tkt{tttttttttt uuuu-u=uFuGuHuuuuuuuuuuuuuuuuuvv,v3v:v@vFvGv^vevlvsvzv{v|vvvwwwwwwwx xx%x&xNxUx[xbxixkxlxxxxxxxxxxxxxxxyyyyy'y(y?yFyHyOyWyaybyhypyvy~yyyyyyyzzzzt{u{{{{{||}}}}~~_`ȃwx78OPbcnÆH[hip"-;_hio}ʼnƉ|}9:PQab͎̎ҐӐZ[klߕ OPVi|}і/@O`opȗɗ$%@MZgtuǘȘ!"=KYguvՙיٙۙݙޙ"/0КҚԚؚ֚ٚ %&BP^ituśƛ $/0JXftǜԜ՜ &'wʝםٝ"',167W\afklÞĞ { "#tu̡͡Ρԡ()*+,-.68BLM[\htuvwxyzƢǢ΢բ֢ %&09:IJS\]}~ģƣͣԣգ&'()*+,STUVWmnu|}789:STUV[`abckstuv&,01rszĦŦͦѦҦӦԦզ֦צ ()*+,-.XY`ghijklm§çݧާ@AGTefghpxyz{¨ɨ˨̨"*+UV^fg}~թ֩ީ <=DKLMNOPQRS]ghijklm|}~Ī̪ͪ"#&()NOU[\lmsyzȫɫʫ˫̫ͫΫϫЫګ%-.?@GNOrsy¬ʬҬӬԬլ֬׬ج٬ڬ @AKUVWXYZ[pqrst˭̭έխ֭׭ح٭ڭۭ 89@GHIJKLMZ[eopqrstuîĮ̮Ԯծ#$%&'()*+3;<=>?@ABCMWX˱ͱ12,-Ǵȴ޴'(>jkGH]̶RS[rs|Ƿ!Ը ':;XwxùĹڹ%`ab.st./()ABSTj !"fghijuv#+3;CKLMNOPQRST\]^_`abct|  !"#$%&'()8?EKTU\]^_`abcde QRSTijkxy &.6=?IJ^dls{ +,-./078GHIJKLUVdefghirsno"#$9:G]z{ !"#$%&'(<=>?@JKLijk #+56789:;<=Z[\]^fghijklmnRSij>DJKnrtu()^fhi>?@YZ[`efgowxy !"34CD|}$123456789: +,-6;MNOW_`amxyz{|} <CJK$*01_ekl}:@FGuy}~06<=NRVWx~$&'CJQRfhlmnopq|}~9@GHegklmst4z{ -.qr00000000000000000000000000000000000000000000000000000000000000000000000000000 000 00 0000 w0 00000 000000000 0 00 00 0 00 00000 00000 00000 00000 00000 00000 00000 00000 0000@0 @0@0K00d@0@0 @0@0K00d@00-0-0-0 -0 -0 0 w0 0w0 0 w0 0w0 0 w0 0w0 0 w0 0 0 0 w00 00 w00 00 00 00 000000000 00 0 0 00 0 0 00 0 0 00 0 0 @0 @0 @0 @0 @0 @0 00000000 00 0 0 00 0 0 @0K00@0 00 0 0 000000000  000000 00 0 0 00 00 000000 00 0 0 00 000000 000000 00000000000000000 0 0 00 00 0 0 0 0v0 0 0 0 0 0v0 0 0 0 0 0v0 0 0 0 0 0v0 0 0 0 0 0v0 0 0 0 0 0v0 0 0 0 0 0v0 0 0 0 0 0v0 0 0 0 0 0v00 0 0 0 00000000 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0X0 0 0 0 0 0 0X0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0000 0 0000 0 0 0 0 0 00000 0 0 00 0 0 00 0 0 00 0 0 0X0 0 0 0X0 0 0 00 0 0 00 0 000 0 0 000 0 00 0 0 0000000000000000000 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 00 0 0 0 0 0 000 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 0 0 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 0000000000000000K02"$K020K02"K02000000000000000000000000000000000000 0 0 0 0 0 0 0 0 00 000 0 00 000 0 00 000 0 00 000 0 00 000 0 000 0 0 0 00 00000 00000 00000 00000 00000000 0 0 0 0 0 0 0 0 0@0 @0 @0 @0 @0 @0@0 @0 @0 @0@0 @0@0 @0 @0 @0@0 @0000000 00 00 00 0 0 00 0 0 0 0 0 00 0 0 0 0 y0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 000000000000000000000000000000000000000000 0 0 0 0 0 0 0 0 00 0 0 0 0 0 0 0 0 00 0 0 0 00000 00 0 0 0 0 00 0 0000000000000000000000000000000000000000000 0 0 00 0 0 0 0 00 000 0 00 000 0 00 000 0 00 000 0 00 000 0 00 0 00 0 000 0 00 0 00 0 00 0 00 0 0 0 0 00 0 0 0 0 00 000 0 00 000 0 000 0 000000000000000000000000000000000000000000000000000000000 000000 000000 000000 000000 000000 00000000 0 000 0000000000000%0%00 00000 00000 00000 00000 00000 00000 00000 00000 00000 0 0 0 0 0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000'0'000000%0%00 00000 00000 00000 00000 00000 00000 00000 00000 00000 00000 00000 00000 00000 00000 00000 00000 00000 00000 00000 00000 00000 0 00L 0L %0L %0L 0L 0L 0L %0L %0L 0L 0L 0L %0L %0L 0L 0L 0L %0L %0L 0L 0L 0L %0L %0L 0L 0L0L%0L~0L 0L 0L0L%0L~0L 0L 0L0L%0L~0L 0L 0L 0L %0L ~0L 0L 0L 0L %0L %0L 0L 0L 0L %0L %0L 0L 0L 0L %0L %0L 0L 0L 0L %0L %0L 0L 0L 0L %0L %0L 0L 0L 0L %0L %0L 0L 0L 0L %0L %0L 0L 0L 0L %0L %0L 0L 0L 0L %0L %0L 0L 0L 0L %0L %0L 0L 0L 0L %0L %0L 0L 0L 0L %0L %0L 0L 0L 0L %0L %0L 0L 0L 0L %0L %0L 0L 0L 0L %0L %0L 0L 0L 0L %0L %0L 0L 0L 0L %0L %0L 0L 0L 0L %0L %0L 0L 0L 0L %0L %0L 0L 0L 0L %0L %0L 0L 0L 0L %0L %0L 0L 0L 0L %0L %0L 0L 0L 0L %0L %0L 0L 0L 0L %0L %0L 0L 0L 0L %0L %0L 0L 0L 0L %0L %0L 0L 0L 0L %0L %0L 0L 0L 0L %0L %0L 0L 0L 0L %0L %0L 0L 0L 0L %0L %0L 0L 0L 0L %0L %0L 0L 0L 0L %0L %0L 0L 0L 0L %0L %0L 0L 0L 0L%0L%0L0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L %0L 0L 0L 0L 0L %0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L0L0L0L0L 0L0L0L0L0L0L0L0L0L0L0L0L0L0L0L0L0L0L0L0L0L0L0L0L0L0L0L0L0L0L0L0L0L0L0L0L0L0L0L0L0L0L0L0L0L0L0L0L0L0L0L0L0L0L0L0L0L0L 0L 0L0L 0L 0L0L 0L 0L0L 0L 0L0L0L0L0L0L0L0L0L0L0L0L0L0L0L0L0L 0L0L,0L,0L0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L ,0L,0L 0L0L0L0L0L0L0L0L0L0L0L0L0L0L0L0L0L0L0L0L0L0L 0L0L0L0L0L0L0L0L 0L0L0L0L0L0L0L0L 0L0L0L0L0L0L0L0L 0L0L0L0L0L0L0L0L 0L0L0L0L0L0L0L0L 0L0L0L0L0L0L0L0L 0L0L0L0L0L0L0L0L 0L0L0L0L0L0L0L0L 0L0L0L0L0L0L0L0L 0L0L0L0L0L0L0L0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L0L0L0L0L0L0L0L 0L0L0L0L0L0L0L0L 0L0L0L0L0L0L0L0L0L0L0L0L0L0L0L0L0L0L0L 0L0L0L0L0L0L0L0L 0L0L0L0L0L0L0L0L 0L0L0L0L0L0L0L0L 0L0L0L0L0L0L0L0L 0L0L0L0L0L0L0L0L 0L0L0L0L0L0L0L0L 0L0L0L0L0L0L0L0L 0L0L0L0L0L0L0L0L 0L0L0L0L0L0L0L0L 0L0L0L0L0L0L0L0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L 0L0L0L0L0L0L0L0L 0L0L0L0L0L0L0L0L 0L0L0L0L0L0L0L0L 0L0L0L0L0L 0L0L0L0L0L0L0L 0L 0L0L 0L 0L 0L0L 0L0L 0L 0L 0L 0L 0L 0L0L 0L 0L 0L 0L 0L 0L0L 0L 0L 0L 0L 0L 0L0L 0L 0L 0L 0L 0L 0L0L 0L 0L 0L 0L 0L 0L0L 0L 0L 0L 0L 0L 0L0L0L0L0L0L0L 0L0L0L0L0L0L0L0L0L0L0L0L0L 0L0L0L0L0L0L0L 0L0L0L0L0L0L0L 0L0L0L0L0L0L0L 0L0L0L0L0L0L0L 0L0L0L0L0L0L0L 0L0L0L0L0L0L0L 0L0L0L0L0L0L0L 0L0L0L0L0L0L0L0L0L0L#0L0L0L0L#0L0L0L0L#0L0L0L0L#0L0L0L0L#0L0L0L0L#0L0L0L0L #0L0L0L0L #0L0L0L0L#0L0L0L0L#0L0L0L0L #0L 0L 0L 0L #0L0L 0L 0L 0L0L0L0L0L0L0L #0L0L0L0L #0L0L0L0L #0L0L0L0L #0L0L0L0L #0L0L0L0L #0L0L0L0L #0L0L0L0L #0L0L0L0L 0L0L0L0L0L0L0L0L0L0L0L0L0L0L0L0L0L0L0L0L 0L 0L#0L 0L 0L 0L#0L 0L 0L 0L#0L 0L 0L 0L#0L 0L 0L 0L#0L 0L 0L 0L#0L 0L0L0L0L 0L0L0L0L 0L0L0L0L0L0L0L0L0L 0L0L0L0L 0L#0L#0L0L 0L#0L#0L0L 0L#0L#0L0L 0L#0L#0L0L 0L#0L#0L0L %0L0L0L0L %0L0L0L0L %0L0L0L0L 0L#0L#0L0L %0L0L0L0L %0L0L0L0L %0L0L0L0L %0L0L0L0L 0L0L0L0L0L0L0L0L #0L0L0L0L #0L0L0L0L #0L0L0L0L #0L0L0L0L #0L0L0L0L #0L0L0L0L #0L0L0L0L #0L0L0L0L #0L0L0L0L 0L0L0L0L0L0L0L0L 0L0L 0L 0L#0L 0L 0L 0L#0L 0L 0L 0L#0L 0L 0L 0L#0L 0L 0L 0L#0L 0L 0L 0L#0L 0L 0L 0L#0L 0L 0L 0L#0L 0L 0L 0L#0L 0L 0L 0L#0L 0L 0L 0L#0L 0L 0L 0L#0L 0L 0L 0L0L0L0L 0L0L0L0L0L #0L0L0L0L #0L0L0L0L #0L0L0L0L #0L0L0L0L #0L0L0L0L #0L0L0L0L #0L0L0L0L #0L0L0L0L #0L0L0L0L #0L0L0L0L #0L 0L 0L 0L @#0L @0L @0L #0L #0L 0L 0L 0L #0L 0L 0L 0L #0L 0L 0L 0L #0L 0L 0L 0L #0L 0L 0L 0L #0L 0L 0L 0L #0L0L0L0L #0L0L0L0L #0L0L0L0L #0L0L0L0L 0L0L0L0L 0LK0 ; l0 K0 ; Hl0 K0; l0 K0; l0 K0; l0 K0; (m0 K0; `m0 K0; m0 K0; K0;K0;0 K03(w}0 K03`w}0 0 %%%( P ^8H<F k!j"#$X%&Z&E'')+X,^./&0257??K@@AB_CHDDNIJsL*QU+^gaknpsuVw7y{~{ ċ3F٘;88 Oش):(n ]:?84տPc\2r(S^l~f E E/  l]<<} !#$%'()+,-./0234:BDFJLQVWYZ^dfghikloz "&(*07FU^bjpw    p':!Who?r !"!j"""0#z#$T$$%%&Z&C'''2((*))+o,,+-H-n---.^...601L11111*2+2Y2Z222222264844436b6666 7&7E777C?4@I@q@@@EAuAAA(BrBxBBBC4CcCiCCCCDNDyDDI$Uha&rփJtDŽCJz߆ 5zۉJ|E"3`֩EXU٬c YcZ7jNL״"1\a̵ @m/4Z_طݷ0n¸Ǹd \aк#49{Żʻ3^>ѽ8\Ӿ5aտ #HM Q{7W\ot[E'nF:2h`dpACIQ .P[]cw`dpBDJR-OZ\bv*8Njd&HSl}S4^R*Oa| #7Ibf4~Ulpٵݵ6mնٶŷ,FptҸA\`nù7[#lĿ<n<<~    "&*156789;<=>?@ACEGHIKMNOPRSTUX[\]_`abcejmnpqrstuvwxy{|}~    !#$%')+,-./12345689:;<=>?@ABCDEGHIJKLMNOPQRSTVWXYZ[\]_`acdefghiklmnoqrstuvxyz{|}~   !<:J  J)KJKXXXXX !(!!l,b$l?xK-}*1D@(  f  c 6A!SHANDONB S  ?s`8t _Hlt267921118_Hlt267921119 OLE_LINK10 OLE_LINK11 OLE_LINK2 OLE_LINK3_Hlk267059321 OLE_LINK8 OLE_LINK9 OLE_LINK6 OLE_LINK7ΡΡ...~~@@ ӡӡ4uux uw uTw uw uv v$ v䔢 v v vDvvvtv v:  v:  v:  v9 vl< v,< v; vd; v\vvܣvv vԚ vL vlQv,QvPvPv<vvv| vD!v"vĀ#v$v|%v<&v'vd3(v)vI*v+v,v-vV  }22=. ` ` BABAFFFNed>fEfVfVf`fhlrrssvpp^9%33     !"#$%&'()*+,-./0123;EE7 h h PAPAF F FNrdDfIf_fdfdfh%lrrsswuuc>*77   !"#$%&'()*+,-./0123 =!*urn:schemas-microsoft-com:office:smarttags PlaceType="*urn:schemas-microsoft-com:office:smarttags PlaceName:,*urn:schemas-microsoft-com:office:smarttagsStreetB.*urn:schemas-microsoft-com:office:smarttagscountry-region81*urn:schemas-microsoft-com:office:smarttagsCity93*urn:schemas-microsoft-com:office:smarttagsState94*urn:schemas-microsoft-com:office:smarttagsplace;-*urn:schemas-microsoft-com:office:smarttagsaddress< *urn:schemas-microsoft-com:office:smarttagschmetcnvV2*urn:schemas-microsoft-com:office:smarttags PersonNamehttp://www.microsoft.com  01130000001820112012212733000000385430000943610009696000a Cao ChangqiuFalseHasSpaceinNegative NumberType ProductID SourceValueTCSCTrueUnitName432134.-,413443.44"!   "!4"!   444.  4.       4141414141U_[b}{26 i o [ d 9Bnw1:J"P""###n#u#########"$'$($.$x$~$$$/&6&7&=&&&&&&&&&&&&&&&9'?' 0'0B0E0F0L0u0w0x0~00011|11111111^2g222223333T3Z333333333334"4BBBBFFcHiHzHHHHJJJJPP3_8_9aCaEaNacc1c7ceckclcxcccccccccRdXdYd^ddddd>fDfVf_fgghhhhnn9p>p(y/y5;?EV_JP†;C <Mɏoxmn %&w|¯˯V\tz޾3;go%.FO KWz"%.bk 37 LOPV[]ssuuvvxy{|~v! Pxy ` b %%44@@NNPP``bbccccgdodeeh hjkkkllm mnnp"pqqt tvv\wdwmpb-.rSf ssuuvvxy{|~s3333333333333333333333333333333333333v;dYn G Z  = e m 86Mr"Gat.Nv#$5hw,P+b =B.c$= +\\ E!!""T#Q$$%%%%/&e&'''|//0k0q00001151<1B1O1g1n1t111111292W222222223/3L3[3v3y33333333333 44M4^4~[[6hsherssssttGuuuuv,v|v}vvww x&xNxyu{{8Pci;_hiӐmpEOV}И*=ՙ4(Bț0J՜'wʝ"9WlĞ{̡Ρ]~,W:&1sŦצ.YmA+V =ͪ#)OOsAV[ۭ ծXͱȴ޴(>kH]̶SǷԸ Ĺڹ%)BTj "j Ts"$>Knu)^@": -<K$1_:Gu0Wx9t7aA] >HWssuuvvxy{|~ssuuvvxy{|~|qD}NDC~(B* A@eNrޚMr0Liv@KS}@07J A5TV`H2E;(whcr >evV %V[S& q-4#f\e;7v`R70^uEY`Q\F`9iUԽ^ c"V$FB`[z.1nrvr VD WD8^`. TTVDXWD8^T`. VDWD8^`.   VDWD8^ `. VD WD8^`OJQJo(l TTVDXWD8^T`OJQJo(l VDWD8^`OJQJo(l   VDWD8^ `OJQJo(lhhWD8^h`. hhWD8^h`OJQJo(l--^-`o(()  ^` hH0 e e^e` hH. E  E ^E ` hH. %  % ^% ` hH0  ^` hH.  ^` hH.  ^` hH0  ^` hH.8^8`o(. \^`\hH) \^`\hH. ` \^` `\hH.  \^ `\hH)  \^ `\hH. L\^L`\hH. \^`\hH) \^`\hH.8^8`PJo(.  ^` hH0 p ^p` hH. P  ^P ` hH. 0  ^0 ` hH0  ^` hH.  ^` hH.  ^` hH0  ^` hH.9^9`o(() \^`\hH) \^`\hH. a\^a`\hH.  \^ `\hH)  \^ `\hH. M\^M`\hH. \^`\hH) \^`\hH.0^`0o(. H\H^H`\hH) \^`\hH. \^`\hH. 4\4^4`\hH)  \ ^ `\hH. | \| ^| `\hH.  \ ^ `\hH) \^`\hH.hh^h`PJo(0 H\H^H`\hH) \^`\hH. \^`\hH. 4\4^4`\hH)  \ ^ `\hH. | \| ^| `\hH.  \ ^ `\hH) \^`\hH.hh^h`o(.  ^` hH0  ^` hH.  ^` hH. `  ` ^` ` hH0 @  @ ^@ ` hH.    ^ ` hH.  ^` hH0  ^` hH. ^` o(hH.  ^` hH0  ^` hH.  ^` hH. `  ` ^` ` hH0 @  @ ^@ ` hH.    ^ ` hH.  ^` hH0  ^` hH.hh^h`o(. ^` 0 ^` . ^` .`  ` ^` ` 0@  @ ^@ ` .   ^ ` . ^` 0 ^` .p^p`PJo(() P\^P`\hH) \^`\hH.  \^ `\hH. < \^< `\hH)  \^ `\hH. \^`\hH. (\^(`\hH) \^`\hH.0^`0PJo(. H\H^H`\hH) \^`\hH. \^`\hH. 4\4^4`\hH)  \ ^ `\hH. | \| ^| `\hH.  \ ^ `\hH) \^`\hH.hh^h`PJo(. H\H^H`\hH) \^`\hH. \^`\hH. 4\4^4`\hH)  \ ^ `\hH. | \| ^| `\hH.  \ ^ `\hH) \^`\hH.--^-`o(() ^` 0e e^e` .E  E ^E ` .%  % ^% ` 0 ^` . ^` . ^` 0 ^` .^`PJo(() \^`\hH) @\@^@`\hH. \^`\hH.  \ ^ `\hH) , \, ^, `\hH.  \ ^ `\hH. t\t^t`\hH) \^`\hH. ^` PJo(.  ^` hH0  ^` hH.  ^` hH. `  ` ^` ` hH0 @  @ ^@ ` hH.    ^ ` hH.  ^` hH0  ^` hH.e;7S&iU`[c"V A5vV %\FR7~}|1nrcr uEq-E;(N        U        |:        TL        ^n                m2o                 4S        |d0]        kP                                ހ        4qAP } GrP b b**h40p{~,h40!xqSwN!EOEb[!.}R"LkW= ,'DZ4+GQF.. ^9mMP3go63QF.. ^9} >:! LkW=@X]'4?WelCc8lEz#3e EOE ,'G$-_H~aOvR8QvR(qo.}RuaeMSv }nxKU4+uprW8QDZ@X]uprW$-_aeMSz#3eb[!We~v jbc8lEl"v }n(qoHgo>:xq63Gro {u~aO~v$IlwqAt${z$Ilwo {p{~'4?bSwN!)| ;4e 6XIX!dh:C- ! 5 " $ #: ` %/ u/ @ @ _ d9-bPq9E ;%^}1Cel :8$]e3A}EETd ,%o >1 h | +!{q!x!p"#A$u|$@C%!S%t%l&&S("v(5)%*+\I,-4$.9.)/9`/{/U0X0_21h1X2E4)5ua5B5&6]6i8|F8959B9K9e9;=;7 <S= >H>X>T,?N^?@*@+@?@KP@A&ABABDITI 5JMJKlI6Tl'gqug9Yw5[[L]=q_^ezt )&;M/' 17<'\ 3IZ2iIi7vY!U4SdX'D7y&Opr]x5TAen (jVCOt"}=TY'x{_} nF'*1@u~x#w+z ,Tcx %?.L@)WX+L_+9XjV;?yhx7CG}~^c`(7 t :4k |/rSX },~^26 {=2~:) /82;<Er^mFHZ65|}'MnT5O:wm:L{;M4N:YFGafkst.38MNv 45hwPQ,JKPy#*+bipq  #-.@LXYs|<=Bx.<J[lm cp}G$=Z[ "$&(*+\ho{     5 A H T [ \ !!!!!"@"A"""""""""""""""/#T#_#d#f#h#i#v#####################$$$$$!$"$/$?$G$L$N$P$Q$$$$$$$$$% %%%%%%%%%%%%%&&%&.&/&e&p&y&z&&&&&&&&&&&&&&&&&''''''''''''|//////0000000000000(0105090=0>0M0d0h0l0p0q000000001 111115191=1A1B1O1g1k1o1s1t111111111111122262:2>2?2@2A2B2C2D2E2R2S2T2U2V2W2h2222222222222222333#3'3+3/303132333435363G3H3I3J3K3L3[3r3v3z3~333333333333333 44444'494=4A4E4F4L4M4S4W4]4^4(58:KM}[jmmq?rerxrrrrrrrrrrrrrrrrrssss s(s0s8s@sAsHsOsVs]sdsesksussssssssstt$t4tDtMtNt[tkt{tttttttttt uuuu-u=uFuGuuuuuuuuuuuuuuuuvv,v3v:v@vFvGv^vevlvsvzv{vwwwww xx%x&xNxUx[xbxixkxlxxxxxxxxxxxxxxxyyyyy'y(y?yFyHyOyWyaybyhypyvy~yyyyǃDcnÆH[hip"-;_hio}PVi|}і/@O`opȗɗ$%@MZgtuǘȘ!"=KYguvՙיٙۙݙޙ"/0КҚԚؚ֚ٚ %&BP^ituśƛ $/0JXftǜԜ՜ &'wʝםٝ"',167W\afklÞĞ { &̡͡Ρԡ()*+,-.68BLM[\htuvwxyzƢǢ΢բ֢ %&09:IJS\]}~ģƣͣԣգ&'()*+,STUVWmnu|}6789:STUV[`abckstuv&,01rszĦŦͦѦҦӦԦզ֦צ ()*+,-.XY`ghijklm§çݧާ>@AGTefghpxyz{¨ɨ˨̨"*+UV^fg}~թ֩ީ <=DKLMNOPQRS]ghijklm|}~Ī̪ͪ"#&()NOU[\lmsyzȫɫʫ˫̫ͫΫϫЫګ%-.?@GNOrsy¬ʬҬӬԬլ֬׬ج٬ڬ @AKUVWXYZ[pqrst˭̭έխ֭׭ح٭ڭۭ 89@GHIJKLMZ[eopqrstuîĮ̮Ԯծ#$%&'()*+3;<=>?@ABCMWX˱-Ǵȴ޴'(>jkGH]̶RS[rs|Ƿ!Ը ':;XwxùĹڹ%`aSTj "fghij#+3;CKLMNOPQRST\]^_`abct|  !"#$%&'()8?EKTU\]^_`abcdeQRSix &.6=?IJ^dls{ +,-./078GHIJKLUVdefghirs"#$9G]z !"#$%&'(<=>?@JKijk #+56789:;<=Z[\]^fghijklmn>DJKnrtu()^fhi?@YZ[`efgowxy !}$123456789: +,-;MNOW_`amxyz{|} <CJK$*01_ekl}:@FGuy}~06<=NRVWx~$&'CJQRfhlmnopq|}~9@GHegklt34_`az{| #z-.pqrZI }wU==a2a2a2a2!7!7y0!7!7!7!7!7a2a2!7)r!7^@Tvv mmm$%GH̖̔̕EE @ @$@0@"$L@4l@X@T@@@@h @ @x @Unknown Lenovo UserStephen TsangUserGz Times New Roman5Symbol3& z ArialKE  .DFKai-SBPMingLiU;[SOSimSunC .PMingLiUe0}fԚ9: ZWAdobeF3Times] Times-BoldTimes New Roman_ Times-RomanTimes New Roman] HelveticaNeueLTStd-LteckSOU Arial Unicode MSArial;ўSOSimHei?5 z Courier New[DFPFangSongW4-B5PMingLiU?A  eckwiSO_GBKўSO;Wingdings F $j{ $j{!xxd**2qHX?O2 2006 ANNUAL RESULTS ANNOUNCEMENTWonderful SkyhggSfp                    Oh+'0(8 HT t  $2006 ANNUAL RESULTS ANNOUNCEMENTWonderful Sky$generated by an Adobe applicationNormal262Microsoft Office Word@ax@NՀ@D[3-@` i $j՜.+,D՜.+,  `h Wonderful Sky{  8@ _PID_HLINKSAD{- @http://www.lrqa.co.uk/standards-and-schemes/food/fssc22000.aspxRF http://www.cninfo.com.cn/?mailto:xhzy@xhzy.comOGhttp://www.xhzy.com/yPmailto:guolei@xhzy.com  !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~     !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~     !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~     !"#$%&'()*+,-./012345679:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~     !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~     !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~Root Entry FPData 81TableWordDocumentnSummaryInformation(DocumentSummaryInformation8CompObjm  FMicrosoft Office Word ĵ MSWordDocWord.Document.89q